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SUMMARY
SUMMARY
Bone turnover is regulated by a cocktail o f hormones and signalling factors 
controlling key cell processes such as proliferation, differentiation, 
mineralisation and apoptosis. Disruption to the overall mineralisation- 
resorption balance leads to bone disorders, such as osteoporosis -  a ‘silent’ 
disease affecting around 7 million people in England and Wales. Ion channels 
that are presumed targets for bone signalling factors include voltage-gated K+ 
channels, ATP-dependent K+ channels and transient receptor potential (TRP) 
channels, and several of these channel-types reportedly have roles in cell 
proliferation, apoptosis, and differentiation in various tissues. This Thesis 
shows that human osteoblasts express a number of channels in these families, 
including maxi-K, ATP-dependent K+ channels, TRPV1 and TRPM7. The 
maxi-K channel, displaying characteristic electrophysiological hallmarks, is 
abundant in patch-clamp recordings o f primary human osteoblasts implying a 
functional role, and the K a t p  agonist pinacidil is shown to promote osteoblast 
proliferation. Electrophysiological evidence for the TRPV1 channel is not 
found, although the mRNA signal for a TRPVI splice variant (TRPVlb) may 
provide an answer, as it renders the channel less sensitive to capsaicin and 
protons. However, Ca imaging indicates that osteoblastic TRPV1 channels 
allow Ca2+ influx, and are sensitive to 1 pM capsaicin and protons. In 
functional studies the TRPV1 ligands capsaicin and capsazepine do not 
influence mineralisation, but interestingly the TRPV1 agonists capsaicin, 
resiniferatoxin and anandamide appear to prevent differentiation o f osteoblastic 
pre-cursor cells to adipocytes, and instead encourage maturation along the 
osteoblast pathway, whilst TRPV1 antagonists do not affect adipocyte 
differentiation. In conclusion, a number o f K+ channels and the TRPV1 
channel are expressed in osteoblasts and may have important putative roles in 
osteoblast cell function. Further steps are required to confirm this before the 
channels can be considered targets for drug development to treat bone 
disorders.
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CHAPTER 1: INTRODUCTION
1 INTRODUCTION
1.1 Outline
Bone tissue is in a constant dynamic state, balanced between the removal of old 
bone by resorptive osteoclasts and the construction of new bone by 
mineralizing osteoblasts, to allow growth and repair o f the tissue, and to 
maintain blood-plasma calcium homeostasis. The proliferation, differentiation, 
secretion and apoptosis of osteoblasts and osteoclasts are finely tuned to ensure 
that bone mineral density (BMD) is maintained during remodelling. Disruption 
of the mineralisation-resorption equilibrium results in bone disorders such as 
osteomalacia, Paget’s disease and osteoporosis: the latter of these affects 1 in 2 
women and 1 in 5 men over the age o f 50 in England and Wales (van Staa et 
al., 2001) which approximates 7 million people, and hip fractures in women 
due to osteoporosis cost the NHS £1.73 billion per annum in treatment and 
respite (National Osteoporosis Society, 2006). Osteoblast functions are 
regulated by hormones, signalling factors, growth factors and ion channels, and 
osteoblasts secrete signalling factors such as osteoprotegerin and receptor 
activator of nuclear factor kappa B ligand (RANKL), which regulate osteoclast 
differentiation. Therefore osteoblasts are important not only for the synthesis of 
bone, but also in controlling bone resorption (Mackie, 2003). A variety o f ion
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channels have been identified in osteoblasts, which are putative target receptors 
for hormones, signalling factors, cytokines, etc. It is emerging that this 
complement of ion channels includes voltage-gated K+ channels, ATP- 
dependent K+ channels and transient receptor potential (TRP) channels -  a 
large and diverse superfamily o f cation channels that are permeable to Ca , 
Mg2+, Na+, K+ and other monovalent cations. Interestingly, many TRP 
channels have recently been shown to have roles in cell proliferation, 
apoptosis, and differentiation in a variety o f tissue and cell types and several 
specific TRP channels, such as TRPV1, TRPM7, TRPV5 and TRPV6, likely 
have roles in osteoblast cell function (Abed & Moreau, 2007; Arnett, 2008; 
Brandao-Burch et al., 2006; Elizondo et al., 2005; van der Eerden et al., 2005; 
Hoenderop et al., 2003a). The cellular influx of Ca2+ and Mg2+ ions is 
important for many cellular functions including proliferation, differentiation, 
secretion and apoptosis (Berridge et al., 2000) and Ca2+ signalling is known to 
be implicated in osteoblast cell functions (e.g. Labelle et al., 2007). Whilst the 
roles of TRP channels in osteoblast cell function are becoming more evident, 
only the tip o f the iceberg has been uncovered and the full remit of TRP 
channels in these cells has yet to be defined. In the search for new therapeutic 
strategies for the treatment of bone diseases such as osteoporosis, TRP 
channels are potential targets for drug treatments which warrants further 
investigation in this field. The introduction to this Thesis describes the 
background to the problem o f bone diseases, the current situation with regard 
to ion channel functionality in bone, gives an overview of the superfamily of 
TRP channels, and finally presents the aims and objectives of the Thesis.
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1.2 Bone and bone disorders
1.2.1 Bone
Bone is a dynamic tissue that is constantly being remodelled, depending on a 
fine balance between the removal of old bone by resorption and the 
construction of new bone by mineralisation (Hadjidakis & Androulakis, 2006). 
Osteoclast cells dissolve the mineral matrix while osteoblast cells secrete 
collagenous and non-collagenous components of bone matrix to promote 
mineralisation (Eriksen, 1986). Cellular proliferation, differentiation, secretion 
and apoptosis are critical to ensuring that bone mineral density (BMD) is 
maintained (Abed & Moreau, 2007). A short description of bone composition 
and regulation follows.
1.2.1.1 Bone composition
The osseous (mineralised) tissue of bone is composed mostly of calcium 
phosphate, which in bone is deposited as calcium hydroxyapatite, 
Caio(P0 4 )6(OH)2 (Weiner & Traub, 1992). Osteoblasts secrete bone matrix in 
the form of osteoid containing collagens and alkaline phosphatase, causing 
dephosphorylation and allowing Ca2+ and phosphate crystals to form (Ali et al., 
1970; Anderson, 2003). The non-osseous component of bone is collagen which 
provides some elasticity to an otherwise fragile structure (under tensile 
strength) (Viguet-Carrin et al., 2006). Two basic ‘types’ o f osseous bone are 
constructed by the processes carried out by osteoblasts and osteoclasts: cortical 
bone (also known as compact bone) is dense and forms the outermost layers of 
bone, and trabecular bone (also called cancellous bone) is sponge-like in
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construction, forming lots of space for blood vessels and marrow and making 
bone light whilst retaining strength (Hadjidakis & Androulakis, 2006).
1.2.1.2 Cellular complement
It has been stated above that bone formation and destruction are tasks carried 
out by osteoblasts and osteoclasts respectively, but bone also contains other 
cells as described here, and also in Figure 1.1.
Osteoblasts are osteoid-producing cells that are responsible for promoting 
mineralisation and bone construction. These cells also secrete hormones and 
signalling factors which act upon osteoblasts themselves, or on osteoclasts, and 
therefore osteoblasts are able to partly regulate the entire cycle of bone 
remodelling. Parathyroid hormone, oestrogens and androgens are examples of 
osteoblast-regulating hormones (Pugsley & Selye, 1933; Endoh et al., 1997; 
Notini et al., 2007). Osteoblasts are formed from osteoprogenitor cells found 
mainly in the bone marrow and periosteum, which differentiate in response to 
growth factors including fibroblast growth factor (FGF), platelet derived 
growth factor (PDGF), transforming growth factor (TGF) and bone 
morphogenetic proteins (BMPs) (Datta et al., 2008; Karsenty & Wagner, 
2002). Markers o f osteoblastic formation and activity include alkaline 
phosphatase (ALP), osteocalcin and the master regulatory factor RUNX2 (runt- 
related transcription factor 2) (Ducy et al., 1997).
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Figure 1.1 Illustration of cells required for normal bone turnover.
Osteoprogenitor cells differentiate into osteoblasts under the influence of 
RUNX2 and osterix. Osteoblasts mineralise new bone matrix, and embedded 
osteoblasts become osteocytes which have a putative paracrine role. 
Osteoclasts resorb bone and are influenced by RANKL and osteoprotegerin 
signalling from osteoblasts.
As the mineral matrix is formed, osteoblasts become trapped within, stop 
producing osteoid and promoting mineralisation and become osteocytes, the 
roles of which are unclear but may be involved in mechanosensation and 
paracrine signalling (Han et al., 2004; Marotti, 2000; Zhao et al., 2000).
Osteoclasts are large, multinucleate bone-destroying cells that work in 
opposition to osteoblasts. Osteoclasts form resorption pits in the mineral matrix 
by secreting enzymes to disrupt the mineralised tissue and solubilise it for 
resorption. Like osteoblasts, osteoclasts are subject to hormonal, cytokine and
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other forms of chemical stimuli, in particular receptor activator for nuclear 
factor kappa B ligand (RANKL) and osteoprotegerin which are secreted by 
osteoblasts, and are inhibitory to osteoclast activity (Takahashi et al., 1988; 
Yasuda et al., 1998).
1.2.2 Bone disorders
1.2.2.1 Osteoporosis
Osteoporosis is a disorder of the skeleton in which the bone mineral density is 
diminished and the trabecular bone microarchitecture is weakened, leading to 
fragility and increased risk of fracture (see Figure 1.2). The morbidity of 
osteoporosis is far higher in the elderly than the young and is therefore 
typically, though not exclusively, a disease of the aging: postmenopausal or 
ovariectomised women are at risk of osteoporosis due to lower levels of the 
bone-promoting female sex-hormone oestrogen, and to a lesser extent men are 
also at risk from middle-age onwards when levels of the male sex-hormone 
testosterone begin to decrease. In England and Wales alone, 1 in 2 women and 
1 in 5 men over the age of 50 years can expect to sustain a fracture, probably 
due to osteoporosis (van Staa et al., 2001) which is a staggeringly high cohort 
of this age-group, and approximates to 7 million people. To put this into 
context, the projected risk of fracture in women from 50 years old is greater 
than the risk of breast cancer or cardiovascular disease (WHO study group, 
1994). The financial burden to the NHS of treating hip fractures in the elderly 
is approximately £1.73 billion per annum and is comparable to the cost of
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treating coronary heart disease at £1.75 billion per annum (National 
Osteoporosis Society, 2006).
Risk factors that further increase the likelihood or severity of osteoporosis 
include genetics (Kanis et al., 2004a), prolonged periods of low physical 
activity (Bonauiuti et al., 2002; Wallace & Cumming, 2000), history of poor 
calcium and vitamin D intake (Tang et al., 2007; Dept, of Health, 1998) 
(particularly important up to the age of 25), menopause or hysterectomy with 
ovariectomy (Aitken et al., 1973), tobacco smoking (Kanis et al., 2004b; Wong 
et al., 2007), high alcohol consumption (Berg et al., 2008; Khanis et al., 2005), 
and medication -  particularly chronic use of glucocorticoids (Bone and Tooth 
Society of Great Britain, National Osteoporosis Society, & Royal College of 
Physicians, 2003; McKenzie et al., 2000), but also antiepileptics (Petty et al.,
2007), peroxisome proliferator-activated receptor-y (PPARy)-inhibitors 
(Murphy & Rodgers, 2007), and many others.
A B
Figure 1.2 Low-power scanning electron microscope images of (A) normal 
bone in the 3rd lumbar vertebra of a 30 year old woman, and (B) osteoporotic 
bone in the 3rd lumbar vertebra of a 71 year old woman. Notice the eroded, 
thin rods of bone in (B) resulting in bone fragility, which is characteristic of 
this disease. (Images courtesy of T. Arnett, downloaded June 2008. 
http: //www.anat.ucl.ac.uk/research/amett lab/gallery.html).
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1.2.2.2 Diagnosis, prognosis and current treatments fo r  osteoporosis
Osteoporosis is a disease which is symptom-free or has no specific symptoms 
and is usually only identified after a fracture. Because of this, it has been called 
the ‘silent epidemic’ (Kanis, 1989). Diagnosis is made by measuring bone 
mineral density (BMD) by dual energy x-ray absorptiometry (DEXA) 
scanning, which calculates absorbance by bone of two x-ray beams of different 
energies -  the principle is the higher the absorbance, the higher the BMD 
(Sartoris & Resnick, 1989). A T-score is given which is a comparison of the 
patient’s BMD with that of a 30-year old of the same sex, and osteoporosis is 
diagnosed when the T-score is -2.5 or lower (i.e. 2.5 standard deviations below 
the mean o f the compared 30-year old BMD) (WHO Scientific Group, 2003). 
The prognosis for patients with osteoporosis depends on the severity of the 
disease and whether they sustain serious fractures, such as hip or vertebral 
fractures. Complications from sustaining serious fractures lead to an increased 
mortality, but generally patients do not die of osteoporosis itself.
Current treatments include weight-bearing exercise, a nutritious diet often with 
calcium and vitamin D supplements, and medication (Bonaiuti et al., 2002; 
Tang et al., 2007). The mainstay of medical intervention is the group of drugs 
known as bisphosphonates (BNF 54, Sept. 2007), which inhibit osteoclast bone 
resorption by either disrupting ATP metabolism or preventing prenylation, and 
ultimately forcing osteoclasts to undergo apoptosis (Fleisch, 2002; Frith et al., 
1997; van Beek et al., 1999). Other treatments include teriparatide which is a 
synthetic parathyroid hormone analogue which stimulates osteoblasts to
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proliferate and mineralise, strontium ranelate which promotes osteoblast 
function and inhibits osteoclast activity (Meunier et al., 2004), and hormone 
replacement therapy (HRT) which replaces lost oestrogens in post-menopausal 
women (Villareal et al., 2001).
1.2.2.3 Other bone disorders
Osteoporosis is not, of course, the only bone disorder but it is certainly the 
most prevalent (e.g., Zmuda et al., 2006). Other bone disorders include 
osteomalacia (rickets) which is characterised by ‘soft’ bones due to much 
reduced mineralised matrix (Lips, 2006), osteogenesis imperfecta (brittle bone 
disease) which is caused by a mutation in the collagen gene (Martin & Shapiro, 
2008), Paget’s disease which is characterised by localised remodelling 
abnormalities producing deformities (Ralston, 2008), and bone cancers which 
can be ‘lytic’ or ‘blastic’ (Lipton et al., 2001), meaning respectively that the 
bone is dissolved or heavily overgrown.
1.3 Ion channels and receptors in bone
The evidence in the literature with regard to ion channels and receptors in bone 
will now be reviewed, beginning with what was known at the outset of this 
work in January 2005.
1.3.1 Functional ion channels in non-excitable cells
At the beginning o f 2005, there was a growing body of evidence indicating that 
ion channels were involved in a variety of key cellular processes of non-
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excitable cells, such as proliferation, apoptosis and secretion. For example, 
several ion channels were found to be implicated in tumour growth and 
metastasis suggesting important roles in proliferation, including various 
voltage- and ligand-gated K+ channels (Farias et al., 2004; Klimatcheva et al., 
1999; Pardo et al., 1999; Parihar et al., 2003; Wang, Z. 2004), chloride 
channels (Shuba et al., 2000) and voltage-dependent Ca2+ channels (VDCCs) 
(Wang et al., 2000).
In particular, voltage-gated K+ channels, previously thought to be limited to 
excitable cells and which control firing patterns and repolarisation rate 
following an action potential in nerve cells (Hille, 2001), were found to have 
important physiological roles in cell proliferation of immune and cancer cells 
(Leonard et al., 1992; Wonderlin & Strobl, 1996; Chandy et al., 2004) and 
secretion in osteoblasts (Moreau et al., 1997). Ligand-gated K+ channels, such 
as ATP-dependent K+ (Katp) channels, also have recognised roles in non- 
excitable cells; for example, Katp channels are involved in secretion of insulin 
from pancreatic (3 cells (Aguilar-Bryan & Bryan, 1999). Involvement of Katp 
channels in proliferation has also been shown in cancer cells (Wondergem et 
al., 1998), nephrons (Braun et al., 2002) and in hair growth (Goldberg et al.,
1988). Clearly, important physiological roles for K+ channels were being 
unveiled in non-excitable cells, undoubtedly with more roles yet to be 
identified.
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At the same time, an entirely new and exciting family of ion channels had 
recently been identified which became known as transient receptor potential 
(TRP) channels, owing to the transient Ca response observed in a mutant 
Drosophila TRP channel (see section 1.4). This ion channel family, which is 
non-selective and is permeable to Ca2+, Mg2+ and monovalent cations, was 
showing signs of a diverse range of functions and the family appeared to be 
expressed in a wide variety of excitable and non-excitable tissues. TRP 
channels were found to be involved in various sensory processes, including 
temperature sensation (Caterina et al., 1997; McKemy et al., 2002; Peier et al., 
2002a), mechanosensation (Corey, 2003; Nauli et al., 2003), osmosensation 
(Liedtke et al., 2000; Strotmann et al., 2000) and pain (Caterina et al., 1997; 
Caterina et al., 2000; Story et al., 2003). But as with the K+ channels, TRP 
channels which were originally discovered in excitable tissues were beginning 
to emerge as putative key players in vital non-excitable cell processes: for 
example, the cold-sensitive channel TRPM8  was found to be upregulated in 
androgen-sensitive prostate cancer, implying a role for this channel in cell 
proliferation (Tsavaler et al., 2001; Zhang et al., 2004) and TRPM7 was shown 
to be vital for cellular Mg2+ uptake and progression through the cell cycle 
(Nadler et al., 2001; Schmitz et al., 2003). Although in the early stages of 
discovery, TRP channels were showing promise as functional channels in non- 
excitable cells.
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1.3.2 The evidence for functional ion channels in bone
The proliferation, differentiation and secretory properties of osteoblast cells in 
vivo are intrinsically regulated by a cocktail of hormonal and signalling factors 
to maintain the correct balance between bone resorption and bone production. 
The plasma membranes of osteoblasts are found to be suitably decorated with a 
complement of ion channels and receptors which are putative targets for 
oestrogens (Endoh et al., 1997; Lieberherr et al., 1993), androgens 
(Vanderschueren et al., 2004), prostaglandins and other inflammatory 
cytokines (Moreau et al., 1996; Rezzonico et al., 2002), neuro-excitatory 
amino acids such as glutamate (Gu et al., 2000; Gu et al., 2002), adenosine and 
other nucleosides and nucleotides (Hoebertz et al., 2003), parathyroid hormone 
(Ryder & Duncan, 2001), and calcium (Dvorak et al., 2004; Dvorak & 
Riccardi, 2004) to name but a few. All the above are known to influence bone 
turnover.
By early 2005, the complement of ion channels found in osteoblasts and 
osteoprogenitor cells with evidence of putative involvement in the regulation of 
bone function included an inward rectifier K+ channel (Yellowley et al., 1998), 
Katp channels (Moreau et al., 1997; Gu et al., 2001a), Ca2+-activated K+ 
channels including a small conductance Ca2+-activated K+ channel (Gu et al., 
2001a), an intermediate conductance Ca2+-activated K+ channel (Weskamp et 
al., 2000) and a large conductance Ca2+-activated K+ channel (Moreau et al., 
1996; Moreau et al., 1997; Rezzonico et al., 2002; Rezzonico et al., 2003; 
Weskamp et al., 2000), TTX-insensitive Na+ channels (Richter & Ferrier,
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1991), voltage-dependent calcium channels (VDCCs) (Gu et al., 2001b; Hattori 
et al., 2001), a volume-sensitive Cl channel (Steinert & Grissmer, 1997) and 
mechanosensitive cation channels (Davidson et al., 1996; Duncan & Hruska, 
1994). By implication, TRPV5 was thought to be expressed in mouse bone 
(Hoenderop et al., 2003b) as TRPV5 ~~ mice were phenotypically 
underdeveloped skeletally.
It is worth noting that such a large complement of ion channels and receptors in 
cultured cells may well be an artefact of the culture conditions, rather than a 
true representation of the expression of these proteins in vivo (e.g. see Ma et 
al.,. 2005). But given the role of osteoblasts in bone, it must be presumed that 
some of these ion channels and receptors are involved in the proliferation, 
differentiation, secretion or apoptosis of these cells.
L3.2.1 i f  channel functions in bone
In osteocytes, K+ channels and VDCCs were shown to be involved in paracrine 
signalling and mechanotransduction (Gu et al., 2001a; Gu et al., 2001b). In 
osteoblasts, the Ca2+-activated K + channels appear to contribute to cell volume 
(Weskamp et al., 2000) and to resting membrane potential (RMP); Kca channel 
activation would hyperpolarise the membrane, which may balance the 
depolarisation associated with [Ca2+]j increases, thus regulating [Ca2+]j by 
feedback (Moreau et al., 1996; Ravesloot et al., 1990; Yellowley et al., 1998). 
The large conductance calcium-activated K+ channel, maxi K+, and K a t p  
channels have been shown to be involved in osteocalcin secretion by
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osteoblasts (Moreau et al., 1997) and presumably have roles in other vital cell 
processes (see above).
1.3.2.2 TRP channel functions in bone
By the end of 2004, there was very little evidence of TRP channel expression 
in bone, let alone any evidence for functional TRP channels. However, one 
encouraging publication reported that the phenotypes of TRPV5-knockout 
mice showed reduced bone thickness and hypercalciuria (Hoenderop et al., 
2003b). This implied a role for TRPV5 in osteoblast proliferation and 
secretion.
1.3.3 The thesis: which way forward?
The outline plan for the thesis was to research an ion channel or group of ion 
channels and investigate the electrophysiology and functional aspects of the 
channels in human osteoblasts. Given the literature at the end of 2004, there 
were two groups of ion channels which clearly showed potential as important 
regulators of osteoblast cell functions; namely the Ca2+-activated K+ channels 
(in particular maxi K +)  and the K a t p  channels. There was growing evidence for 
these as functional channels in a variety of non-excitable cells, including 
osteoblasts, with roles in proliferation, apoptosis and secretion (see above). In 
addition to this, evidence for functional TRP channels in non-excitable cells 
was beginning to build. These channels were relatively newly discovered and 
functions appeared to be extraordinarily diverse, but these channels potentially 
also had important roles in key cellular processes.
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Whilst the K+ channels could be considered a relatively safe bet for developing 
the understanding of their functions in osteoblasts, the TRP channels were 
more of a long-shot with only a modicum of evidence in comparison, but were 
attractive due to their novelty and potential for discovery.
With this in mind, the path chosen to follow was that of TRP research in 
human osteoblasts. The original thesis was that TRP channels would be found 
to be expressed and functional in human osteoblasts and osteoblast-like cells, 
with the aim to investigate a selection of promising TRP channels, and that at 
least one of these would have an important role in cell proliferation, secretion, 
differentiation or cell death. The choice of TRP channels to research was to 
include TRPM8  (given its putative role in proliferation), TRPV1 (due to 
relatively well defined pharmacology), TRPV5 and TRPV6  (as highly Ca2+ 
permeable channels, which may be of particular interest in bone), and TRPM7 
(which had evidence for importance in cell progression). In addition, due to the 
obvious importance of K+ channels in non-excitable cell functions, and rather 
than neglect this entirely, a short investigation into the expression and 
functions of maxi-K+ and K At p  channels would be pursued at the outset, and 
for purposes of comparison with TRP channels.
What now follows is a review of the evidence to date, which has been 
published during the work for this thesis.
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1.3.4 Ion channels and receptors in bone: an update
Since the beginning of the research for this thesis, there have been a number of 
important publications in the fields of TRP channels and K+ channels in bone 
cells and other non-excitable cells. Some of the ideas and opportunities created 
by the data published during this time were able to be incorporated into this 
Thesis.
Some particularly interesting findings have recently been reported in the field 
of ion channels and receptors in bone, including identification of functional 
adenosine receptors (Notini et al., 2007; Vanderschueren, et al., 2008) and 
androgen receptors (Evans et al., 2006; Orriss et al., 2006), which have clear 
implication for growth and proliferation. Extracellular calcium concentration is 
now known to regulate the expression of parathyroid hormone-related peptide 
(Ahlstrom et al., 2008), thus in turn regulating bone turnover by switching 
osteoclasts and osteoblasts on or off. In addition, the complement of ion 
channels known to be expressed in bone cells has increased, and now includes 
a two-pore domain K+ channel in osteoblasts which may have a role in 
mechanotransduction and promote bone remodelling (Hughes et al., 2006), a 
TTX-sensitive Na+ channel (Li et al., 2005; Li et al., 2006) (a TTX-insensitive 
Na+ channel was reported previously -  see above), chloride channels (C1C-3 
and C1C-7) which promote osteoclastic bone resorption (Okamoto et al., 2008), 
and further evidence of voltage-gated K+ channel expression, including maxi 
K+ (Li et al., 2005; Li et al., 2006).
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The number of identified roles for K+ channels in non-excitable cells has 
expanded to now include apoptosis (Burg et al., 2006) and further evidence 
strengthens the arguments for the involvement of maxi K+ channels, and 
various other K+ channels, in cancer cell proliferation (e.g. Bloch et al., 2005; 
Kunzelmann, 2005) and cell volume regulation (Lang et al., 2007).
Similarly, the number of reports of TRP channels expressed in bone and other 
non-excitable cells has increased during this project from very little 
(Hoenderop et al., 2003a), to an encouraging list of expressions and functions 
in a wide variety of tissues. Further evidence has been reported for the 
increased expression of the cold-sensitive channel TRPM8  in early stage 
androgen-sensitive prostate cancer compared with normal tissue, and that this 
channel down-regulates in line with androgen receptor expression, and 
therefore androgen-sensitivity, and metastasis (Bidaux et al., 2005; Zhang & 
Barritt, 2006). TRPV6 , a highly calcium-selective cation channel, may also be 
implicated in prostate cancer proliferation (Lehen’kyi et al., 2007) and as 
TRPV6  expression is mediated by vitamin D (Taparia et al., 2006), channel 
expression in bone could have implications for calcium regulation. Bianco et 
al., (2007) show that TRPV6  appears to play a role in calcium homeostasis of 
the bone. TRPV1 has also been shown to have altered levels of expression in 
prostate and bladder cancers compared to normal tissues/cells (Lazzeri et al., 
2005; Sanchez et al., 2005) and capsaicin appears to inhibit androgen-sensitive 
prostate cancer progression (Mori et al., 2006).
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Recent publications have shown that various TRP channels are expressed in 
osteoblasts, osteoclasts and osteoprogenitor cells, in which they appear to have 
roles in fundamental bone cell functions. The highly calcium-selective TRPV5 
channel expressed in osteoclasts appears to be necessary for normal 
osteoclastic function including resorption (van der Eerden et al., 2005). 
TRPM7 expression is reportedly important for osteoblast cell proliferation 
(Abed & Moreau, 2007) and TRPM7 mutations in dwarf zebrafish result in 
defective skeletogenesis phenotypes (Elizondo et al., 2005). Ghilardi et al. 
(2005) have shown that TRPV1 block relieves bone cancer pain, implicating 
these channels in this particular pain pathway. TRPV1 is also expressed in 
human osteoclasts and has a putative role in resorption activity (Brandao-Burch 
et al., 2006), and Arnett’s group has extensively researched the effects of pH 
changes on osteoclast and osteoblast activity, and TRPV1 is emerging as a 
candidate for the sensor of extracellular pH changes in these cells (Arnett, 
2008).
1.3.4.1 Osteoporosis: obesity o f  the bones?
Two disorders of tissue composition, obesity and osteoporosis, were previously 
thought to be unrelated, but studies now show similarities between these 
disorders, with common genetic and environmental factors (e.g. Zhao et al.,
2008). With age, bone marrow adipocyte content increases, osteoclast activity 
increases and osteoblast activity decreases leading to osteoporosis (Rosen & 
Bouxsein, 2006). Thompson et al. (1998) reported that adipocytes and 
osteoblasts have a common precursor cell, and that differentiation into
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adipocytes occurs at the expense of osteoblast maturation. Further supporting 
the link, several factors and hormones secreted by adipocytes directly influence 
osteoblast and osteoclast functions and therefore fatty tissue may play a part in 
regulating bone turnover and composition. For example, leptin, the appetite- 
suppressant hormone derived from adipocytes, influences bone turnover (Zhao 
et al., 2008) and may also promote differentiation of mesenchymal stem cell 
precursors into osteoblasts, rather than adipocytes (Thomas et al., 1999). Also, 
the inflammatory cytokine interleukin- 6  (IL-6 ), which is secreted by 
adipocytes, influences bone turnover either as a resorptive factor (Roodman,
1992) or by promoting proliferation or differentiation of osteoblasts (Taguchi 
et al., 1998; Yoshitake et al., 2008), although it appears not to be essential for 
normal bone turnover (Franchimont et al., 2005).
Importantly, an interesting and very recent publication shows that TRPV1 is 
expressed in 3T3-L1 mouse pre-adipocyte cells, and implicates TRPV1 in the 
regulation o f precursor cell differentiation into mature lipid-producing 
adipocytes (Zhang et al., 2007). What remains unanswered by this article and 
by the findings o f Thompson et al. (1998) discussed above, is whether TRPV1 
has a role in regulating the differentiation of common precursor cells into either 
adipocytes or osteoblasts. Clearly, if this is the case, this would make TRPV1 
an obvious target for novel drug treatments of diseases such as osteoporosis.
Given that the major focus o f this thesis is on TRP channels in osteoblasts, an 
up-to-date overview o f TRP channels now follows, which introduces the
20
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structures, putative functions and electrophysiological characteristics of the 
TRP channel superfamily, and the TRP channelopathies currently known. An 
overview of the K + channels (Ca2+-activated K + channels and K a t p  channels) 
investigated in this thesis can be found in the introduction to chapter 3.
1.4 Transient receptor potential channels -  an overview
Recent years have seen a spurt of growth in the scientific interest of the 
transient receptor potential, or TRP, family of ion channels, which shows far 
from any sign of plateau and is reflected by a proportionately proliferative 
output of publications. A quick PubMed search clearly shows this: as of June 
2008 at least 1,837 publications exist with “transient receptor potential” in the 
title or abstract (Figure 1.3). So, the question is: what are TRP channels and 
why the interest?
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Figure 1.3 Number of publications found by a PubMed search with “transient 
receptor potential” as part of the title or abstract, by year.
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1.4.1 TRP channels: Background
The importance of calcium for the survival and function of animal cells was 
first described by Sydney Ringer, FRS whose pioneering research showed that 
calcium was required for the normal contraction of the frog heart (Ringer, 
1882). Since this major discovery over 125 years ago, research in living tissues 
and animal cells has revealed a variety of biological roles for calcium which 
can be subdivided into four categories: structural, electrical, as a cofactor for 
extracellular enzymes and proteins, and regulatory (Campbell, 1983). Calcium 
signalling regulates many essential cellular processes, including muscle 
contraction, secretion, gene expression and many others (Berridge et al., 2000), 
which in turn regulate cellular proliferation and apoptosis. The intracellular 
calcium signal is, in part, controlled by plasma membrane calcium-permeable 
ion channels which permit an influx of Ca ions (Campbell, 1983). Coupled 
with this, the depletion of intracellular Ca2+ stores by endoplasmic reticulum 
(ER) Ca2+ channels stimulates currently undefined Ca2+-permeable channels in 
the plasma membrane to replenish the stores from extracellular fluid -  this is 
termed store operated calcium entry (SOCE) (Parekh & Putney, 2005).
The relatively recent discovery of a novel superfamily of ion channels called 
transient receptor potential (TRP) channels has aided the advance in our 
knowledge of calcium signalling mechanisms. Almost all TRP channels are 
Ca2+ permeable and contribute to cytoplasmic changes in free Ca2+
concentration, either by permitting Ca2+ entry across the plasma membrane, or
2+
Ca release from intracellular organelles. The contribution of TRP channels to
22
CH A PTER 1: INTRODUCTION
calcium signalling and therefore essential functions of the cell are becoming 
clearer as research into this interesting group of ion channels advances, and 
there is evidence to suggest that several TRP channels may be implicated in the 
pathogenesis of disease, either in part or as full channelopathies (Nilius et al., 
2007).
1.4.2 TRP channel discovery
The first TRP protein genes were discovered and defined in the fruitfly 
Drosophila melanogaster (Montell et al., 1985; Montell et al., 1989; Hardie & 
Minke, 1992). Flies with TRP mutant genes expressed photoreceptors that 
responded transiently to continuous light producing an abnormality in the 
electroretinogram recording (hence the name transient receptor potential), 
rendering the flies temporarily blind after the initial response to the light
'y i
(Figure 1.4) due to a lack of sustained Ca entry. Wild-type flies produced a 
sustained response throughout the exposure to light.
The origins of TRP channels are certainly very old as members are found in all 
Animalia in which the full genome has been sequenced, including worm 
(Caenorhabditis elegans), fly (Drosophila), mouse, and human (Clapham et 
al., 2005; Harteneck et al., 2000). The Drosophila genome is now known to 
encode for at least 13 TRPs, and 28 human TRP and TRP-related proteins have 
been identified to date plus splice variants (Montell, 2005a).
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Figure 1.4 Electroretinogram recordings obtained from wild-type and TRP 
mutant Drosophila, showing different responses to 10 second pulses of light 
(figure adapted from Montell, 2005a).
1.4.3 TRP channel structural homology & nomenclature
All of the TRP channel subunits are putatively built of six-transmembrane 
domains S1-S6 analogous to so many voltage-gated ion channels, with the S5 
and S6  subunits forming the pore of the tetramerically assembled channel and 
the S5-S6 loop of amino acids forming the channel selectivity filter 
(Hoenderop et al., 2003c) (Figure 1.5). Both NH2 and COOH termini are 
intracellular but vary in length and are poorly conserved throughout the 
superfamily, whereas the transmembrane subunits are relatively well 
conserved. Unlike the voltage-gated K+ channels, the S4 transmembrane 
domain does not contain the regularly spaced positively charged lysine and 
arginine amino acids that are thought to be responsible for the voltage gating in 
the K+ channels (Long et al., 2005; Montell, 2005b), but several of the
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mammalian TRP channels are weakly voltage sensitive although the voltage 
sensing structure remains to be identified (Nilius et al., 2005). TRP channels 
are generally said to be non-selective (but see p. 27): Ca2+, Mg2+, Na+, K+ and 
other monovalent cations are all permeant to some extent, though in their 
physiological environment each TRP channel has its own preferential 
permeability and selectivity.
The most conserved regions within and between subfamilies of the TRPs are 
parts of the transmembrane domains, the N-terminal 33 amino acid ankyrin 
repeats, and the highly conserved 25 amino acid region C-terminal to S6  which 
contains a 6  amino acid chain (EWKFAR) known as the TRP domain because 
of its unvarying sequence (Ramsey et al., 2006). It must be stressed that even 
these features are not universal, but other than these the TRP channels are 
structurally diverse, and TRP sequence length varies from 553 up to 2,022 
amino acids in length.
C a 2+ Na*
Figure 1.5 General architecture of the TRP superfamily of ion 
channels. This figure shows the SI to S6  transmembrane domains, with 
the S5-S6 linking amino acid loop forming the putative pore. Both N and C 
termini are intracellular, and contain features such as ankyrin repeats (N 
terminus) and the TRP domain (C terminus).
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The TRP superfamily is categorised into seven subfamilies according to amino 
acid sequence homology and structural similarities as the functions, gating 
mechanisms and ligand selectivity of the TRP channels are poorly understood 
(Clapham, 2003; Corey, 2003; Delmas, 2004; Montell et al., 2002a; Montell et 
al., 2002b; Moran et al., 2004; Pederson et al., 2005). These subfamilies are 
TRPC (canonical) consisting of 7 channels, TRPM (melastatin) with 8  
channels, TRPV (vanilloid) with 6  channels, TRPA (ankyrin) with only 1 
member, TRPP (polycystin) and TRPML (mucolipin) each have 3 channels, 
and TRPN (no mechanopotential) with 1 channel. TRPN has not yet been 
identified in mammals (Nilius et al., 2007).
Until recently there was no standardisation of the nomenclature, often leading 
to complex and confusing names that bore no resemblance to channels in the 
same subfamily. Montell et al. (2002b) proposed the current unified 
nomenclature, which focussed on three of the subfamilies (TRPC, TRPV and 
TRPM) related to the founding Drosophila TRP. Figure 1.6 shows the 
phylogenetic basis for this nomenclature. These three subfamilies plus TRPA 
and TRPN have the strongest homology to the founding Drosophila TRP and 
are often referred to as group 1 TRPs, while TRPP and TRPML subfamilies, 
having more distantly related homologies, make up the group 2 TRPs (Montell, 
2004).
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Figure 1.6. Phylogenetic relationship between TRPC, TRPV and TRPM 
subfamilies. The evolutionary distance is shown by the total branch lengths 
in point accepted mutation (PAM) units, which is the mean number of 
substitutions per 100 residues. Here, the unifying nomenclature as 
recommended by Montell et al. (2002b) is used. Figure adapted from 
Clapham et al. (2001).
1.4.4 TRP functional features
Ca2+ permeability is one functional feature of almost all TRP channels, with 
the notable exceptions of TRPM4 and TRPM5 which select for monovalent 
cations only (Hofmann et al., 2003; Launay et al., 2002). TRPV5 and TRPV6  
are highly selective for Ca2+, each with a permeability ratio /W^Na > 100 (Den 
Dekker et al., 2003; Nijenhuis et al., 2003a; Nijenhuis et al., 2003b), but all 
other TRP channels are relatively non selective. As stated above, voltage 
sensitivities of TRP channels are heterogeneous and weaker than for voltage-
lORM'Imts
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sensitive K+ channels, for example. TRP activation is by diverse means and 
channels are gated by both intracellular and extracellular ligands, chemical 
stressors such as pH changes and oxidative stress, temperature changes, and the 
much-discussed store operation (Clapham et al., 2005; Nilius et al., 2003; 
Ramsey et al., 2006).
1.4.4.1 TRP signalling path way
The TRP signalling pathways remain elusive but appear to be diverse across 
the subfamilies. Some TRP channels may be phospholipase-C (PLC) activated 
(Nilius et al., 2004), whereas others may require phosphatidylinositol 4,5- 
bisphosphate (PIP2) binding for activation (Brauchi et al., 2007; Lukacs et al., 
2007; Voets & Nilius, 2007). Several mechanisms have been proposed which 
in principle link PLC activation/inhibition and TRP channel opening. The three 
main and recurring theories are the receptor-operated theory of G-protein 
activation, the cellular-sensing theory, and the much discussed and contentious 
store-operated channel theory (Clapham, 2003; Minke et al., 2002).
1.4.4.1.1 Receptor operated theory
The receptor operated theory involves G-protein activation o f an unknown 
messenger which directly and specifically activates a TRP channel. Clapham et 
al. (2003) suggest that this is the most likely mechanism for gating of TRPC 
channels, as all TRPC channels in mammals can be activated by G protein- 
coupled receptors (GPCRs): TRPCI, TRPC4 and TRPC5 by muscarinic type 1 
receptors, TRPC3 and TRPC6  by histaminergic type 1 receptors, and TRPC7
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by purinergic receptors. Unfortunately, identification o f this messenger is 
complicated by the fact that uncoupled G-proteins often activate 
phosopholipase C (PLC), hydrolysing PIP2 and forming secondary messengers 
such as diacyl glycerol (DAG), polyunsaturated fatty acids (PUFAs) and 
inositol 1,4,5-trisphosphate (IP3) (Clapham et al., 2003). IP3 then subsequently 
activates the IP3 receptor on the endoplasmic reticulum (ER), releasing 
intracellular Ca2+ from ER stores. However, PIP2 itself is a candidate as a 
direct second messenger, and is known to regulate the activity of several ion 
channels, including TRPV1 and TRPM4, for example (Hilgemann et al., 2001; 
Voets & Nilius, 2007). The latter authors state that PIP2 binding promotes TRP 
channel activation, but in some cases, PIP2 binding prevents channel gating, 
and thus hydrolysis by PLC ‘frees’ the channel for gating. Rohacs et al. (2005) 
have shown that PIP2 regulates the activation of TRPM8  via the TRP domain 
and suggest that PIP2 could be a generic modulator of TRP channels. 
Unfortunately, this mechanism o f PIP2 activation does not unify all TRP 
channels. PUFAs or DAG are also candidates for direct activation o f TRP 
channels, but there is no conclusive evidence for this to date.
1.4.4.1.2 Cellular sensing theory
As previously mentioned, all manner of sensations can produce TRP responses: 
temperature changes, mechanical force and intracellular messengers all activate 
TRP channels. The principle o f the cellular sensing theory is that the total 
energy transduction to each channel must be large enough to result in gating, 
and that this energy can be directly imparted by the above forces (Clapham et
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al., 2003; Minke et al., 2002). The measure of the change in channel opening 
due to energy transfer can be quantified by the temperature coefficient value 
Qio, a factor by which the rate o f change increases for every 1 0  °C rise in 
temperature. Mechanical forces that induce membrane distortion transfer more 
than enough energy to mechano-sensitive TRP channels to overcome the 
required threshold energy for channel gating. Ciliated cells may aid this 
mechanical transduction from sound waves, osmolarity, taste, stretch, etc. The 
binding o f intracellular signalling molecules may also provide enough energy 
to activate channels, dependent on the binding affinity o f each molecule for its 
receptor. The signal transduction mechanism o f temperature-sensitive TRP 
channels remains unsolved, but may involve protein unfolding and refolding at 
different temperatures (Brauchi et al., 2004), or perhaps by messengers 
regulated by an unidentified temperature-sensitive intracellular enzyme 
(Clapham et al., 2003). Alternatively, temperature-sensitivity of the channels 
may depend on membrane potential, and that temperature-activation o f a 
channel, either by increased or decreased temperatures, shifts the voltage- 
dependence o f the channel activation towards physiological potentials. In 
support o f this, Voets et al. (2004) showed that for TRPM8  the Qio value for 
channel opening was much smaller than the value for channel closing, and vice 
versa for TRPV1, indicating channel activation with cooling and heating 
respectively. This theory is perhaps not unifying for the TRP superfamily, but 
may hold in part for some TRP channels, such as the temperature-gated 
channels.
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1.4.4.1.3 Store operated channel (SOC) theory
The release o f free Ca2+ ions from intracellular stores is regulated, at least in 
part, by G-protein or tyrosine kinase activation of PLC, hydrolysing PIP2 to 
form IP3 which opens IP3-sensitive ion channels on the endoplasmic reticulum 
(HR). Depletion of internal Ca2+ stores provokes the influx of Ca2+ through 
Ca2+-permeable channels in the plasma membrane, but both the signal for this 
and the store-operated channels, as they are known, remain elusive. Store 
operated calcium entry (SOCE) presents as a transient Ca2+ influx followed by 
a high [Ca2+]j plateau and is dependent on [Ca2 + ] 0 (Clapham et al., 2005; 
Parekh & Putney, 2005). Channel currents measured in the plasma membrane 
on store-depleted activation have revealed channels known as I c r a c  channels 
(Ca2+ release activated channel) which are highly Ca2+ selective. Early 
excitement that TRP channels may be SOCs has since waned as most TRP 
channels do not have the necessary electrophysiological characteristics 
displayed by SOCs (Parekh & Putney, 2005; Venkatachalam et al., 2002). 
However, several o f the canonical TRPs (1-5 and 7) and TRPV6  do show some 
promise as store operated channels. TRPV6  is particularly interesting as it has 
several features in common with I c r a c  channels, but problematically there are 
inequalities in voltage-dependent Mg2+ blockade and current rectification 
(Nilius, 2003). So, TRPV6  is perhaps not an I c r a c  channel but remains a 
candidate for a SOC. It would be wrong to call all TRP channels SOCs, but 
some SOCs could be TRPs.
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1.4.5 TRP subfamilies
1.4.5.1 The canonical TRP subfamily (TRPC)
Sharing the closest similarity to the Drosophila TRP sequence, with between 
32 % and 47 % overall sequence identity (Schilling et al., 2004), members 
appear to exist in all cell types tested (Riccio et al., 2002). The canonical 
subfamily has seven members, plus splice variants, which can be further 
subdivided into two groups: TRPC1, C4 and C5, and TRPC3, C6  and C7. 
TRPC2 is a pseudogene in humans (Wes et al., 1995; Zhang et al., 2003), but 
plays a vital role in pheromone sensing in the vomeronasal organ of rodents 
(Liman et al., 1999). TRPC2-deficient mice are unable to distinguish between 
male and female mice (Stowers et al., 2002). Channels of the TRPC subfamily 
appear to form heteromultimers within the above assigned subgroups, but not 
between these subgroups (Clapham et al., 2001).
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Figure 1.7 Structural similarities and differences between TRPC, 
TRPV and TRPM subfamilies. (CIRB: calmodulin and IP3R binding).
32
C H A PT E R  1: INTR OD U CTIO N
TRPC members are activated by G protein-coupled receptors (GPCR) or 
receptor tyrosine kinases (TK) linked to PLC. TRPC3, C6  and C7 appear to be 
regulated by DAG (independent of protein kinase C), whereas TRPC1, C4 and 
C5 channels are not. TRPC2 may be gated in a similar fashion to TRPC3, C6  
and C7 (Clapham et al., 2003; Schilling et al., 2004). Conserved regions of the 
TRPCs include 3 - 4  N-terminal ankyrin repeats, a proline-rich sequence in the 
C terminus, and the highly conserved TRP domain (Minke & Cook, 2002). 
TRPC channels do not exhibit voltage regulation.
Members are between 793 and 1,172 amino acids in length and are non- 
selective for cations with PcJPn& < 10. TRPC channels are widely expressed 
with the highest expression in brain, heart, testis and ovary (Wes et al., 1995) 
but general functions are unknown, although possible roles exist in 
proliferation in the CNS and prostate cancer (Wissenbach et al., 2004a).
1.4. S. 2 The vanilloid TRP subfamily (TRPV)
TRPV1 was identified by expression cloning in the search for a functional 
capsaicin receptor in sensory neurons (Caterina et al., 1997), and was 
originally termed VR1, for vanilloid receptor subtype 1 as it is activated by 
capsaicin, a vanilloid compound derived from hot chilli peppers. Six TRPV 
members in total are known to exist (Caterina et al., 1999; Hoenderop et al., 
2003a; Peier et al., 2002b; Peng et al., 1999; Strotmann et al., 2000) plus 
several splice variants (Lu et al., 2005; Wang, C. et al., 2004) which likely 
form channels as heteromeric or homomeric tetramers (Kedei et al., 2 0 0 1 ;
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Kuzhikandathil et al., 2001). TRPV channels are activated by chemical and 
mechanical stimuli, lipids, pH changes and hot and cold temperatures, and 
although their functions have not generally been determined, at least some o f 
the TRPV members have a role to play in nociception and thermosensation. 
Mechanisms of signal transduction in the TRPV subfamily are largely 
unknown.
Conserved structural features within the TRPVs are 3 - 4  N-terminal ankyrin 
repeats, and a less conserved C-terminal TRP domain. Members of the TRPV 
subfamily are between 725 and 871 amino acids in length, and are relatively 
non-selective with the notable exceptions o f TRPV5 and TRPV6 , which both 
have high selectivity for Ca ions (PcJP nh > 100).
TRPV1, V2, V3 and V4 are temperature sensitive channels, and several TRPVs 
are upregulated by translocation to the plasma membrane in response to cell 
swelling in hypotonic solutions (Liedtke et al., 2000; Muraki et al., 2003; 
Strotmann et al., 2000) and in response to insulin-like growth factor 1 (IGF-1) 
(Kanzaki et al., 1999). TRPV5 and TRPV6  are the two non-temperature 
sensitive members o f the TRPV subfamily and share 6 6 % identity (Clapham et 
al., 2001). Both TRPV5 and V6  are the only TRPs that are highly Ca2+ 
selective {PcJPu* > 1 0 0 ) and strongly inwardly-rectifying, which suggests a 
role in Ca2+ uptake. They are expressed in prostate, kidney, ileum and placenta 
tissues, and are thought to be involved in epithelial transport of Ca2+ (Den 
Dekker et al., 2003; Nijenhuis et al., 2003a; Nijenhuis et al., 2003b). As these
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processes are regulated by 1,25-dihydroxyvitamin D3 and parathyroid 
hormone, there may be a role for these two TRPV members in other tissues in 
which Ca2+ transport is important, such as bone.
1.4.5.2.1 TRPV1
As mentioned above, TRPV1 was originally identified by Caterina et al. (1997) 
by expression cloning with capsaicin in dorsal root ganglia, but is also 
expressed in brain, heart, skeletal muscle, lung, liver, pancreas, kidney, colon, 
bladder, spleen, thymus and neutrophils. It is a relatively nonselective cation 
channel {PcJPn* ~ 10) with a single channel conductance o f about 80 pS, a 
reversal potential (Erev) of ~ 0 mV and an outwardly rectifying I/V relationship. 
Heat > 42 °C activates the channel, along with capsaicin and other more 
recently identified ligands: the capsaicin analogue, resiniferatoxin (Raisinghani 
et al.. 2005), the cannabinoid anandamide (Smart et al., 2000), the compound 
responsible for the pungency of garlic, allicin (Macpherson et al., 2005), and 
olvanil (Appendino et al., 2005), and also acidic cytoplasmic conditions (Ryu 
et al.. 2003). Channel blockers include ruthenium red, the synthetic vanilloid 
receptor antagonist capsazepine (Bevan et al., 1992), the more selective 
compound SB366791 (Rami et al., 2004), PIP2 (Chuang et al., 2001) and 
adenosine (Puntembekar et al., 2004). A splice variant has been identified and 
termed TRPV lb, which has an N-terminal 60 amino acid deletion which 
includes a deletion o f one o f the ankyrin repeats. This shortened variant is 
activated by temperatures > 44 °C, but is not activated by capsaicin or any o f 
the other known ligands or pH 5.0 (Lu et al., 2005). Additionally, capsazepine
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does not inhibit the heat-induced currents of this splice variant, but ruthenium 
red was able to completely abolish them. TRPV1 is known to play a role in 
pain sensation pathways and has been linked with heat hyperalgesia following 
trauma (Pogatzki-Zahn et al., 2005). Anandamide may cause vasodilatation via 
TRPV1, and also the channel participates in bladder purinergic signalling 
(Birder et al., 2002) but the functions of TRP VI in other tissues are less clear.
Interestingly, the activation of TRPV1 in sensory nerve fibres may be 
potentiated by or sensitized to temperature and protons by inflammatory 
mediators such as ATP (Tominaga et al., 2001), bradykinin and nerve growth 
factor (Chuang et al., 2001). TRPV1 activation and resultant cytosolic Ca2+ 
increase in primary afferent spinal cord nerve terminals results in enhanced 
adenosine release (Cahill et al., 1993a; Cahill et al., 1993b; Sweeney et al.,
1989) which promotes analgesia through adenosine Ai and A2A receptor 
activation (Sawynok & Liu, 2003). Puntembekar et al. (2004) have shown that 
in TRPV1-transfected HEK-293 cells, adenosine does indeed act as an 
inhibitor o f both capsaicin- and resiniferatoxin-induced TRPV1 channel 
activity and that adenosine analogues have similar effects, all by direct 
interaction with the TRPV1 receptor and competing with capsaicin and 
resiniferatoxin binding.
1.4.5.3 The melastatin TRP subfamily (TRPM)
Named after the founding member, melastatin (termed TRPM1) (Duncan et al., 
1998), the TRPM subfamily has eight members which can be further
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subgrouped into four pairs o f homologous channels: TRPM1 and M3; M2 and 
M8; M4 and M5; and M6 and M7 (Fleig et al., 2004). Functional properties of 
the TRPMs are diverse, as are the gating mechanisms, regulation, current- 
voltage relationships and voltage-dependence, but the possibility of 
heteromultimeric tetramers seems likely, particularly for each pair: M6 and M7 
are already known to coassemble (Chubanov et al., 2004). Splice variants have 
been identified for the first five TRPM channels (Fleig et al., 2004) and could 
occur for all eight, leading to further diversity and complexity within this 
subfamily. Unique within the TRP superfamily are TRPM2, M6 and M7, 
which also have enzymatic properties (Cahalan, 2001; Runnels et al., 2001).
The TRPM subfamily was originally termed TRP-L (long) due to the length of 
the N-termini. The diverse characteristics o f the members of the TRPM 
subfamily may be due, at least in part, to the varied C-terminal lengths and 
structures, with the protein lengths ranging from 1,104 to 2,022 amino acids. 
Ankyrin repeats are not conserved in the N-termini, which instead contain four 
regions o f amino acids that share similarity within the subfamily known as the 
TRPM homology region. N-terminal coiled-coil domains may play a role in the 
formation o f the tetrameric channels (Fleig et al., 2004). On the C-termini the 
TRP domain is conserved and TRPM2 has a Nudix enzymatic domain 
(nucleoside diphosphate pyrophosphatase) that binds ADP-ribose which gates 
the channel (Perraud et al., 2001). TRPM6 and TRPM7 also have C-terminal 
enzymatic activity in the form o f a-kinase (phospholipase C-interacting kinase, 
or PLIK) (Fleig et al., 2004).
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2^ .  2TTRPM channels display variable Ca and Mg permeabilities: TRPM4 and 
M5 are Ca2+-impermeable, whereas TRPM6 and M7 are highly permeable to 
Ca2+ and Mg2+. Activation mechanisms o f the TRPMs include oxidative stress 
and heat (TRPM2), mechanical stimuli (TRPM3), [Ca2+]j increases and heat 
(TRPM4 and M5), [Mg2+]j and [MgATP]j (TRPM6 and M7), and cooling 
agents or cold (TRPM8) (McKemy et al., 2002; Peier et al., 2002a). Duncan et 
al. (2001) have shown that downregulation o f TRPM 1 in primary melanomas 
is a prognostic marker for metastasis, showing that TRPM1 is clearly involved 
in cell proliferation and differentiation. TRPM7 is also thought to be 
responsible for Mg2+ transduction and may also be important for cell 
proliferation and viability (Nadler et al., 2001) due to its role in cellular Mg 
homeostasis (Schmitz et al., 2004). The sensitivity of TRPM2 to oxidative 
stress suggests a role in apoptosis (Fleig et al., 2004; Hara et al., 2002). The 
expression o f TRPM8 in prostate cancer cells (Bidaux et al., 2005; Tsavaler et 
al., 2001) suggests perhaps a proliferative role. Bidaux et al (2005) report that 
TRPM8 expression requires a functional androgen receptor, so TRPM8 is 
androgen-dependent, and TRPM8 ligands could possibly be used to target 
prostate cancer growth and treat this disease.
1.4.5.4 Other TRP subfamilies
TRPA
TRPA1 (ankyrin) is a cold-sensitive, Ca -permeable nonselective channel 
activated by temperatures < 15 °C and icilin but not menthol, and is found to
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be co-expressed with TRPV1, but not TRPM8 (Story et al., 2003). TRPA1 
contains 14 N-terminal ankyrin repeats.
TRPML
The mucolipins (TRPML) are involved in Mucolipidosis Type IV (TRPML1) 
and Ashkenazi Jewish alleles (TRPML2 & TRPML3) (Wissenbach et al., 
2004b), a neurodegenerative lysosomal storage disorder, and affect the late 
endocytic pathway (Clapham et al., 2001).
TRPP
The Ca2+-permeant polycystic kidney disease proteins TRPP2, TRPP3 and 
TRPP5 may result in polycystic kidney disease when the channel is mutated 
and function is lost (Wissenbach et al., 2004b).
TRPN
TRPN channels have not been identified in mammals, but are present in fish, 
insects and nematodes and appear to be involved in mechanosensory 
transduction (Wissenbach et al., 2004b).
1.4.6 TRP-related diseases and channelopathies
Given the presumed roles of TRP channels in cellular proliferation, 
differentiation and apoptosis, it is likely that channel dysfunctions manifest as 
various diseases. Indeed, at least five TRP channelopathies have been 
identified to date due to defective genetic encoding o f TRP channels, namely
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focal segmental glomerulosclerosis (TRPC6 mutation), hypomagnesaemia and 
secondary hypocalcaemia (TRPM6 mutation), autosomal dominant polycystic 
kidney disease (TRPP1/2 mutations), mucolipidosis type IV (TRPML 1 
mutation), and Guamanian amyotrophic lateral sclerosis/Parkinsonism 
dementia (TRPM7) (Nilius et al., 2007).
Other diseases relate to the functions o f TRP channels (e.g. the temperature 
sensitive TRPs in pain sensation (Caterina et al., 1997)), or the expressions 
(e.g. TRPM8 is upregulated in androgen-dependent prostate cancers (Tsavaler 
et al., 2001)). Clearly in these cases, TRP channels are obvious targets for new 
drugs, and certainly a great deal o f research is currently being pursued to target 
TRPV 1, for example in the treatment o f neuropathic and bladder pain (Dray, 
2008; Tamayo et al., 2008; Wang, 2008; Birder, 2007).
1.5 Hypothesis, aims, and experimental strategies
The principle hypothesis of this thesis is that ion channels belonging to the 
transient receptor potential channel superfamily and to the K+ channel 
superfamily are expressed, active and functional in human osteoblasts, where 
they are involved in the regulation of key cellular processes such as 
proliferation, differentiation, secretion and apoptosis.
In light of the advances in TRP channel research and the recent evidence for 
the putative functions o f TRP channels in non-excitable cells, especially 
osteoblasts and osteoclasts, and given that bone disorders such as osteoporosis
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are so costly, in terms o f reduced quality o f life, increased risk of death due to a 
serious fracture, and financial burden on the health services, it seems pertinent 
to pursue research into the role o f TRP channels in bone. O f course, 
idealistically the long term goal would be to develop drugs that target TRP 
channels to address the imbalance in bone remodelling that forms the basis of 
many bone disorders. However, as the roles of TRP channels in osteoblasts and 
osteoclasts are still emerging, research must for now concentrate on developing 
and mapping out these roles, discovering new roles, and understanding the 
machinery o f the channels and signalling cascades, including that of the 
universal regulator, Ca2+. It is emerging that TRPV1 has putative key roles in 
the fundamental cell functions o f osteoblasts, and is likely to be an important 
target for new therapies.
The key aims o f this thesis were:
1 to establish working in vitro cultures o f human osteoblast-like cells in the 
laboratory, including the non-mineralising MG63 and mineralising SaOS- 
2 cell lines, the mouse 7F2 mineralising osteoblast cell-line which also 
has the ability to undergo complete adipocyte differentiation, and HOB-c 
human primary mineralising osteoblasts.
2 to show whether or not selected TRP channels, maxi K+ channels and 
K atp  channels are expressed at messenger (mRNA) level, and later at 
protein level in the membrane, in human osteoblasts and osteoblast-like 
cells and mouse 7F2 cells.
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3 to identify and characterise any channels found electrophysio logically
using the patch-clamp technique, with appropriate channel agonists and 
antagonists or blockers, with particular emphasis on the maxi K channel 
and the heat- and capsaicin-sensitive channel, TRPV 1.
4 to test whether the above channels are involved in key functional
processes in osteoblasts, including proliferation, mineralisation and 
differentiation, which have obvious consequences for bone mineral 
density.
5 to test whether TRPV1 is directly involved in calcium signalling in
osteoblasts, using recognised TRPV1 ligands and fluorescent calcium- 
chelating dyes.
1.5.1 Experimental strategies
In order to fulfil the above aims, a host o f experimental techniques were 
employed including reverse transcription polymerase chain reaction (RT-PCR) 
for messenger RNA detection, gene sequencing for validation of RT-PCR 
products, the patch-clamp technique (as described by Hamill et al., (1981) for 
electrophysio logical recording of ion channel activity, cell counting by means 
of haemocytometry and MTS-dye conversion measurements, osteoblast cell 
mineralisation and differentiation assays, and ffee-Ca2+ imaging with 
fluorescent dyes using confocal microscopy.
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2 METHODS & MATERIALS
2.1 Cell Culture
2.1.1 Culture media
Specific culture media were selected for each cell-type according to 
instructions from the respective suppliers. Prepared culture media were kept 
refrigerated between 2 and 8 °C and warmed to room temperature or 37 °C 
prior to use. Generally, media were used within 14 days o f preparation or 
discarded. All cell culture media ingredients, unless otherwise stated, were 
obtained from Gibco®, Invitrogen Ltd., Paisley, UK.
DMEM fo r  MG63, SaOS-2 and HOB-c cell culture
Dulbecco’s modified Eagle medium (DMEM) containing L-glutamine, 
pyruvate and 4.5g f 1 glucose was supplemented with 5% foetal bovine serum 
(FBS) and with 100 pg ml'1 streptomycin and 100 U m f1 penicillin (Penicillin- 
Streptomycin 10,000: 10,000, Invitrogen).
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DMEM fo r  D U N S cell culture
As above but supplemented with 10% FBS.
R P M I1640fo r  LNCaP and MCF-7 cell culture
Roswell Park Memorial Institute (RPMI) 1640 culture medium was 
supplemented with 10% FBS, 100 pg m l'1 streptomycin and 100 U ml"1 
penicillin.
M EM -a fo r  7F2 cell culture
Alpha minimum essential medium, containing Earl’s salts, 1 mM sodium 
pyruvate and 2 mM L-glutamine, but without ribonucleosides or 
dexoxyribonucleosides, was supplemented with 10% FBS, 100 pg ml"1 
streptomycin and 100 U ml"1 penicillin.
7F2 cell adipocyte differentiation medium
This medium was based on the above MEM-a for 7F2 cell culture, but further 
supplemented with 50 pM indomethacin, 50 pg m l'1 ascorbic acid and 100 nM 
dexamethasone (all supplements from Sigma) to induce adipocyte 
differentiation (Thompson et al., 1998).
2.1.2 Cell husbandry
MG63, SaOS-2 and HOB-c cells were kindly supplied by Dr B.A.J. Evans, 
Department of Child Health, School o f Medicine, Cardiff University. MG63 
human osteosarcoma cells are originally derived from a 14-year-old male
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(Heremans et al., 1978). SaOS-2 human primary osteogenic sarcoma cells are 
derived (Fogh & Trempe, 1975) from an 11-year-old female Caucasian 
(ATCC). HOB-c human primary osteoblast cells are derived from the normal 
hipbone o f a 64 year old Caucasian female during routine operation. Passage 
numbers 3 and 4 were obtained from PromoCell GmbH, and maintained as 
proliferating cultures. PromoCell confirm that the cells are positive for 
osteocalcin by immunofluorescence, and maintain their osteoblast phenotype 
for at least 10 passages.
Rat osteoclasts (kindly supplied by Dr B.A.J. Evans) were derived from 
monocytes/macrophages (from rat bone marrow), by supplementation o f a- 
MEM (containing 10% FBS) with macrophage colony-stimulating factor (M- 
CSF) and RANKL to encourage osteoclast differentiation.
LNCaP, DU145 and MCF-7 cells were kindly supplied by the Tenovus Centre 
for Cancer Research at Cardiff University. LNCaP human Caucasian prostate 
carcinoma cells are originally derived (Horoszewicz et al., 1983) from ‘a 
metastasis at the left supraclavicular lymph node of a 50 year old patient with a 
confirmed diagnosis o f  metastatic prostate carcinoma’ (ECACC) and are 
androgen-sensitive. DU 145 human metastatic prostate carcinoma cells are 
derived (Stone et al., 1978) from ‘a lesion in the brain of a patient with 
metastatic carcinoma o f the prostate and a 3 year history of lymphocytic 
leukaemia’ (ATCC) and are not sex-hormone sensitive. MCF-7 human
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Caucasian breast adenocarcinoma cells are originally derived (Soule et al., 
1973) from the pleural effusion o f a 69-year-old female Caucasian (ATCC).
All cells were cultured in 25 cm or 75 cm flasks and incubated at 37 °C in 5% 
CO2 humidified air, with a working volume of 3 ml or 9 ml medium, 
respectively. Confluent cultures were divided weekly and cell medium was 
replaced every 3 - 4  days. To detach cells, cultures were washed with lx D- 
PBS (calcium- and magnesium-free, Gibco*, Invitrogen Ltd.) and then 500 pi 
trypsin solution (trypsin 0.025 %, EDTA 0.2 %) (trypsin from bovine pancreas. 
Sigma; EDTA, Sigma) per 25 cm was added for up to 10 minutes. When cells 
were detached, 2 - 3 ml of culture medium was added to stop the trypsinisation 
and cells were evenly suspended by gentle repeated pipetting. The suspension 
was centrifuged at 500 xg for 3 minutes at room temperature to pellet the cells, 
the supernatant was aspirated and replaced with culture medium. The pellet 
was resuspended and aliquots were pipetted accordingly into flasks.
2.1.3 Cell-seeding onto coverslips
Cells were detached as above, resuspended in medium and centrifuged at 
500*g for 3 minutes to form a pellet. The supernatant was removed by 
aspiration and the pellet o f cells was resuspended in a known volume o f the 
working culture medium. Cells were counted using a Neubauer 
haemocytometer (see below) and then a new suspension was created of density
3,000 or 5,000 cells per 100 pi. Heat-sterilised 16 mm diameter circular glass 
coverslips (Best - Gerhard Menzel) in 6-well plates were seeded with 3,000 or
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5,000 cells and left to attach in the incubator for several hours before topping 
up the culture medium to 2 ml per well. All cell types were usually attached 
and considered ready for electrophysio logical recording after approximately 24 
hours.
2.2 Cell counting
2.2.1 Haemocytometry
1 laemocytometry is the process of counting cells to determine the density of a 
cell suspension. The Neubauer haemocytometer is a slide with two flat 
chambers, each engraved with a microscopic grid of 1 mm squares, and when 
fixed with a coverslip the chambers have a depth of 0.1 mm. Thus, each 1 mm 
x 1mm square o f depth 0.1 mm has a volume of 0.1 pi. The coverslip is 
properly attached to the slide when the interference patterns known as 
Newton's rings can be seen.
Cells were detached and pelleted as above (see section 2.1.2), and the pellet of 
cells was resuspended evenly in a known volume of culture medium. 8 pi of 
suspension was pipetted into each of the haemocytometer chambers and 
allowed to be drawn in by capillary action. At 10* magnification under a 
microscope, the central 1 mm square o f one chamber was found and all cells 
within the boundaries were counted including cells that lay on the top and left- 
hand boundary lines, but not those on the right or bottom to ensure only 1 mm2 
was counted. If the square contained less than 100 cells, one or more additional
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squares in the same chamber were counted to improve accuracy. Counting was 
also performed on the second chamber in the same way.
The average o f the counts was calculated and the density o f the cell suspension 
was determined using the equation:
CD = nav/v
where CD is cell density, nav is average number of cells counted, and v is 
volume in ml. Effectively, as the volume counted is 10^ ml:
CD = nJlO -4 or CD = nav x i ( f
2.2.2 Cell counting by dye-conversion assay
Cells were counted and then seeded into the central 60 wells of 96-well plates 
(i.e. omitting the 36 wells around the perimeter)* at 3,000 cells per well in 100 
pi and left to settle for 24 hours in culture medium under normal growth 
conditions (see above). The medium was then aspirated and replaced with 
medium containing various concentrations o f test drugs and incubated for 2 to 
7 days in the usual conditions unless otherwise stated. For the assay, the 
CellTiter 96 A Q ue0us Non-radioactive Cell Proliferation Assay (Promega) 
protocol was followed using the tetrazolium compound MTS1^ and the electron 
coupling reagent PES+ combined in the ratio 20:1, such that 20 pi of the
Cultures in the perim eter w ells have been observed in the laboratory to grow  at a different 
rate to the central wells. C ulture m edia contain ing phenol red indicates a pH difference here.
+ 3-(4,5-dim ethylth iazol-2-yl)-5-(3-carboxym ethoxyphenyl)-2-(4-sulfophenyl)-2H -tetrazolium
* Phenazine ethosulfate
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MTS/PMS mixture was added to each test well on top of the 100 pi test 
medium. Results were read with a Tecan* ELISA plate reader at 490 nm 
following 1 -  4 hours incubation in the dark at 37 °C. Figure 2.1 shows that 
there is a linear correlation between MG63 cell number and absorbance at 490 
nm between 0 and 25,000 cells (typical culture density range).
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Figure 2.1. Correlation curve of absorbance/MG63 cell number for MTS
assay. Cells in DMEM were added to wells and allowed to equilibrate for 1 
hour, then MTS/PMS was added. After 1 hour at 37 °C, absorbance at 490 
nm was measured using an ELISA plate reader. Each point represents mean 
± SE of 4 replicates. Background absorbance at zero cells/well was not 
subtracted.
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2.3 Cell function assays
2.3.1 Mineralisation assays
Assay cultures of SaOS-2 or 7F2 cells were incubated for up to 14 days in cell- 
specific growth medium (see above) with 50 pg ml'1 L-ascorbic acid 2- 
phosphate and 2 mM (3-glycerol 2-phosphate (Sigma) at a density of 100,000 
cells per well in 6-well plates for SaOS-2 cells, and 10,000 cells per well in 24- 
well plates for 7F2 cells. Test compounds and the p-glycerol 2-phosphate were 
not added until day 2 of the assay and then media and test compounds were 
replenished twice weekly during the assay period.
Alizarin red S  staining
Alizarin red S (Sigma) was dissolved in distilled H2O to prepare a 1% w/v 
solution, adjusted to pH 4.2 with 0.5 M KOH and filtered through coarse filter 
paper to remove precipitate. Medium was removed from the wells and cells 
were washed with phosphate buffered saline (PBS). After aspirating the PBS, 
cells were fixed with formal saline (10% formaldehyde in PBS) for 15 minutes, 
then washed with distilled H2O and allowed to dry completely. Fixed and dried 
cells were stained with 1 % alizarin red S stain for 5 minutes, then the stain was 
aspirated and cells were washed 5* with 50% ethanol to remove excess stain, 
leaving the last wash on the cells for 15 minutes. After removing the final 
wash, cells were left to dry completely. Stained mineral nodules in wells were 
photographed at 100x - 400* magnification.
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2.3.2 Adipocyte differentiation assays (7F2 cells)
Mouse primary bone marrow stromal (7F2) cells, which have the ability to 
differentiate into adipocytes under certain conditions, were used for these 
assays. Cells were seeded into 24-well plates at a density o f 10,000 cells/well 
and left overnight to attach in 7F2 culture medium. The next day, the medium 
was aspirated and replaced with adipocyte differentiation medium and test 
compounds. Cultures were incubated under the usual conditions for 7 days, and 
medium/test compounds were replenished every 2 - 3  days.
Oil red O staining for lipids
A 0.5% w/v stock solution o f stain was prepared by dissolving Oil Red O 
(Sigma) in isopropanol. An Oil Red O working solution was prepared by 
mixing 6 parts Oil Red O stock solution with 4 parts distilled water (e.g. for 10 
ml working solution, mix 6 ml Oil Red O stock solution with 4 ml distilled 
water). The staining procedure was as follows: the medium was aspirated from 
the cells, wells were washed with PBS and the cells were fixed with formal 
saline (10% formaldehyde in PBS) for 15 minutes. Cells were then washed 2x 
with distilled water and allowed to dry completely. Stain was applied to each 
well and incubated for 15 minutes on a plate rocker, and then wells were 
washed with 60% isopropanol to remove excess stain, followed by several 
washes with PBS until no further pink colour could be removed. Cells were 
stored in PBS and photographed under the microscope. Lipids droplets were 
stained pink/red.
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2.4 Electrophysiology
2.4.1 Physiological recording solutions
Physiological solutions were routinely prepared as required and stored at 2 - 8 
°C for up to one week when not in use. All chemical components were 
obtained from Sigma and were prepared in distilled H2O. Table 2.1 lists the 
composition of each solution. ‘Extracellular’ physiological solutions high in 
Na+ ion content were termed ‘Locke’ solutions (sodium chloride Locke or 
sodium gluconate Locke as appropriate) and will be referred to as such from
1
here on. Following unsuccessful attempts to detect TRPV1 in Ca -containing 
solutions, low- and zero-Ca2+ solutions were prepared to minimise possible 
TRPV1 channel desensitisation (see e.g. Koplas et al., 1997), particularly 
within the interval between seal formation and the start of recording. Drug 
solutions were prepared in an appropriate physiological solution suitable for 
experimental requirements, from drug stock solutions as specifically stated. All 
electrophysiological solutions were filtered on application through a non-sterile 
0.2 pm PVDF-membrane 4 mm syringe filter (Whatman).
2.4.2 Electrode fabrication
Recording electrodes were pulled from 1.5 mm outside-diameter, 0.86 mm 
inside-diameter borosilicate glass capillaries (GC150-F10, Harvard Apparatus 
Ltd.) by one of two available means:
(i) a Narashige PP-83 two-stage vertical electrode puller set to produce 
two equal length electrodes with an outside tip diameter of
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approximately 1 pm. These were then heat-polished using a 
Narashige MF-83 microforge to smooth the tip.
(ii) a DMZ-Universal Puller (Zeitz-Instruments GmbH), set to pull and 
heat-polish two equal-length electrodes, again with an outside tip 
diameter of approximately 1 pm.
Reference electrodes were pulled in the same way but were not heat-polished 
and the electrode tips were gently broken back slightly to reduce the resistance 
o f the electrode to < 1 MQ to minimise contribution to the overall resistance of 
the circuit. The reference electrodes were backfilled as standard with NaCl or 
Na gluconate Locke using a Microfil 34G fused-silica syringe needle to create 
a salt-solution reference. Recording electrodes were backfilled in the same way 
with an appropriate recording solution.
Table 2.1 Chemical composition of physiological solutions
NaCl
Locke
(mM)
Na gluconate 
Locke 
(mM)
High K* 
solution 
(mM)
TRP 
K gluconate 
solution 
(mM)
TRP 
Na gluconate 
solution 
(mM)
NaCl 150 - 5 - 10
NaGluc - 150 5 - 140
KCI 3 3 140 2.5 -
KGluc - - - 140 -
CaCI2 2 2 1* - -
MgCI2 2 2 1 1 1
HEPES 10 10 10 5 5
EGTA - - 11 1.5 1.5
Z)-glucose 10 10 - - -
pH 7.4 7.4 7.2 7.35 7.35
* free [Ca ] has been m easured as 30 nM  by ion sensing electrode.
NB: Sodium -based solutions w ere adjusted  to desired to pH with N aO H  or HC1, and 
potassium -based solutions w ere adjusted  with KOH or HCI.
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2.4.3 Electrophysiology apparatus
An Ag-AgCl recording wire was connected to an I-V converter amplifying 
headstage (CV4, Axon Instruments) mounted on a Narishige HW-3 three- 
dimensional hydraulic micromanipulator. Electrical activity was represented 
visually on a Gould 400 oscilloscope (Gould Instrument Systems). Signals 
were amplified by an Axopatch ID amplifier (Axon Instruments) with filter 
cut-off at 5 kHz (unless otherwise stated) by a -3 dB, four pole Bessel filter, 
and then digitised at 20 kHz (unless otherwise stated) by a 12-bit AD converter 
(Digidata 1200A, Axon Instruments).
Due to the sensitivity of the patch-clamp technique, recordings were acquired 
within a Faraday cage surrounding an anti-vibration table (TMC 63-540) 
supplied by a Jun-Air Compressor Model 3, in order to minimise electrical and 
vibrational interference. As much as possible, all metallic apparatus and 
electronic instruments in use were electrically earthed, and mains circuitry 
supplying the apparatus was surge-protected.
2.4.4 Patch-clamp methodology
Cells were cultured on 16 mm circular glass coverslips at seeding densities o f
3,000 or 5,000 cells (see 2.1.3). Cultures were inspected by microscope before 
use to check they were healthy-looking (clean membranes, agranular) and 
subconfluent. In a class 2 laminar-flow cabinet, a coverslip was rinsed with the 
bathing solution and transferred to a Perspex recording chamber, using a small 
amount of petroleum jelly to hold it in place. Approximately 50 pi o f bathing
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solution was gently dropped onto the coverslip to form a convex meniscus of 
solution. The Perspex recording chamber was then transferred to the stage of 
the inverted microscope set on the antivibration table, and the reference 
electrode tip was placed into solution. At 100x magnification, the coverslip 
was visually scanned for physically isolated cells, which offered a higher seal 
success rate than tight clusters o f cells or confluent cultures. At 400* 
magnification, a cell was chosen to patch-clamp that was phase-bright, 
agranular and preferably not in contact with another cell. A recording electrode 
was backfilled with the appropriate solution and threaded over the Ag-AgCl 
wire and sealed into place. The electrode tip was advanced into solution and 
positive pressure was applied to prevent the build-up of debris on the tip. Any 
junction potential* that appeared was adjusted to zero with the DC offset on the 
amplifier (true junction potential corrections were made during data analysis as 
described in section 3.3.1.1.1). A 20 mV DC oscillating square-wave pulse 
(seal test) was applied across the electrode tip so that the electrode resistance 
could be determined from the current amplitude seen on the oscilloscope, using 
Ohm’s Law (R = V/I). Ideal electrode resistances1 were between 4 and 8 MQ 
with High K+ solution in the electrode and NaCl Locke as the bathing solution.
The recording electrode tip was advanced towards the cell using the 
micromanipulator and contact was seen both by the appearance of a halo 
around the electrode tip on the cell membrane and an increase in electrical 
resistance in the seal test. Positive pressure was removed and gentle suction
A junction  potential is created  when two solutions with different com positions com e into 
contact, and is created by d iffe ren t concentra tions o f  ions with different ionic m obilities.
+ The resistance gives a good indication  o f  electrode reproducibility.
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applied to form a seal, with application of depolarising voltage (typically 
around 60 mV) in some cases to encourage seal formation. Seals with electrical 
resistance in the giga-Ohm range (a giga-seal) were typically achieved quickly 
in a matter of seconds, but occasionally took up to 3 or 4 minutes with gentle 
encouragement by applying voltages, as above.
The patch-clamp techniques, as described by Hamill et al. (1981), were used to 
form desired patch configurations, and recordings were begun soon after at 
room temperature (20 -  26 °C) unless otherwise stated. Coverslips were 
discarded after approximately one or two hours because cells began to 
deteriorate significantly after this period.
2.4.5 Data acquisition and analysis
For cell-attached or excised patches, recordings of (usually) thirty seconds and 
between ±200 mV were made onto the hard-disk of a PC and saved as PAT 
files or EDR files, using Windows Electrophysiology Disk Recorder 
(WinEDR) software (Dr J. Dempster, University of Strathclyde). Data were 
regularly written to compact disk for analysis on a different PC, and for back­
up/storage purposes. For cell-attached and inside-out patch-clamp 
configurations, voltages and currents were inverted during analysis; the terms 
‘depolarisation’ (more positive) and ‘hyperpolarisation’ (more negative) used 
with regard to these configurations therefore refer to patch membrane potential 
rather than patch holding potential throughout this Thesis.
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Cell-attached and excised patch data recordings were analysed using WinEDR 
v2.2.4 or v2.5.9. Origin 7 software (OriginLab®) was used to perform 
statistical tests and to plot graphs. In statistical tests, significance was set at the 
0.05 level. Data are presented as mean ± SEM where n > 1.
2.4.6 Junction potential adjustments
To achieve true reversal potential values, liquid junction potentials were 
calculated and adjustments were made accordingly throughout the Thesis as 
described: the magnitudes o f the junction potentials were calculated using the 
generalised Henderson Liquid Junction Potential Equation (quoted from Barry 
& Lynch, 1991), giving the potential E o f bathing solution S  with respect to 
pipette solution P, by:
(Eqn. 2.1) 
where
S F =  2  l(ZiUi){af -  a f ) ]  / 2  [z}u,{af  -  af ) ]  (Eqn. 2.2)
1=1 /  i=i
N /  N
E S - E F =  (R T / F ) S f In X  t u r f  /  2
and where N  represents the number of polyvalent ions, and u, a and z 
respectively represent mobility, activity and valency o f each ion. The above 
complex equations can be simplified according to Barry & Lynch (1991) into 
the following equation for a simple bi-ionic setup:
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Fs Fr  _  R T  k V I  -  IIs. )  -  (up , up_)] . . [a f (np_. + »PJ ]
F  + t F j  - a p(up+ + wpJ ]  [< ^ ^ +  + w5-^]
(£</«. 2.3)
where « t and w represent the mobilities o f cations and anions. For the purpose 
of this thesis, the simplified equation 3.3 will be used to calculate junction 
potentials as the presence of other ionic species are relatively minor in 
concentration and will make very little difference to the final figures. Ionic 
mobilities with respect to K+ are quoted as K+ = 1.0, Na+ = 0.68, C f  = 1.04, 
gluconate = 0.33 (Barry & Lynch, 1991; Ng & Barry, 1995).
Therefore, with 140 mM KC1 in the pipette and 150 mM NaCl as the bathing 
solution at 293 K room temperature, the junction potential created is given by:
j*  r p [150(0.68-1.04) - 140(1-1.04)] . \140(I + 1.04)]
[150(0.68 + 1.04) -  140(1 + 1.04)] [150(0.68+ 1.04)]
— +4.5 mV (Eqn. 2.4)
and, with 140 mM KC1 in the pipette and 150 mM Na gluconate as the bathing 
solution, the junction potential created is:
Es Ep ~ 0.0252 [150(0.68 -  0.33) 140(1 -1.04)] In [140(1 + 1.04)]\ 150(0.68 + 0.33) 140(1 + 1.04)] [150(0.68 + 0.33)]
-6.92 mV (Eqn. 2.5)
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One further essential consideration is whether the calculated junction potential 
value should be added to or subtracted from the membrane potential (given 
here as Erev). For an intact cell-attached patch with a nullified patch-clamp 
amplifier, the membrane potential across the patch, Vm, is given by the 
equation:
according to Kirchoffs Loop Rule, where Em is the actual membrane potential, 
Vp is the patch potential, and El is the liquid junction potential between bath 
solution and pipette. This equation implies that the calculated junction potential 
value should be added to the membrane potential (or Erev) value, which shifts 
the curve along the abscissa of the I/V graph.
For an excised inside-out configuration patch, where Em = 0:
Therefore, the calculated junction potential values also require addition to the 
experimentally derived values.
V m =  ( Em -  Vp) +  E l Eqn. 2.6
Vm = - V P + El Eqn. 2.7
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2.5 Molecular Biology
2.5.1 RT-PCR
Some aspects of this work were carried out with the help of Dr. B.A.J. 
Evans at the Department of Child Health, School of Medicine, Cardiff 
University.
2.5.1.1 RNA Extraction
Method A: Total RNA was extracted ffom one 25 cm2 culture flask of 
MG63 cells (passage number 70) using the Midas® PureRNA Isolation Kit 
(Biogene, UK).
Method B : Total RNA was extracted from one 25 cm culture flask each of 
MG63 cells (passage number 34), LNCaP cells, DU 145 cells, MCF-7 cells, 
SaOS-2 cells, and HOB-c cells using Trizol® (Invitrogen) following the 
manufacturer’s protocols to give final volumes o f between 30 and 150 pi of 
product each time.
Following an overnight freeze-thaw cycle to -80 °C, each RNA sample 
was DNase treated with DNA-free (Ambion Ltd.) to clean up the product, 
according to the product protocol provided.
RNA was then quantified by absorption at 260 nm and 280 nm (A260/280). 
An absorbance ratio close to 2 (and at least > 1.6) was taken to be 
indicative o f high quality nucleic acid. For all samples reported in this 
Thesis, the A260/280 values were above 1.6. RNA samples were diluted
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when necessary with nuclease-free H2O to a maximum concentration o f 1 
jig p f1. RNA was aliquoted and stored at -80  °C.
2.5.1.2 Reverse transcription
Reverse transcription (RT) was carried out with the Promega Improm-II 
Reverse Transcription System, using 1 pg RNA in a 20 pi reaction (see 
Table 2.2 for composition) alongside a negative control, from which avian 
myeloblastosis virus (AMV) reverse transcriptase was omitted. The RNA 
template, primer and nuclease-free H2O initial 5 pi reaction mixture was 
run at 70 °C for 5 minutes then held on ice until needed. The RT was run at 
25 °C for 5 minutes annealing time, 42 °C for 60 minutes extension time, 
and 70 °C for 15 minutes to heat-inactivate the AMV-reverse transcriptase, 
in a Perkin Elmer 480DNA Thermal Cycler (Applied Biosystems, 
Cheshire). The cDNA product was stored at -20  °C.
Table 2.2 Composition of reverse transcription reaction.
Components Final concentrations Volumes
RNA tem plate • Jig
Random  Prim ers 0.5 pg 1 pi
N uclease-free H20 to 5 pi
Im prom -II™  5x Reaction Buffer lx 4 pi
M gC l2 (25 m M ) 3 mM 2.4 pi
dN TP m ixture (10 m M  each) 0.5 mM each dNTP 1 pi
R ecom binant RNasin® R ibonuclease 
Inhibitor
1 u/pl 0.5 pi
Im prom -II™  AM V Reverse 
Transcriptase*
15 u/pg 1 pi
N uclease-free H20 to 20 pi total volum e
* om itted from negative control reaction
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2.5.1.3 Polymerase Chain Reaction (PCR)
Amplification o f the cDNA took place in 12.5 pi or 25 pi reactions using 
oligonucleotide primers obtained from Invitrogen, Ltd. (see relevant 
chapter for primer details). PCR was conducted using the GoTaq® Flexi 
DNA Polymerase kit (Promega) and control reactions were carried out 
either with sterile nuclease-free water instead of cDNA, or using the no- 
AM V-RT reaction samples instead o f cDNA. The standard composition of 
PCR reactions is shown in table 2.3, but it should be noted that in some 
cases MgCL and oligonucleotide primer concentrations were adjusted for 
optimum performance and adjusted compositions are shown in the relevant 
chapters. The PCR amplification products were analysed by gel 
electrophoresis and stained with ethidium bromide, in 1 x TAE buffer*, and 
visualised under UV light.
Table 2.3 Composition of 12.5 pi PCR reactions
Components Final concentrations Volumes
5* Green GoTaq® Flexi Buffer lx 2.5 pi
M gC l2, 25 mM 1.5 mM 0.75 pi
PCR nucleo tide (dN T P ) m ixture 200 pM  each dN TP 1.25 pi
Forw ard prim er (sense) 0.4 pM 0.5 pi
R everse prim er (antisense) 0.4 pM 0.5 pi
GoTaq® DNA polym erase (5u p i '1) 0.3125 u 0.0625 pi
cDNA (or H20 ,  or N o-A M V .R T ) 0.5 pi
N uclease-free H20 to 12.5 pi
2.5.1.4 Sequencing
Visualised bands cut from agarose gels were dissolved in water and 
sequenced to confirm identity, using the same primers as in RT-PCR 
reactions.
* 40 mM  Tris-A cetate, 1 mM  ED TA
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3 FUNCTIONAL K+ CHANNELS IN 
OSTEOBLAST CELL MEMBRANES
3.1 Introduction
3.1.1 Potassium channels
With more than 80 genes identified, potassium channels are a large family of 
ion channels heterogeneously expressed in the cell plasma membrane 
controlling membrane potential. The roles o f K+ channels in excitable cells (i.e. 
those cells that can conduct action potentials such as neurones and myocytes) 
are clear and have been extensively studied, showing that K+ channels, for 
example, control the repolarisation rate following an action potential and firing 
patterns (Hille, 2001; Shao et al., 1999). Now the K+ channel family is 
emerging as a major player in non-excitable cells with important physiological 
roles in key cellular processes such as apoptosis (Burg et al., 2006), volume 
regulation (Lang et al., 2007), cell proliferation (Wonderlin & Strobl, 1996; 
Chandy et al., 2004), differentiation (Roura-Ferrer et al., 2008) and secretion 
(Moreau et al., 1997). As a variety o f potassium channel subtypes have been 
identified in bone (Gu et al., 2001a; Hughes et al., 2006; Moreau et al., 1996;
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Ravesloot et al., 1990; Yellowley et al., 1998; Weskamp et al., 2000) their 
presumed role is to contribute to these processes.
3.1.2 K channel subtypes
K+ channels can be divided into 5 subcategories by function and structure: 
voltage-gated K+ channels (Kv), calcium-activated K+ channels (Kca), inward- 
rectifier K+ channels (Kir), ATP-dependent K+ channels (Katp) and 2-pore 
domain K+ channels (K2p). This chapter will concentrate on maxi-K (BKca) and 
Katp channels which are described in detail below.
N S5S6
B
S U R
Figure 3.1 Architecture of the maxi-K and K a t p  channels. (A) maxi-K 
a subunits are 7-transmembrane (TM) domain structures which associate 
with 2-TM domain regulatory P subunits. Maxi-K has a unique calcium 
bowl near the end of the a subunit C-terminus. (B) Katp channels are built 
from pore-forming 2-TM domain structure homologous with Kir channels 
and multiple TM domain SUR regulatory subunits. (Figure adapted from 
Burg, et al., 2006).
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3.1.2.1 Calcium-activated i f  channels (Kca)
Kca channels have been subcategorized into large conductance (BKca), 
intermediate conductance (IKca) and small conductance (SKca) channels and 
each subgroup also has slightly different pharmacological characteristics. BKca 
(also known as maxi-K) channels have conductances in the range 150 -  300 pS 
and are typically >200 pS. They are voltage-dependent channels but an 
increased [Ca2+]j into the micromolar range shifts the Popen/V curve to the left 
indicating that calcium enhances the voltage activation of the channel. Because 
o f this calcium-dependence, maxi-K channels have been implicated in the 
negative feedback of voltage-dependent calcium channels (VDCC): increased 
[Ca2+]j by VDCCs activates maxi-K which causes membrane hyperpolarisation 
and subsequent inactivation of VDCCs, ultimately limiting calcium entry. 
Maxi-K channels are also sensitive to inhibition by the scorpion peptides 
charybdotoxin (CTX) and iberiotoxin (IbTX), and the non-specific K+ channel 
blocker tetraethylammonium (TEA).
The IKca and SKca channels are much less voltage-dependent than maxi-K and 
rectify at depolarising potentials due to intracellular block by divalent cations 
such as Mg2+ (Soh & Park, 2001; Xia et al., 1998). Conductance values range 
from 50 to 180 pS for IKo» and the much smaller 2 to 15 pS for SKca. Both are 
sensitive to block by TEA, and are more selectively blocked by clotrimazole 
(Ouadid-Ahidouch et al., 2004) or apamin (Stocker, 2004) respectively.
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The Kca channel a subunits which form the channel pore are structurally 
similar to those of the voltage-dependent K+ channels. The a subunits comprise 
six transmembrane domains S1-S6 for IKca/SKca, with an extra SO domain in 
the maxi-K a subunit. The S5-S6 pore-forming loop and K+ selective-region 
are highly conserved, and S4 contains positively charged arginine and lysine 
residues which confer voltage-sensitivity to the channel. SKca and IKca have 
fewer o f these residues than maxi-K which might explain the reduced voltage- 
dependence of these sub-types. The additional SO domain o f maxi-K is thought 
to link with regulatory p subunits which associate with the a subunits in a 1: 1 
stoichiometric ratio in this sub-type. All three sub-types form a tetrameric 
structures, with associated P subunits for maxi-K. The C-termini o f the a 
subunits are less conserved and maxi-K has a calcium-sensitive region (Toro et 
al., 1998) which is not found in IKca or SKca which instead rely on calmodulin 
binding near to the S6 transmembrane domain for their weaker calcium- 
sensitivity (Keen et al., 1999).
There are now four known maxi-K p subunit types, labelled pi -  P4. Each p 
double transmembrane-spanning subunit links with an SO domain o f the maxi- 
K a subunit and affects the channel’s calcium- and voltage-dependence and 
determines its pharmacology (Wang et al., 2002). The p subunits appear to 
heteromultimerise (Joiner et al., 1998) to create maxi-K channels with differing 
electrophysio logical and pharmacological profiles.
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3.1.2.1.1 BKca or maxi-K
The existence and role of maxi-K channels in excitable cells have been 
described previously (above and Hille, 2001) but maxi-K is also known to be 
almost ubiquitously expressed in mammalian tissues, including skeletal tissues 
(Grandolfo et al., 1992; Ravesloot et al., 1990). Evidence is building that the 
remit of maxi-K includes roles in bone cell metabolism, secretion, 
mineralisation, bone resorption, and apoptosis (Guggino et al., 1989; Moreau et 
al., 1996; Ypey et al., 1988). The channel composition with regard to p subunit 
arrangement and co-expression is currently unknown in bone cells and various 
conflicting reports of sensitivities to CTX and IbTX (Moreau et al., 1997; 
Rezzonico et al., 2002; Weskamp et al., 2000), and voltage-dependence have 
been made for MG63 osteoblast-like cells. As the p subunits likely 
heteromultimerise but can also homomultimerise, the possibilities for different 
pharmacological and electrophysiological profiles are 35 different 
permutations. The profile of the maxi-K channel in primary human osteoblasts 
so far remains unexplored.
3.1.2.2 A TP-dependent i f  channels
Katp channels are expressed in many tissues including pancreatic p cells 
(Schmid-Antomarchi et al., 1987), skeletal muscle (Chutkow et al., 1996), 
hippocampal cells (Mourre et al., 1989), liver (Malhi et al., 2000) and in some 
cancers (Kunzelmann, 2005), where they have roles in secretion, proliferation, 
and metabolism. Perhaps the best studied role of KAtp channels is in pancreatic 
P cells where they are involved in regulation of insulin secretion (Aguilar-
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Bryan & Bryan, 1999). High intracellular glucose is thought to increase [ATP]j 
which closes the channels, resulting in membrane depolarisation and Ca entry 
via VDCCs, which in turn causes insulin secretion (Ashcroft & Gribble, 2000). 
Amoroso et al (1990) have also identified a secretory role for Katp channels in 
Substantia Nigra GAB A release.
As the name suggests, these K+ channels are sensitive to changes in [ATP]j 
which inhibits the channel when at sufficient concentrations. Activation can 
occur by binding of nucleotide diphosphates (e.g. ADP) which in the presence 
of Mg2+j antagonise inhibition by ATPj, and channels are modulated by 
phospholipids (PIP2) which also decrease ATP-binding to the regulatory SUR 
channel subunit. Katp channels can be subcategorised into smaller conductance 
Kir6.1 channels (35 -  40 pS) or larger conductance KiR6.2 channels (65 -  80 
pS) according to their subunit composition, and also by their pharmacology. 
Both types are relatively voltage-independent and display inward-rectification 
at depolarising potentials due to time-dependent blockade by Mg ions in the 
pore (Lopatin et al., 1994). Probably all Katp subtypes are sensitive to some 
degree to inhibition by sulphonylureas such as glibenclamide and tolbutamide, 
but their pharmacological profiles differ with regard to Katp channels openers 
(KCOs). There is no clear pharmacophore link between the known KCOs, but 
they can be broadly categorised into four groups: benzothiadiazines (such as 
diazoxide), pyrimidines (such as minoxidil), cyanoguanidines (pinacidil), and 
benzopyrans (such as cromakalim or the eutomer levcromakalim).
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Figure 3.2 Structures of the K a t p  channel openers.
The structure o f the pore-forming subunits of Katp channels is similar to that 
of the inward-rectifier K+ channels, consisting of two transmembrane-spanning 
domains with a highly conserved pore-forming loop similar to that of the Kca 
channels. A large C-terminus domain is thought to act as a lining of p sheets 
and regulates inward rectification by Mg2+, and causes conformational changes 
to the pore in the closed state (Kuo et al., 2003; Nishida & MacKinnon, 2002; 
Yang et al., 1995). The Kir6 .x subunits alone do not form functional K+- 
conducting pores, but must be associated with regulatory sulphonylurea 
receptor (SUR) subunits, together forming an octameric channel complex in 
the stoichiometric ratio (Kjr6 .x /SU R )4 . ER retention motifs on both K|r6 .x and
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SUR subunits prevent membrane surface expression unless one is associated 
with the other (Zerangue et al., 1999). SUR subunits are members o f the ATP- 
binding cassette protein family and structurally consist of 17 transmembrane 
domains arranged into three groups of 6, 6 and 5, with 2 nucleotide-binding 
domains NBD1 and NBD2, which appear to be important for KCO and Mg- 
nucleotide binding.
There are two known genes for K i r 6 . x  forming two distinct subunit types 
which have different electrophysiological properties. These are K i r 6 . 1  and 
K i r 6 . 2 .  The SUR subunit type can also be genetically separated into SUR1 and 
SUR2, the latter of which also has two known variants labelled as SUR2A and 
SUR2B. The SUR composition of the Katp channels determines their 
pharmacology.
Katp subunit composition has been shown to be tissue specific (Ashcroft & 
Gribble, 2000). The pore-forming subunit in most tissues appears to be K ir6.2, 
except in some smooth muscle, such as vascular smooth muscle, in which it is 
Kir6.1 (Sakura et al., 1995; Inagaki et al., 1995). The SUR subunit specificity 
is more diverse, and SUR1 appears dominant in p cells and some neurones 
(Aguilar-Bryan et al., 1995; Liss et al., 1999), whilst SUR2A is regulatory in 
cardiac and skeletal muscle cells (Chutkow et al., 1996), whereas SUR2B takes 
precedence in smooth muscle and some neurones (Chutkow et al., 1996; 
Isomoto et al., 1996). The combinations of Kir6 .x/SU R  subunits make the 
pharmacology o f Katp channels complex, and therefore tissue-specific
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responses are found to KCOs, inactivators and modulators. For example, 
pinacidil is known to activate channels built with SUR2 but not SUR1, and the 
effect is greater for SUR2B than for SUR2A (Babenko et al., 2000), whereas 
diazoxide binds to and activates via SUR1 and SUR2B (Gribble et al., 1997; 
Shyng et al., 1997), but does not cause activation via SUR2A although it can 
increase activity in the presence o f MgADP (D’hahan et al., 1999).
Although the Kir6 .x/SU R  pharmacology is complex, the electrophysiology 
matches it in this regard and different subunit combinations with modulator 
binding differentials result in channel conductances seemingly anywhere 
between the smaller conductance K ir6.1 and larger conductance K|R6.2 in 
heteromultimers.
3.1.3 K channels have important roles in proliferation
The evidence for a functional role for K+ channels in cell proliferation is 
growing, but mechanisms are poorly understood. Hyperpolarisation of the cell 
membrane by activation o f Katp channels is thought to be necessary for early 
stage progression between the Gj growth phase and the S phase of the cell 
cycle (Wonderlin & Strobl, 1996), and KAtp channels have been implicated in 
cancer cell proliferation (Woodfork et al., 1995; Wondergem et al., 1998). 
Maxi-K channels may also have an important role in proliferation, as reported 
by Wondergem et al. (1998) who show increased HTB-9 human bladder 
carcinoma cell proliferation by presumed inactivation of maxi-K channels with 
CTX and IbTX.
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Direct increases in cell number have been reported with pinacidil on nephron 
epithelial tubules (Braun et al., 2002) and diazoxide on bladder carcinoma cells 
(Wondergem et al., 1998), and increases in DNA synthesis with pinacidil, 
cromakalim/levcromakalim and diazoxide (Braun et al., 2002; Malhi et al., 
2000; Wondergem et al., 1998). The Katp channel opener minoxidil has also 
been shown by others to increase DNA synthesis (Malhi et al., 2000) and to 
increase proliferation of various cell-types including fibroblasts, keratinocytes 
and stimulate hair follicles (Messenger & Rundegren, 2004). Other Katp 
openers have also been shown to increase hair growth (rate & thickness) 
including pinacidil (Goldberg et al., 1988), diazoxide (Burton et al., 1975) and 
cromakalim (Bulh et al., 1993), and minoxidil is a medicine licensed for use in 
androgenetic alopecia.
The roles o f maxi-K and Katp channels in bone cells are relatively unexplored, 
but these channels do appear to be involved in osteocalcin secretion by 
osteoblasts (Moreau, et al., 1997).
3.1.4 Chapter hypothesis, aims and experimental strategies
The chapter hypothesis is (i) that the maxi-K and Katp channels will be 
expressed and active in human osteoblast-like cell lines and primary 
osteoblasts, and (ii) that Katp ligands will have a functional role in MG63 cell 
proliferation.
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This chapter aims to establish the patch-clamp technique with MG63 and 
SaOS-2 cells, to demonstrate the abundance and activity o f K+ channels in 
MG63 and SaOS-2 osteoblast-like cell membranes, and show some of the first 
important data demonstrating that K+ channels are also active in primary 
human osteoblasts. RT-PCR will be used to confirm the expression of the 
maxi-K channel a and p i-4 subunits and Katp channel Kir6 and SUR subunits. 
The putative roles of Katp channels in osteoblast proliferation will also be 
explored, with the objective o f testing whether KAtp channels are important in 
osteoblast cell growth by means o f haemocytometry and MTS dye-conversion 
assays.
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3.2 Methods
3.2.1 Electrophysiology
MG63, SaOS-2 and HOB-c cells were seeded at densities o f between 3,000 and 
5,000 cells per coverslip and incubated for at least 24 hours before patch-clamp 
recording. Stock solutions o f drugs were prepared in distilled water unless 
otherwise stated, and were obtained from Sigma. HOB-c primary human 
osteoblasts with passage numbers between 4 and 10 were used.
The patch-clamp methods described in chapter 2 (2.4) were used, with freshly- 
pulled electrodes with a resistance of between 4 and 8 MQ (measured with 
High K+ in the pipette and Locke solution in the bath). Criteria for successful 
seals included a seal resistance o f > 1 GQ, low variance o f noise when 
channels were closed (RMS noise < 1), and stability over a range o f holding 
potentials.
3.2.1.1 Single channel analysis
Using Strathclyde electrophysiology Software WinEDR v2.8.2, recordings 
were initially scanned at low resolution by eye for potentially interesting 
events, anomalies, etc. followed by software construction o f distribution of 
current amplitude histograms for all digitised points to determine single­
channel current amplitudes and the number of channels active in the patch. 
Peaks were fitted with Gaussian probability density functions using the least 
squares method to estimate the mean current for the peak. From the Gaussian
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curve, estimates of the single channel open probability could be made from 
area under the curve, corresponding to the percentage of time spent in that 
current state, and provided that only one channel appeared in the patch.
Occasionally, in recordings from less-stable patches, or where current states 
were close together, the all points histogram was not successful at resolving 
current peaks, and the Patlak average method (Patlak, 1988) was used to 
construct current amplitude histograms. This method allows effective 
resolution o f peaks by averaging a sequence of digitised data points (user 
defined from 2 - 256) and excluding averages with a standard deviation that 
exceeds the variance of a portion o f closed state record. This effectively 
excludes transitional states, allowing construction of resolved peaks.
Transition detection was used to measure the transitions from channel closed to 
open states, and the dwell times in these states. This was achieved by placing a 
threshold at 50% o f the open single channel current level. This provided 
valuable open probability data (as NP0) and the dwell times for kinetic 
analysis. Logarithmic dwell time histograms (as described by Sigworth & Sine, 
1987) were constructed to determine how the length of open and closed states 
of the maxi K channel varied with changes in potential. Histograms were fitted 
with exponential probability density functions (least squares method) to reveal 
open (t0) or closed (xQ) time components.
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3.2.1.2 Filtering
The recording apparatus made use of in-built filters to decrease the amount of 
random electrical noise in the recordings. However, though filtering can be a 
very useful tool, heavy filtering may erase short-duration channel openings and 
in doing so, decrease the quality o f the data record. Also, in some cases rather 
than complete erasure o f short-duration openings, filtering results in failure to 
record the full amplitude o f a channel current, which has clear consequences 
for I/V plots and conductance calculations. Therefore, filtering has to be a 
payoff between improved signal/noise and minimising loss o f data quality.
The effective cut-off frequency o f filtering used in the experimental apparatus 
for the single-channel recordings detailed in this chapter can be calculated by 
the following equation (Colquhoun, 1994):
1 / / c2  =  1 / / 12 + 1 / / 2 2 . . . +  1 / / » 2
where f c is the effective cut-off frequency and / i ,  f i  and / n are the cut-off 
frequencies o f each filter in the system. Thus, in the system used here with a 20 
kHz filter and a 5 kHz filter, the calculated effective cut-off is 4.85 kHz. 
Another way to describe the level o f filtering is by the rise time, which is the 
time taken for a signal to rise from 10% of its low value to 90% o f its 
maximum value. The rise time, tT, is given by (Colquhoun, 1994):
tr = 0.3321 / / c
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Therefore, a 4.85 kHz filter has a rise time of 68 ps. The f c and /r values are 
important in determining the minimum duration of an event which can be 
detected at a specified fraction o f its full amplitude, which is often called the 
minimum resolvable event. Colquhoun & Sigworth (1983) showed that for the 
errors in duration of events caused by filtering to become negligible and for the 
signal to reach at least 90% o f its full amplitude, the minimum event duration 
needs to be above 1.3tT and for a reliable amplitude measurement, an opening 
must be above 2tT.
The minimum resolvable event for an opening at 90% of its full amplitude for 
the 4.85 kHz effective filter is given by 1.3/r which is 88 ps. Event durations 
shorter than double this value (for greater confidence), i.e. shorter that 176 ps, 
were not included in the kinetic analysis.
3.2.2 Cell growth assays
For proliferations and growth assays, cells were seeded at densities o f 3,000 
cells per well for 96-well plates and 50,000 cells per well for 6-well plates. 
Assays were generally read, unless otherwise stated in the results, after 72 
hours for 96 well-plates by MTS/PMS dye conversion and absorption 
measurements, and for 6-well plates assays were read at the intervals indicated 
by haemocytometry. See section 2.2.2 for details of the assay method. Stock 
solutions of pinacidil and tolbutamide were prepared in ethanol, and diazoxide, 
levcromakalim and glibenclamide were prepared in DMSO. Vehicle
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concentrations were kept to a minimum and vehicle controls were run 
alongside the test compounds during assays.
3.2.3 RT-PCR
General RT-PCR methods are detailed in Chapter 2: Materials and Methods, 
section 2.4.1.
3.2.3.1 Oligonucleotide primers: K a t p  channels and associated SUR subunits
Oligonucleotide primers for ATP-dependent potassium channel (K atp) 
subunits K ir6.1 (KCNJ8) and Kir6.2  (KCNJ11), and associated sulphonylurea 
receptor (SUR) subunits SUR1 (ABCC8) and SUR2B (ABCC9), as used by 
Curley et al. (2002) (see table 3.1 and Figure 3.3), were obtained from 
Invitrogen.
Table 3.1 Oligonucleotide primer details for K a t p  channels and associated 
SUR subunits
Primer Sequence Product size Location Acc. No.
Kir6.1 F :  C A T C T T T A C C A T G T C C T T C C  
R :  G T G A G C C T G A G C T G T T T T C A
334 560-893 NM 004982
Kir6.2 F :  A C T C C A A G T T T G G C A A C A C C  
R :  C T G C T G A G G C C A G A A A T A G C
353 1198-1550 D50582
SUR1 F :  ATG A G G A A G A G G A G G A A G A G  
R :  T C G A T GGT G T T  A C  A G T CAGA
493 2941-3433 L78207
SUR2B F :  T G G G A A C A C A T T T T C T G C A A  
R :  C G C A T G G G T C A C A A A T G T A G
150 1528-1677 NM 020297
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Figure 3.3 K a t p  and SUR subunit primers and amplification sequences.
Target primer sequences are shown in red.
Kir6.1
4 8 1  a g a a c a t c c g  t g a g c a a g g a  c g c t t t c t a c  a g g a c a t c t t  c a c c a c c t t g  g t g g a c c t g a
5 4 1  a a t g g c g c c a  c a c g c t g g t c  a t c t t t a c c a  t g t c c t t c c t  c t g c a g c t g g  c t g c t c t t c g
6 0 1  c t a t c a t g t g  g t g g c t g g t g  g c c t t t g c c c  a t g g g g a c a t  c t a t g c t t a c  a t g g a g a a a a
6 6 1  g t g g a a t g g a  g a a a a g t g g t  t t g g a g t c c a  c t g t g t g t g t  g a c t a a t g t c  a g g t c t t t c a
7 2 1  c t t c t g c t t t  t c t c t t c t c c  a t t g a a g t t c  a a g t t a c c a t  t g g g t t t g g a  g g g a g g a t g a
7 8 1  t g a c a g a g g a  a t g c c c t t t g  g c c a t c a c g g  t t t t g a t t c t  c c a g a a t a t t  g t g g g t t t g a
8 4 1  t c a t c a a t g c  a g t c a t g t t a  g g c t g c a t t t  t c a t g a a a a c  a g c t c a g g c t  c a c a g a a g g g
9 0 1  c a g a a a c t t t  g a t t t t c a g c  c g c c a t g c t g  t g a t t g c c g t  c c g a a a t g g c  a a g c t g t g c t
K,r6.2
1 0 8 1  t g g a a a c c a c  g g g c a t c a c c  a c c c a g g c c c  g c a c c t c c t a  c c t g g c c g a t  g a g a t c c t g t
1 1 4 1  g g g g c c a g c g  c t t t g t g c c c  a t t g t a g c t g  a g g a g g a c g g  a c g t t a c t c t  g t g g a c t a c t
1 2 0 1  c a a g t t t g g  c a a c a c c a t c  a a a g t g c c c a  c a c c a c t c t g  c a c g g c c c g c  c a g c t t g a t g
1 2 6 1  a g g a c c a c a g  c c t a c t g g a a  g c t c t g a c c c  t c g c c t c a g c  c c g c g g g c c c  c t g c g c a a g c
1 3 2 1  g c a g c g t g c c  c a t g g c c a a g  g c c a a g c c c a  a g t t c a g c a t  c t c t c c a g a t  t c c c t g t c c t
1 3 8 1  g a g c c a t g g t  c t c t c g g g c c  c c c c a c a c g c  g t g t g t a c a c  a c g g a c c a t g  t g g t a t g t a g
1 4  4 1  c c c a g c c a g g  g c c t g g t g t g  a g g c t g g g c c  a g c c t c a g c t  c a g c c t c c c c  c t g c t g c t c a
1 5 0 1  t c c a g g g t g t  t a c a a g g c a c  t t g t c a c t a t  g c t a t t t c t g  g c c t c a g c a g  g a a c c t g t a c
1 5 6 1  t g g g t t a t t t  t t g t c c c t g c  t c c t c c c a a c  c c a a t t t a g g  a c t g g c t c a c  c c c t c t c c c c
SUR1
2 8 8 1  c c a c a g a g c c  a c c c c a g g g c  c t a t c t c g t g  c c a t g t c c t c  g a g g g a t g g c  c t t c t g c a g g
2 9 4 1  a t g a g g a a g a  g g a g g a a g a g  g a g g c a g c t g  a g a g c g a g g a  g g a t g a c a a c  c t g t c g t c c a
3 0 0 1  t g c t g c a c c a  g c g t g c t g a g  a t c c c a t g g c  g a g c c t g c g c  c a a g t a c c t g  t c c t c c g c c g
3 0 6 1  g c a t c c t g c t  c c t g t c g t t g  c t g g t c t t c t  c a c a g c t g c t  c a a g c a c a t g  g t c c t g g t g g
3 1 2 1  c c a t c g a c t a  c t g g c t g g c c  a a g t g g a c c g  a c a g c g c c c t  g a c c c t g a c c  c c t g c a g c c a
3 1 8 1  g g a a c t g c t c  c c t c a g c c a g  g a g t g c a c c c  t c g a c c a g a c  t g t c t a t g c c  a t g g t g t t c a
3 2 4 1  c g g c t g t c t g  c a g c c t g g g c  a t t g t g c t g t  g c c t c g t c a c  g t c t g t c a c t  g t g g a g t g g a
3 3 0 1  c a g g g c t g a a  g g t g g c c a a g  a g a c t g c a c c  g c a g c c t g c t  a a a c c g g a t c  a t c c t a g c c c
3 3 6 1  c c a t g a g g t t  t t t t g a g a c c  a c g c c c c t t g  g g a g c a t c c t  g a a c a g a t t t  t c a t c t g a c t
3 4 2 1  g t a a c a c c a t  c g a c c a g c a c  a t c c c a t c c a  c g c t g g a g t g  c c t g a g c c g c  t c c a c c c t g c
3 4 8 1  t c t g t g t c t c  a g c c c t g g c c  g t c a t c t c c t  a t g t c a c a c c  t g t g t t c c t c  g t g g c c c t c t
SUR2B
1 4 4 1  c a g a a a a g t a  c a c t t g a t t a  t t c c a c t g a g  a g a c t c a a g a  a a a c a a a t g a  a a t a t t g a a a
1 5 0 1  g g c a t c a a a c  t t c t a a a a t t  g t a t g c c t g g  g a a c a c a t t t  t c t g c a a a a g  t g t g g a g g a a
1 5 6 1  a c a a g a a t g a  a a g a a c t a t c  t a g t c t c a a a  a c c t t t g c a c  t a t a t a c a t c  a c t c t c c a t c
1 6 2 1  t t c a t g a a t g  c a g c a a t t c c  c a t a g c a g c t  g t t c t t g c t a  c a t t t g t g a c  c c a t g c g t a t
1 6 8 1  g c c a g t g g a a  a c a a t c t g a a  a c c t g c a g a g  g c c t t t g c t t  c a c t g t c t c t  c t t c c a t a t c
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3.2.3.2 Oligonucleotide primers: Maxi-K channel a andp  subunits
Oligonucleotide primers for maxi-K (BKca) channel pore subunit a 
(KCNMA1) and associated (31 - p4 subunits (KCNMB1, KCNMB2, KCNMB3 
and KCNMB4) were designed from human mRNA coding sequence (CDS) as 
follows:
The National Center for Biotechnology Information’s (NCBI) nucleotide 
database was searched for the above maxi-K channel subunit genetic sequences 
in the human genome. mRNA sequences were copied into the ‘source sequence 
box’ o f the web-based Primer3 primer design software (Rozen & Skaletsky, 
2000). The software selected left and right primers for the given sequence 
without modification of the default software settings. Primer3-suggested 
primers were checked against the complete genetic sequence using Ensembl 
web-based software (Hubbard et al., 2007) to look for intron-spanning primers 
(i.e. where forward and reverse primer sequences are in different exons), which 
would also enable detection of unwanted genomic DNA in the reactions by 
larger amplicon size. Primers (see table 3.2 and Figure 3.4) were obtained from 
Invitrogen.
Table 3.2 Oligonucleotide primer details for maxi-K channel subunits
Primer Sequence Productsize Location Acc. No.
KCNMA1 F :  A C G C A A T C T G C C T C G C A G A G T T G  
R :  C A T C A T G A C A G G C C T T G C A G
408 1640-2047 AAA85104
KCNMBI F :  C T G T A C C A C A C G G A G G A C A C T  
R : G T A G A G G C G C T G G A A T A G G A C
189 668-856 NM 004137
KCNMB2 F :  C A T G T C C C T G G T G A A T G T T G  
R :  T T G A T C C G T T G G A T C C T C T C
237 808-1044 NM181361
KCNMB3 F :  A A C C C C C T T T T C A T G C T T C T  
R :  T C T T C C T T T G C T C C T C C T C A
277 1404-1680 NM J71830
KCNMB4 F :  G T T C G A G T G C A C C T T C A C C T  
R : T A A A T G G C T G G G A A C C A A T C
245 648-892 NM_014505
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Figure 3.4 Maxi-K channel a and pi - p4 subunit primers and 
amplification sequences. Target primer sequences are shown in red.
KCNMA1
1 5 6 1  a t c a t c a c t c  a a a t g c t g c a  g t a t c a c a a c  a a g g c c c a t c  t g c t a a a c a t  c c c g a g c t g g  
1 6 2 1  a a t t g g a a a g  a a g g t g a t g  a a g t t g g g  c t t c a t a g c c
1 6 8 1  c a g a g c t g c c  t g g c t c a a g g  c c t c t c c a c c  a t g c t t g c c a  a c c t c t t c t c  c a t g a g g t c a
1 7 4 1  t t c a t a a a g a  t t g a g g a a g a  c a c a t g g c a g  a a a t a c t a c t  t g g a a g g a g t  c t c a a a t g a a
1 8 0 1  a t g t a c a c a g  a a t a t c t c t c  c a g t g c c t t c  g t g g g t c t g t  c c t t c c c t a c  t g t t t g t g a g
1 8 6 1  c t g t g t t t t g  t g a a g c t c a a  g c t c c t a a t g  a t a g c c a t t g  a g t a c a a g t c  t g c c a a c c g a
1 9 2 1  g a g a g c c g t a  t a t t a a t t a a  t c c t g g a a a c  c a t c t t a a g a  t c c a a g a a g g  t a c t t t a g g a
1 9 8 1  t t t t t c a t c g  c a a g t g a t g c  c a a a g a a g t t  a a a a g g g c a t  t t t t t t a  •
2 0 4 1  a c a  t c a c a g a t c c  c a a a a g a a t a  a a a a a a t g t g  g c t g c a a a c g  g c t t g a a g a t
2 1 0 1  g a g c a g c c g t  c a a c a c t a t c  a c c a a a a a a a  a a g c a a c g g a  a t g g a g g c a t  g c g g a a c t c a
KCNMB1
6 0 1  g g g c a a g a a g  g t g c c c c a g t  a c c c a t g c c t  g t g g g t c a a c  g t g t c a g c t g  c c g g c a g g t g
6 6 1  g g c t g t g  • : • e g  g g a c c a g a a c  c a g c a g t g c t  c c t a c a t c c c
7 2 1  a g g c a g c g t g  g a c a a t t a c c  a g a c g g c c c g  g g c c g a c g t g  g a g a a g g t c a  g a g c c a a a t t
7 8 1  c c a a g a g c a g  c a g g t c t t c t  a c t g c t t c t c  c g c a c c t c g g  g g g a a c g a a a  c c a g c  •
8 4 1  • • g g g c  c c c a g g c c c t  c c t c t t c t c c  c t c t t c t g g c  c c a c c t t c c t
9 0 1  g c t g a c c g g t  g g c c t c c t c a  t t a t c g c c a t  g g t g a a g a g c  a a c c a g t a c c  t g t c c a t c c t
KCNMB2
7 2 1  g c t c c t c c t c  t a c c a c a c a g  a a g a g a c a a t  a a a a a t c a a t  c a g a a g t g c t  c c t a t a t a c c
7 8 1  t a a a t g t g g a  a a a a a t t t t g  a a g a a t c  t e a  t g g a a a a c t t
8 4 1  c a g g a a g t a t  c a a c a c t t c t  c c t g c t a t t c  t g a c c c a g a a  g g a a a c c a g a  a g a g t g t t a t
9 0 1  c c t a a c a a a a  c t c t a c a g t t  c c a a c g t g c t  g t t c c a t t c a  c t c t t c t g g c  c a a c c t g t a t
9 6 1  g a t g g c t g g g  g g t g t g g c a a  t t g t t g c c a t  g g t g a a a c t t  a c a c a g t a c c  t c t c c c t a c t
1 0 2 1  a t g t  t a g a t a  a a t g c a a a a a  t g g a t a a a a t  a a t t t t t g t t
1 0 8 1  a a a g c t c a a a  t a c t g t t t t c  t t t c a t t c t t  c a c c a a a g a a  c c t t a a g t t t  g t a a e g t g e a
KCNMB3
1 3 2 1  t a c a c a c c t a  a g t g c c a c c a  a g a t a g a a a t  g a t t t g e t e a  a c a g t g c t c t  g g a c a t a a a a
1 3 8 1  g a a t t c t t c g  a t c a c a a a a a  t g g  . . . .  . . . . a c a g t c c  a g c c a g c c a a
1 4 4 1  t c t g a a g a t g  t c a t t c t t a t  a a a a a a g t a t  g a c c a a a t g g  c t a t c t t c c a  c t g t t t a t t t
1 5 0 1  t g g c c t t c a c  t g a c t c t g c t  a g g t g g t g e e  c t g a t t g t t g  g c a t g g t g a g  a t t a a c a c a a
1 5 6 1  c a c c t g t c c t  t a c t g t g t g a  a a a a t a t a g c  a c t g t a g t c a  g a g a t g a g g t  a g g t g g a a a a
1 6 2 1  g t a c c t t a t a  t a g a a c a g c a  t c a g t t c a a a  c t g t g c a t t a
1 6 8 1  g c a g a g a a a t  e t t a a g a e g g  t g g c c a a a t t  a a a g t g c t g g  c c t t c a g a t g  t c t g t g a t t t
KCNMB4
5 4 1  g t g t c g c t c t  t c a t c t t c g g  c t t c t g c t g g  c t g a g t c c c g  e g e t g e a g g a  t c t g c a a g c c
6 0 1  a c g g a g g c c a  a t t g e a e g g t  g c t g t c g g t g  c a g c a g a t c g  g e g a g g t  r  ■ : , r  :
6 6 1  ' • g t g  g c g c c g a c t g  c a g g g g c a c c  t c g c a g t a c c  c c t g c g t c c a  g g t c t a c g t g
7 2 1  a a c a a c t c t g  a g t c c a a c t c  t a g g g c g c t g  c t g c a c a g c g  a c g a g c a c c a  g c t c c t g a c c
7 8 1  a a c c c c a a g t  g c t c c t a t a t  c c c t c c c t g t  a a g a g a g a a a  a t c a g a a g a a  t t t g g a a a g t
8 4 1  g t c a t g a a t t  g g c a a c a g t a  c t g g a a a g a t  g a  : • ■ :c t t g c t a t
9 0 1  t t t a a t c a a c  a t c a a a g a c c  a g a t g a t g t g  c t t c t g c a t c  g c a c t c a t g a  t g a g a t t g t c
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3.2.3.3 RT-PCR reaction compositions and conditions
Katp channels and associated SUR subunits
RT-PCR was carried out using MG63 (passage number 72) mRNA and the 
reaction compositions and conditions were optimised and are detailed in tables
3.3 and 3.4 respectively. Reactions of 12.5 pi were routinely performed and 
negative controls using nuclease-free water or no-RT reaction products from 
reverse transcription were run alongside reactions with cDNA. The PCR 
amplification products were analysed by gel electrophoresis in 1 % to 3.5 % 
agarose gels stained with ethidium bromide, in l x  TAE buffer*. K a t p  subunit 
products were not sequenced to confirm identity.
Table 3.3 PCR reaction composition ( K a t p  and SUR primers)
Components Final concentrations Volumes
5* Green GoTaq® Flexi Buffer lx 2.5 pi
M gC l2, 25 mM 1.5 mM 0.75 pi
PCR nucleotide (dN TP) mixture 200 pM  each dN TP 1.25 pi
Forw ard prim er (sense) 0.4 pM 0.5 pi
R everse prim er (antisense) 0.4 pM 0.5 pi
GoTaq® DNA polym erase (5u/pl) 0.3125u 0.0625 pi
cDNA (or H20 ,  or N o-A M V .R T) 0.5 pi
N uclease-free H20 to 12.5 pi
Table 3.4 PCR reaction conditions ( K a t p  and SUR primers)
Step Temperature °C Time No. of cycles
Initial denaturation 95 10 min 1
Denaturation 95 30 s
Annealing 55 45 s 30
Extension 72 1 min
Final extension 72 10 min 1
Soak 4 Indefinite
* Tris-A cetate-ED TA
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Maxi-K channel a and P subunits
RT-PCR was carried out using MG63 (passage number 34) osteoblast-like cell 
mRNA and the reaction compositions and conditions were optimised and are 
detailed in tables 3.5 and 3.6 respectively. Reactions o f 12.5 pi were routinely 
performed and negative controls using nuclease-free water or no-RT reaction 
products from reverse transcription were run alongside reactions with cDNA. 
The PCR amplification products were analysed by gel electrophoresis in 2 % 
agarose gels stained with ethidium bromide, in lx  TAE buffer*. Bands were 
cut from gels, stored in 50 pi sterile nuclease-free water, and cDNA eluted into 
the water was sequenced using the Big Dye® Terminator V 3.1 Cycle 
Sequencing Kit (Applied Biosystems, UK) by Central Biotechnology Services 
at Cardiff University.
Table 3.5 PCR reaction composition (Maxi-K a and p subunit primers)
Components Final concentrations Volumes
5 x Green GoTaq® Flexi Buffer 1* 2.5 pi
MgCl2, 25 mM 1.5 mM 0.75 pi
PCR nucleotide (dNTP) mixture 200 pM each dNTP 1.25 pi
Forward primer (sense) 0.4 pM 0.5 pi
Reverse primer (antisense) 0.4 pM 0.5 pi
GoTaq® DNA polymerase (5u/pl) 0.3125u 0.0625 pi
cDNA (or H20 , or No-AMV.RT) 0.5 pi
Nuclease-free H20 to 12.5 pi
Table 3.6 PCR reaction conditions (Maxi-K a and p subunit primers)
Step Temperature °C Time No. of cycles
Initial denaturation 95 10 min 1
Denaturation 95 30 s
Annealing 55 45 s 40
Extension 72 1 min
Final extension 72 10 min 1
Soak 4 Indefinite
* Tris-Acetate-EDTA
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3.2.4 Statistical methods
Distributions of current histograms from patch recordings were fitted with 
Gaussian distributions, the means o f which were taken as the zero level or 
channel current for each peak. Exponential probability density functions 
(PDFs) were fitted to dwell-time histograms according to best fit, to derive 
channel dwell time values. Statistical significance at the 0.05 level was tested 
using appropriate student /-tests, or analysis of variance with Bonferroni’s 
mean comparison test to identify significantly different groups. Data shown are 
mean ± SEM.
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3.3 Results
3.3.1 Ion channel activity in osteoblasts and osteoblast-like cells
Analysis of single channel data from patch-clamp experiments reveals distinct 
channel currents which indicates that a variety of ion channels are present and 
active in MG63 osteoblast-like cells, SaOS-2 osteoblast-like cells, HOB-c 
human primary osteoblasts and LNCaP and DU 145 prostate cancer cells (data 
not shown for the latter two cell lines). For the purposes of analysis and 
discussion, these will be categorised into large conductance, intermediate 
conductance and small conductance channels.
3.3.1.1 The large-conductance channel
By far the most prevalent channel observed, particularly in the osteoblasts and 
osteoblast-like cells, was a large conductance, voltage-dependent channel. 
With high K solution in the electrode, this channel was observed in 98% (n = 
49/50) of successful cell-attached {i.e. > 1 GO seal, RMS noise < 1.0) MG63 
patches, 72% (n = 18/25) of SaOS-2 patches and 100% (n = 17) of HOB-c 
patches. Conductance values were obtained by linear regression over the linear 
portion of the current-voltage plots.
3.3.1.1.1 Cell-attached
The large conductance channel was rarely spontaneously active at 0 mV 
holding potential, and no recordings were possible in the few instances of 
channel activity. This channel type became active on depolarisation > 90 mV,
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but once ‘primed’ the channel remained active over the voltage range -100 mV 
to +200 mV.
The mean single channel conductance in MG63 cells with high K solution in 
the electrode and Locke as the bathing solution was 198.7 ± 9 pS (n = 8) with a 
corrected reversal potential (Erev) (adjusted for junction potential - see methods 
2.4.6) o f 60.7 ± 7.7 mV. In the same cell-type, changing the bathing solution to 
sodium gluconate Locke resulted in channels with a mean conductance of
212.5 ± 15 pS (n = 6) and a corrected Erev of 56.18 ± 6.7 mV (see Figure 3.5, 
for example). When the electrode solution and bathing solution were both 
sodium gluconate Locke the unitary conductance of the channel was 221.8 pS 
(n = 1) and the curve was shifted to the left with a real Erev of 7.8 mV.
There was no significant difference between mean single channel conductances 
(p  < 0.05) for the three different combinations o f electrode/bathing solutions, 
but the Erev for the channel in the sodium gluconate Locke electrode/sodium 
gluconate Locke bathing solution was significantly different {p < 0.05) from 
the Erev values with the other combinations of solutions (Figure 3.6).
Observational data from HOB-c cells (n = 2) indicated the presence of a 239.5 
± 6.4 pS channel, Erev = 68.6 ± 4.8 mV in High K electrode solution and Locke 
bathing solution.
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In many patches more than one large conductance channel was active, 
particularly at depolarising patch potentials above 140 mV. Figure 3.5 shows 
data records with 3 and 4 channels opening together in MG63 cells. Channel 
open probability ( P open) increased with each increase in patch potential, 
showing that this channel-type is voltage dependent. As there were often two 
or more channels active per patch, NPo was used as a measure of open 
probability, in which N is the number o f channels in the patch and Po is the 
open probability of the channel. 20 mM TEA applied to the outside of cell- 
attached patches in the electrode solution (n = 13 patches) resulted in a 
complete absence of maxi-K channel activity in these patches, at a patch 
potential (120 mV) where the channel was previously active in other cell- 
attached patches (n = 41). A x test showed statistical significance between the 
control and TEA groups for channel activity (p < 0.001).
In all cell-attached recordings in all three osteoblast and osteoblast-like cell- 
types used, the channel current increased linearly with increasing potential up 
to around 140 mV. Further increases in potential, between around 140 mV and 
200 mV, resulted in a decrease in single channel current but at the same time a 
marked increase in channel open probability. This I/V ‘tailing’ at high 
potentials was seen in all cell-attached patch recordings o f this channel type 
(Figure 3.7).
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3.3.1.1.2 Excised inside-out
This patch configuration often displayed active large conductance channels at 0 
mV patch potential. Current amplitudes decreased with depolarising potentials 
and dropped to zero for potentials higher than around 50 mV, but increased 
with hyperpolarising potentials.
In MG63 cells, with High K solution in the electrode and Locke solution 
bathing the cells, the mean slope conductance from excised inside-out 
recordings was 154.2 ± 4.7 pS (n = 8) and the extrapolated corrected mean Erev 
of these channels by polynomial curve fitting was 43.9 ± 4.7 mV (see Figure 
3.8 for an example). In experiments where sodium gluconate Locke was 
substituted for Locke solution, the mean conductance was 129.8 ± 4.9 pS (n = 
2) with a corrected mean Erev o f 59.78 ± 12.6 mV.
Calculating using the Goldman-Hodgkin-Katz equation (equation 3.8), the 
channel was selectively permeable for potassium over sodium by between 4: 1 
(minimum Erev) and 24: 1 (maximum Erev) with High K / Locke, and by 
between 8: 1 and 30: 1 with High K / Na gluconate Locke.
E = 58 |0g + a[^a]| Ec>n 1 8  
PkINc-*- a[Na]„
where E is the reversal potential and a is the channel selectivity ratio Pk/Pn3.
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In the excised inside-out patches, 20 mM TEA applied to the external side of 
the patch (in the patch electrode) resulted in an absence of channel activity at 
potentials where channel activity was previously seen (n = 9) (Figure 3.8).
For HOB-c cells, inside-out patch recordings revealed I/V plots with channel 
conductances of 180.2 ± 4.2 pS (n = 3) with extrapolated slopes revealing a 
corrected mean Erev of 44.5 ±6.5 mV with High K solution in the electrode and 
Locke solution bathing the cells. All o f these patches had two or more active 
large conductance channels, and the example given in Figure 3.9 shows at least 
6 channels active. The channel was selective for potassium over sodium by 
between 5: 1 and 19: 1.
In SaOS-2 cells, a single I/V plot yielded a slope conductance of 193.9 pS and 
with a corrected Erev of 35.9 mV with High K solution in the electrode and 
Locke as the bathing solution (Figure 3.10). From this recording, the channel 
was selective for potassium over sodium by 5: 1.
3.3.1.1.3 Similar characteristics in MG63, SaOS-2 and HOB-c cells 
Figure 3.11 demonstrates that the large conductance channels are 
electrophysio logically similar in all three osteoblast or osteoblast-like cell 
types, both in the cell-attached and excised inside-out configurations, although 
the mean cell-attached conductance value for HOB-c cells was higher than for 
MG63 cells (244 ± 10.3 pS, n = 3 vs. 199 ± 5.1 pS, n = 12). Patch membrane
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reversal potentials (Erev) were similar for all three cell lines in both cell- 
attached and inside-out mode.
3.3.1.1.4 Large conductance channel kinetics
Log-square distribution plots of open and closed times were constructed 
(Figure 3.12) for MG63 cell large conductance single-channel data at 90 mV, 
110 mV and 140 mV to determine if increases in P open with increasing potential 
were due to more short openings, or longer periods of channel openings. Open 
and closed time distribution peaks were fitted with exponential probability 
density function curves where possible. The slower components o f the closed 
dwell time curve fits (xc) decreased with increasing potential from 34 ± 2.1 ms 
at 90 mV to 8.549 ± 0.43 ms at 140 mV. The open dwell time fast component 
t 0i did not appear to change with increasing potential, but the slow component 
t 02 increased from 1.343 ± 0.157 ms at 90 mV to 5.514 ± 0.3 ms at 140 mV.
3.3.1.1.5 Maxi-K activation following application o f glutamate
A short series of experiments was conducted in MG63 cells to test the Ca2+- 
activation o f the large conductance channel reported above, and to further 
confirm the identity o f this channel. Applications of glutamate were made to 
Mg2+-free bathing solution (Locke) of cell-attached patches, held at 100 mV 
depolarising potential, to give final concentrations of 2 pM glutamate or 100 
pM glutamate (Figure 3.13). Coverslips of cells were changed between each 
application, so all cells recorded were naive to glutamate. Patches selected 
were considered to have maxi-K channel activity at +100 mV before glutamate
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application by measurement of the channel current (> 8 pA). 2 pM glutamate 
caused a delayed increase in channel activity (delayed between 25 and 50 
seconds) in 4/7 patches (in the remaining 3 patches the seal became unstable 
and broke during or immediately after glutamate application). Application of 
100 pM glutamate (to different cells) caused marked and almost immediate 
increases in maxi-K activity in 6/8 patches (again, in the remaining 2 patches 
the seals were broken on glutamate application).
3.3.1.2 The 149 pS conductance channel
This channel type was recorded in 12% of successful MG63 cell-attached 
patches with High K solution in the electrode. From these recordings, I/V plots 
were created and slope conductances were derived from 3 patches. The mean 
single channel conductance was 149.9 ± 2.31 pS (n = 3) with a mean reversal 
potential, Erev, of 55 ± 8.96 mV. Channel activity was voltage-dependent over 
depolarising potentials. A representative example is shown in Figure 3.14.
3.3.1.3 The 45 p S  conductance channel
This channel was recorded in 3 cell-attached patches with High K solution in 
the electrode (1 HOB-c cell, 2 MG63 cells) and had a mean single channel 
conductance of 45.46 ± 1.1 pS (n = 3) and a mean Erev of 52.5 ± 4.8 mV. This 
channel-type did not appear to be voltage dependent over the hyperpolarising 
and depolarising potentials used, but was densely packed in each patch with at 
least 6 or 7 channels active per patch (Fig 3.16). The channel displayed inward 
rectification at depolarising potentials.
93
CH A PTER 3: FUNCTIONAL 1C CH A N N ELS IN OSTEO BLA ST CELL M EM B RA NES
Table 3.x Summary of Chapter 3 patch-clamp findings
Categorised into 3 groups according to channel conductance, from the data for which 
I/V plots could be constructed, (c/a: cell-attached, i/o: inside-out).
MG63 HOB-c SaOS-2
High K / 
Locke
High K / 
Na gluconate
Na gluconate / 
N a gluconate
High K / 
Locke
High K / 
Locke
c/a
198.7 ± 9 pS
E rev 60.7 ± 7.7 mV 
(n = 8)
212.5 ± 15 pS
Erev 56.2 ± 6.7 mV 
(n = 6)
221.8 pS
Erev 7.8 
(n = l)
239.5 ± 6.4 pS
Erev 68.6 ± 4.8 mV 
(n = 2)
i/o
154.2 ±4.7 pS
Erev 43.9 ± 4.7 mV 
Pk/P n3= 14:1 
(n = 8)
129.8 ±4.9 pS
Erev 59.8 ± 12.6 mV 
Pk/Pn. = 19:1 
(n = 2)
180.2 ±4.2 pS
Erev 44.5 ± 6.5 mV 
Pk/P nh= 12:1 
(n = 3)
193.9 pS
Erev 35.9 mV
Pk/P n3= 5 :1
( n = l )
c/a
149.9 ±2.31 pS
Ercv 55 ± 8.96 mV 
(n = 3)
149.8 pS
Erev 37.6 mV 
( n =  1)
c/a
43.7 ± 0.7 pS
Erev 48.2 ± 1.4 mV 
(n = 2)
49 pS
Erev 61.1 mV 
(n = 1)
3.3.2 Extracellular calcium and serum concentration changes 
affect MG63 cell growth
Small adjustments to the free calcium concentrations [Ca2+]0 of DMEM culture 
medium (Invitrogen) by chelation with EGTA appeared to result in growth 
differentials o f MG63 osteoblast-like cells after chronic exposure (days). Wells 
with 1.2 mM [Ca2+]0 contained significantly more cells at days 9, 12 and 13 (p 
> 0.05) compared to wells containing the standard (control) 1.8 mM [Ca2+]0 
(see Figure 3.16). Between 2 and 8 days there were no significant differences 
between cell numbers. Wells containing 0.6, 2.4 or 3.0 mM [Ca2+]c were not 
significantly different from the control wells. MG63 cells grown in DMEM 
with foetal bovine serum concentrations of 0 %, 0.1%, 0.5 %, 1 % and 5 % 
showed increased cell numbers with increasing serum concentrations after 72
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hours exposure (Figure 3.17). This may possibly be due to chelation o f the 
calcium, the effects of which would be larger in the smaller concentrations of
_____________  i
serum. The above effects of ffee-Ca dependent proliferation probably share a 
common mechanism, which is likely to be mediated by the calcium-sensing 
receptor (see discussion).
3.3.3 Effect of K a t p  ligands on MG63 cell growth
The Katp channel-blocking sulphonylureas glibenclamide and tolbutamide, and 
the Katp channel openers pinacidil (cyanoguanidine-type), diazoxide 
(benzothiadiazine-type) and levcromakalim (benzopyran-type) were tested at 
various concentrations against the proliferation of MG63 osteoblast-like cells 
over a period of days (72 hours).
After 72 hours of exposure, pinacidil significantly increased MG63 cell 
numbers (P < 0.05, n = 3) at 30 pM, 100 pM and 300 pM compared to vehicle 
control wells (Figure 3.18). Neither diazoxide 0.1 -  300 pM (Figure 3.19), nor 
levcromakalim 0.1 -  100 pM (Figure 3.20), had any significant effect on cell 
numbers after 72 hours exposure.
The sulphonylurea glibenclamide significantly decreased cell numbers at 100 
pM and 300 pM (P < 0.05) whereas lower concentrations had no significant 
effect during the same time. Similarly, tolbutamide significantly decreased cell 
numbers at 300 pM (P < 0.05) but had no significant effect at lower 
concentrations (Figure 3.21).
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In an attempt to begin to map out the pharmacology of the pinacidil-induced 
proliferation of MG63 cells, low non-growth inhibiting doses of glibenclamide 
(10 pM) or tolbutamide (10 pM) were exposed to the cells in combination with 
pinacidil (0.1 -  300 pM). After 72 hours exposure, neither glibenclamide nor 
tolbutamide blocked the proliferative effects of pinacidil, and significant 
increases (P < 0.05) in cell numbers were observed at 30, 100 and 300 pM 
pinacidil with either tolbutamide or glibenclamide (Figure 3.22).
3.3.4 RT-PCR: K channels in MG63 cells
3.3.4.1 MG63 osteoblast like cells contain mRNA fo r  K a t p  channel & SUR 
subunits
The expression of K A t p  channels Kir6.1 (KCNJ8) and Kir6.2 (KCNJ11) and 
associated sulphonylurea receptor subunits SUR1 (ABCC8) and SUR2B 
(ABCC9) in MG63 cells was confirmed by RT-PCR as shown in Figure 3.23.
3.3.4.2 MG63 osteoblast-like cells contain mRNA fo r  maxi-K channel 
subunits
RT-PCR confirms the presence of the maxi-K channel a pore-forming subunit 
KCBMA1 and all four known associated P subunits KCNMB1, KCNMB2, 
KCNMB3 and KCNMB4 in MG63 osteoblast-like cells (Figure 3.24). 
Sequencing o f the products confirmed the identity o f all five maxi-K channel 
subunits.
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3.4 Discussion
3.4.1 Channel activity
3.4.1.1 The large conductance channel
The large conductance, voltage-dependent channel has the hallmarks of the 
maxi-K channel. Channel characteristics were very similar for the primary 
human HOB-c osteoblasts and the MG63 and SaOS-2 human osteoblast-like 
cell lines, in either cell attached or excised inside out configuration, with cell 
attached conductances of 244 pS (n = 3) in HOB-c cells and 199 pS (n = 12) in 
MG63 cells. Single channel I/V plots showed that replacement o f 140 mM K+ 
in the electrode with 150 mM Na+ (as sodium gluconate) shifted the curve to 
the left. This shift was probably due to maxi-K channel outward rectification 
caused by the potassium differential across the membrane and the selectivity of 
the channel for K+, but there are no data at less positive potentials to prove this.
The voltage-dependent inactivation of the maxi-K channels (i.e. the tailing 
effect o f I/V curves) at high depolarising potentials has been identified 
previously and is a hallmark of the maxi-K channel. Yellen (1984a; 1984b) 
reports that the effect is due to internal Na+ blockade of the channel pore, but 
Goodwin et al. (1998) report observations of this phenomenon in excised 
patches of fibroblasts in the absence of Na+ and suggest an intrinsic channel 
gating mechanism. Goodwin et al. (1998) also report the maxi-K channel 
‘priming’ shown here.
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The maxi K channel was seen in so many patches of osteoblasts and osteoblast­
like cells, and in such numbers per patch, that it must be densely packed in the 
cell membrane and fairly evenly distributed rather than in tight clusters. If we 
were to calculate the approximate number of channels per cell from these 
single channel data, we might take an average of three channels per 1 pm2 
patch of membrane (which is perhaps erring on the conservative side) and 
calculate channel number per cell (membrane) as follows: an osteoblast of 
diameter 30 pm, assuming spherical shape for ease of calculation, will have a 
surface area of 47ir2:
4n x 152 = 2827.4 pm
2827.4 x 3 channels = 8482 channels per cell
This is clearly not an insignificant number of maxi-K channels. If  we were to 
calculate the total conducting capacity o f the channels in the membrane, taking 
a value of 220 pS per channel:
8482 x 220* 10'12 = 1.866 pS per cell.
Although maxi K is not active at rest in osteoblasts, the channel may contribute 
to plasma membrane potential following cytosolic calcium dumping, and the 
channel may have other important regulatory roles in these cells. A series of
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whole-cell experiments could be carried out in future studies to confirm the 
above figures and the contribution of the channel to membrane potential.
The glutamate-induced current activation in MG63 cells provides further 
evidence that this large-conductance channel is indeed maxi-K. Osteoblasts, 
including the MG63 cell-line, have been previously reported to express 
functional neuronal-type N-methyl-D-aspartate (NMDA) receptors (Mason et 
al., 1997; Gu et al., 2000; Laketic-Ljubojevic et al., 1999), which are known to 
be blocked by Mg in MG63 cells in a voltage-insensitive way (Gu et al., 
2002), and also several alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic 
acid (AMPA) and kainate glutamate receptor subtypes (see Taylor, 2002a/b for
7+review). By applying glutamate to these cells in Mg -free solution, the 
NMDA-type glutaminergic receptors, or the AMPA/kainate receptors,
'7+presumably allow Ca influx as previously reported which therefore results in
7+Ca -activation o f large conductance channels. This effectively shows that the 
osteoblastic large conductance channel reported in this Thesis is Ca2+-activated 
and is supportive of the conclusion that this belongs to the maxi-K channel 
type.
3.4.1.2 The 45 p S  conductance channel
This channel (45.46 ±1.1 pS; n = 3), although only seen in a small number of 
patches, is active at rest and hyperpolarising potentials, seemingly inwardly 
rectifies in the cell-attached configuration in 140 mM K+ and is voltage- 
independent. Although not seen often enough to begin to create a
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pharmacological profile using patch clamping, it is possible that this channel 
belongs in the inward-rectifier ( K ir )  family o f K + channels, and possibly is of 
the K a t p  subtype although ATP-sensitivity has not been systematically tested 
here.
3.4.1.3 The 149 pS conductance channel
This channel (149.9 ± 2.31 pS; n = 3) was voltage-sensitive and activated by 
depolarising potentials, after which it remained active below reversal potential 
and at hyperpolarising potentials. During recording, the channel appeared to 
behave as a maxi-K channel might and although the conductance is rather low 
and quite different from maxi-K channels discussed in 3.4.1.1, this channel 
might yet be maxi-K as it remains in the very broad window o f conductance 
values for this channel type. Alternatively, the channel could be another 
member o f the SLO K+ channel family, such as SL02.2 -  a putative Na+- 
activated K+ channel with a conductance range of 100 -  180 pS. However, 
SL02.2 is much more weakly voltage-sensitive than maxi-K (also known as 
SLOl) due to the positive charges on the maxi-K S4 domain o f the a  subunit 
being absent, and replaced with two negative charges. Also, it has been 
suggested in a review by Salkoff, et al. (2006) and by Joiner et al. (1998) that 
heteromultimerisation of the a subunits o f maxi-K (SLOl) and other members 
of the SLO family might occur, resulting in functional and pharmacological 
diversity.
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Due to a lack of evidence, it is impossible to make any meaningful conclusions 
about the identity of this channel and the intermediate conductance channel 
will not be discussed further in this thesis. Further experimentation with 
pharmacological agents would be useful to identify this channel in future work.
3.4.2 Extracellular calcium concentration affects MG63 growth
These experiments demonstrated that small <1 mM changes in [Ca2+]0 made to 
the cell culture medium can be detected by osteoblast-like cells. Decreasing 
[Ca2+](> from the standard 1.8 mM Ca2+ of DMEM culture medium to 1.2 mM 
caused significant cell proliferation. The detection of such small changes in 
[Ca2+]0 are thought to be due to surface membrane calcium-sensing receptors 
(CaR) which have been shown to be expressed in osteoblast-like cells (Dvorak 
et al., 2004). Foreman et al. (2006) have also reported a role for extracellular 
calcium in proliferation and differentiation of primary bone marrow stromal 
cells, in the form o f calcium oscillations which can be evoked by serum- 
containing medium. There is no evidence to date that the maxi-K channel is 
able to directly detect extracellular calcium concentration in the physiological 
range 1 -  3 mM, although the HERG channel (human ether-a-go-go related 
gene, or Kvl l . l )  does have an extracellular calcium sensor which has been 
shown to have the ability to detect within this narrow range (Johnson et al., 
1999; Johnson et al., 2001) and Hofer (2005) has reviewed the evidence, 
indicating that extracellular Ca2+ signalling and detection may be more 
significant and diverse than previously thought.
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3.4.3 Effect of K a t p  ligands on MG63 cell growth
While the ATP-sensitive potassium channel openers diazoxide and 
levcromakalim had no effect on MG63 proliferation (cell numbers) over the 
concentrations and durations o f exposure tested, the third opener, pinacidil, 
caused definite and significant increases in cell numbers at higher 
concentrations which were not attenuated by growth-uninhibiting 
concentrations of the sulphonylureas. These data alone begin to paint a 
confusing picture of what the K ir6 . x/S U R  channel compositions might be in 
osteoblast-like cells as the SUR subunits and splice variants identified to date 
are each thought to be able to bind several KCOs in different combinations and 
with different affinities. It is possible that although pinacidil is the only agent 
that caused proliferation, other KCOs might have affected signalling pathways 
or secretions not explored by this work, as has been reported with diazoxide 
which did not increase cell number but increased protein accumulation in 
bladder carcinoma cells (Wondergem et al., 1998). Alternatively, proliferation 
induced by pinacidil might involve a different, unknown mechanism from Katp 
activation.
In MG63 cells, the sulphonylureas alone inhibited growth at higher 
concentrations, similar to those reported on other cell- and tissue-types with 
serum-containing media (Braun et al., 2002; Malhi et al., 2000; Wondergem et 
al., 1998). The growth inhibiting concentrations (> 100 pM) are higher than 
reported channel blocking concentrations ( 1 - 1 0  pM), but as sulphonylureas 
are well documented to bind to plasma proteins in serum-containing medium
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resulting in lower free sulphonylurea concentrations, this is hardly surprising. 
The consequences of sulfonylurea-plasma protein binding on growth inhibiting 
concentrations have also been reported previously by Wondergem et al. (1998).
These data add yet more weight to the argument that K+ channels have an 
important role in the cell cycle, promoting proliferation in human osteoblasts.
3.4.4 RT-PCR: K channels in MG63 cells 
3.4.4.1  Expression o f  K A t p  subunits
The expression of mRNAs for both pore-forming Kir6.1 and Kir6.2 subunits, 
and for SUR1 and the SUR2B splice variant (of SUR2) adds weight to the 
proliferation data and the single channel data. From the semi-quantitative band 
intensities o f the ethidium bromide-stained gel, Kir6.1 and K ir6.2 mRNAs 
appear to be fairly equally expressed. Heteromultimers o f Kir6. 1 and Kir6.2 
subunits forming the pore may be responsible for the 44 pS value of the 
conductance for the presumed Katp channel, derived from a combination of 
conductance values from ho mo multimeric KiR6.1 channels at 33 -  40 pS and 
homomultimeric K ir6.2 channels at 65 -  80 pS in 140 mM K+. The expression 
of SUR1 and SUR2B should result in channel sensitivity to all the KCOs and 
blockers used, although the membrane protein-expressed K ir6.x/SU R  subunit 
combinations remain unknown.
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3.4.4.2 Expression o f  maxi-K subunits
MG63 cells express mRNA for the pore-forming a subunit and all four 
associated p subunits which determine the channel pharmacology. While P2, 
P3 and P4 show similar levels of expression, pi band intensities remained low 
even with 40 cycles of PCR. The RT-PCR data confirms maxi-K channel 
presence in MG63 cells and suggests that if heteromultimers were to form, that 
more likely combinations would include P2, p3 and P4 subunits than pi.
3.4.5 Chapter conclusions and future work
Parts (i) and (ii) o f the hypothesis were both deemed to be true. Both maxi-K 
and K a t p  channels have been identified in human osteoblast-like cells, and for 
the first time the BKca channel is shown to be expressed in primary human 
osteoblasts. There is evidence o f a proliferative role for K a t p  channels in 
human osteoblasts cells as demonstrated by the K a t p  opener pinacidil, and 
maxi-K channels may also have a regulatory role in bone cell growth, possibly 
by [Ca ]0 detection or regulation o f the cell resting membrane potential 
following calcium dumping. The surface membrane maxi-K channel p subunit 
composition in osteoblasts is yet to be discovered, but mRNAs for all four p 
subunits are expressed. Similarly, K At p  channel subunit composition requires 
attention in these cells to begin to understand pharmacology o f the channel and 
the mechanisms behind the proliferative effects. Extracellular calcium 
concentration also appears to be important in bone cell growth and minor 
concentration changes can be detected at the cellular level. In summary, this
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chapter delivers the fullest description yet of the maxi-K channel in bone and 
therefore may be a useful reference for future work in this area.
The results presented in this chapter open up many further questions that 
require addressing in future work, but some immediate suggestions for follow- 
up investigations include:
• the determination of the maxi-K channel subunit composition at protein 
level in osteoblasts, and the consequences of this for maxi-K 
pharmacology in these cells with various known K channel openers and 
blockers
• clarifying the role maxi K channels play in osteoblastic signalling 
pathways involving cytosolic and extracellular calcium
• the role o f maxi-K channels in the functions of osteoblasts, considering 
the abundance of the channel in the plasma membrane, and the 
consequences of maxi K gene knockout on bone, taking advantage of 
recent developments in tissue-specific gene knockout technologies
• further work on the identification o f the intermediate conductance K 
channel observed in osteoblasts, including building a pharmacological 
profile of the channel and importantly determining ATP sensitivity
• in conjunction with the previous suggestion, further investigate the 
interesting effects of pinacidil on osteoblasts including proliferation and 
mineralisation, extending the work to other similar KCOs (such as 
nicorandil and minoxidil)
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Figure 3.5 Large conductance (maxi-K) channel in MG63 cell cell- 
attached patch. (High K pipette, Na gluconate bath) (A) Raw data 
showing at least 3 channels in this patch (140 mV) (B) Patlak average 
distribution of current histogram from data record at 140 mV, showing 
peaks at 11.12 pA and 22.27 pA. (C) I/V plot from these data recordings. 
Single channel conductance y = 207.4 pS (40 to 80 mV), R2 = 0.99417. 
d>) NPo/V plot shows that these channels increase in activity with 
increasing potential.
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Figure 3.6 Large conductance (maxi-K) channels in MG63 cells.
Recorded in the cell-attached configuration. (A) shows mean I/V plots for 
patches with different solution combinations in the electrode and bathing 
the cells respectively, according to the key. Plots are adjusted to mean Erev 
for each curve and are corrected for calculated junction potentials. •  n = 7,
Erev = 60.7 ± 7.7 mV; •  n = 3, Erev = 56.18 ± 6.7 mV; •  n = 1, Erev = 7.8 
mV. (B) Same data as for A, with Erev values corrected to 0 mV for each 
curve for comparison and superimposition. Mean slope conductances are 
very similar: •  y = 186.7 pS; •  y = 191.5 pS; •  y = 221.8 pS.
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Figure 3.7 Examples of maxi-K I/V curves with slopes tailing-off at 
high potentials. These examples are typical of all maxi-K channels seen 
and recorded. Current increases linearly with potential at first, but a point is 
reached after which the current begins to decrease with further increases of 
potential. This is accompanied by a further rise in Popen-
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Figure 3.8 Large conductance (maxi-K) channels in MG63 excised 
inside-out patch. (High K pipette, Locke bath). (A) Raw data records show 
at least 2 channels in the patch. (B) 20 mM external TEA blocks this channel 
(at -60 mV) (C) Patlak average distribution of current histogram at -50 mV 
shows current peaks at -12.64 pA and -25.6 pA. (D) I/V plot showing 
inward rectification and uncorrected Erev = 64.2 mV. Single channel 
conductance y = 136 pS (R2 = 0.99936). Junction potential-corrected Erev =
64.2 + 4.5 = 68.7 mV.
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Figure 3.9 Maxi-K channel data from HOB-c cell excised inside-out 
patch. (High K pipette, Locke bath). (A) Data recording at -40 mV patch 
potential. 6 distinct current levels indicate at least 6 ion channels in the patch. 
(B) Patlak average distribution of current histogram with peaks at -12.71 pA, 
-25.18 pA, -37.42 pA, -49.42 pA and -61.01 pA. (C) I/V plot showing slope 
conductances (linear regression, -100 mV to -40 mV) of 178.3 pS (R2 = 
0.997), 351 pS (R2 = 0.976), 553.3 pS (R2 = 0.994), 717.8 pS (R2 = 0.998) 
and 900 pS (R2 = 0.993). (D) I/V plot (n = 3 cells) showing Ere, = 60 mV. 
When corrected for junction potential, Erev = 60 + 4.5 = 64.5 mV.
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Figure 3.10 Maxi-K channel data from an SaOS-2 cell excised inside-out 
patch. (High K pipette, Locke bath). (A) Data recording at -50 mV patch 
potential. 5 distinct current levels indicate at least 5 ion channels in the patch. 
(B) Patlak average distribution of current histogram, at -50 mV, with peaks at - 
13.91 pA, -25.99 pA, -36.65 pA, -46.17 pA and -54.85 pA. (C) I/V plot 
showing channel reversal potential EreV = 31.4 mV, corrected for junction 
potentials to EreV = 31.4 + 4.5 = 35.9 mV. Slopes (linear regression, -100 mV to 
-40 mV) reveal conductance states of 193.9 pS (R2 = 0.99812), 380.7 pS (R2 = 
0.99834), 572.1 pS (R2 = 0.99844) and 775 pS (R2 = 0.99902).
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Figure 3.11 Comparison of maxi-K channels in MG63, SaOS-2 and 
HOB-c cells. (High K pipette, Locke bath). (A) I/V plot from cell-attached 
patches of MG63 (n = 12) and HOB-c (n = 3) cells, adjusted to Erev = 0. 
Mean MG63 maxi-K conductance y = 199 pS (R2 = 0.999); mean HOB-c 
maxi-K conductance y = 244 pS (R2 = 0.999). (B) I/V plot from excised 
inside-out patches of MG63 (n = 9), HOB-c (n = 3) and SaOS-2 (n = 1). 
Erev = 63.1 mV from mean of the slopes by Boltzmann curve fit, corrected 
for junction potentials to Erev = 63.1 + 4.5 mV = 67.6 mV and Pk/Pn3 = 23.
1 1 2
tc = 34 ± 2.106 ms
5:
1:
'O'
:oo
150
= 0.1387 ± 0.01 ms 
= 23.35 ± 0.6579 ms100
10410-'0'
•0
= 0.1737 ± 0.006 ms 
= 8.549 ±0 .4313  ms400
:oo
• C 10'10*' >
Closed :1m** m'Si Oot»d tm« ims'
300
:59
150 t0i = 0.1062 ± 0.01 ms 
t o2 = 1.343 ± 0 .1 5 7  ms100
50
I01
400
350
300
250
200
t 0] = 0.1393 ± 0.01 ms 
t o2 = 2.805 ± 0.1909 ms
150
100
50
10110* 10-
i 0i = 0.1228 ± 0.006 ms 
t o2 = 5.514 ± 0.3 msiij :ooh
io- 1C'
Figure 3.12 Dwell time histograms demonstrating that increase in Popen in maxi-K cell-attached patches of MG63 cells is due to 
longer states of channel opening, and not just more short openings. Patch holding potentials are (A) +90 mV, (B) +120 mV and (C) 
+ 140 mV.
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Figure 3.13 G lutam ate enhances maxi-K channel activity in MG63 
cells. A at +100 mV patch potential, 2 pM glutamate increases maxi K 
channel activity after 40 s. B also at +100 mV patch potential, 100 pM 
glutamate markedly increases maxi-K channel activity almost immediately
after application. The mechanism is presumably that glutamate-induced2+ 2+Ca influx through NMDA channels causes Ca -activation of the maxi-K 
channel. Data shown are representative examples of experimental results.
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Figure 3.14 An example of the intermediate conductance channel 
recorded in MG63 cells (High K pipette, Locke bath). (A) A sample of 
data record showing channel openings at +140 mV. (B) Distribution of 
current histogram at the same patch potential showing a current peak at 
12.34 pA. (C) I/V plot fitted with a line of best fit by linear regression over 
40 to 150 mV giving a conductance of 154 pS (R2 = 0.994) and an Erev of 
60 mV, corrected for junction potentials to Erev = 60 + 4.5 = 64.5 mV.
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Figure 3.15 A representative example of the small conductance 
channels in MG63 osteoblast-like cell-attached patches. (A) shows the 
density and activity of this channel type, with at least 6 current states 
shown in the data record at -100 mV patch potential. (B) is a distribution of 
current histogram displaying 6 current states which are multiples of -6.432 
pA. (C) NPo/V plot showing this channel type is not voltage dependent 
over the range shown. (D) I/V plot from the 6 current states giving a single 
channel conductance of 44.4 pS from the slope by linear regression (R = 
0.99).
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Figure 3.16 Effects of |Ca2+J0 on MG63 cell growth. 1.2 mM [Ca2+]0 
appears to cause maximum proliferation in MG63 osteoblast-like cells. 
This result was significant at the 0.05 level after 12 and 13 days treatment.
1 6 - —• - 0 . 6  mM Ca2 
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Figure 3.17 Effects of foetal bovine serum on MG63 cell growth.
Proliferation of MG63 cells is shown to be serum-dependent.
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PirvacjcM concentration (pM) Pinacidil concentration (pM)
Figure 3.18 Effects of the K a t p  channel opener pinacidil on MG63 cell 
proliferation. After 72 hours exposure, MG63 cell numbers were 
significantly greater at concentrations of pinacidil between 30 pM and 100 
pM (n = 3. Figures are representative of at least 6 experiments). * indicates 
significance at the 0.05 level.
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Diazoxide concentration (^M)
Diazoxide concentration (^M)
Figure 3.19 Effects of diazoxide on MG63 cell numbers. Diazoxide did 
not significantly affect MG63 cell numbers over the concentration range 
and exposure times tested (n = 2).
Levcromakalim concentration (^M)Levcromakatim concentration (mM)
Figure 3.20 Effects of levcromakalim on MG63 cell numbers.
Levcromakalim did not significantly affect MG63 cell numbers over the 
concentration range and exposure times tested (n = 2).
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G libendam ide concentration (^M)Totbutamide concentration (iiM)
Figure 3.21 Effects of sulphonylureas on MG63 cell numbers. 300 jiM
tolbutamide and > 100 pM glibenclamide significantly reduced MG63 cell 
proliferation after 72 hours exposure (figures are representative of 3 
experiments per sulphonylurea). * indicates significance at the 0.05 level.
Pinacidil concen tration  ( ^ )
Pinacidil concentration  (nM)
Figure 3.22 Effects of pinacidil + sulphonylureas on MG63 cell 
numbers. Low concentrations of sulphonylureas did not attenuate 
pinacidil-induced increases in MG63 proliferation. Figures are 
representative of 3 experiments per sulphonylurea. * indicates significance 
at the 0.05 level.
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1000 -
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Figure 3.23 RT-PCR confirms presence of K a t p  channels in MG63 
cells. The two pore-forming subunits Kir6.1 and Kir6.2, and the 
associated sulphonylurea receptor subunits SUR1 and the splice variant 
SUR2B are expressed. Kir6.1 = 334 bp, Kir6.2 = 353 bp, SUR1 = 493 
bp, SUR2B = 150 bp.
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Figure 3.24 RT-PCR confirms the presence of maxi-K channel subunits 
in MG63 osteoblast-like cells. (A) The pore-forming a subunit KCNMA1, 
and (B) all four known associated P subunits, KCNMB1-4, are expressed, 
a = 407 bp, pi = 189 bp, p2 = 236 bp, P3 = 276 bp, P4 = 245 bp.
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4 TRP CHANNELS IN OSTEOBLASTS AND 
OTHER HORMONE-SENSITIVE CELLS
4.1 Introduction
Since the discovery of the defining transient receptor potential (TRP) channel 
in Drosophila, an entire superfamily of ion channels has been described which 
have an ever-increasing remit of roles within cells, as these become known. 
Functions are diverse and range from taste receptors (Zhang et al., 2003) to 
pain receptors (Cahalan et al., 1997) and regulators of cell Ca2+ and Mg2+ (den 
Dekker et al., 2003; Nadler et al., 2001). A general overview o f the TRP 
channel superfamily is given in the introduction to this thesis (section 1.4). As 
with the K+ channels in chapter 3, what is curious is the expression of TRP 
channels that were originally identified in excitable cells, with clearly defined 
roles such as temperature sensation and nociception (e.g. Cahalan et al., 1997; 
McKemy et al., 2002), being discovered in non-excitable cells such as prostate 
and breast cells (Sanchez et al., 2001; Tsavaler et al., 2001; Fixemer et al., 
2003).
124
C H A PTER  4:
TRP CH A N NELS IN O STEO B LA STS AND O TH ER  H O RM O N E-SEN SITIV E CELLS
Cancers of the prostate and breast will often metastasise to the bone (Buijs & 
van der Pluijm, 2008) and therefore these tissues must share some common 
signalling factors and receptors, which might include some of the TRP 
channels that have been identified in prostate and breast cancers, as discussed 
below. Identification of TRP channels which are common to these tissues will 
act as a basis for the electrophysio logical exploration o f a chosen channel or 
channels in osteoblasts, as bone is currently a tissue in which TRP channels are 
relatively unexplored and uncharacterised.
4.1.1 Bone metastases: the ‘seed and soil’ hypothesis
Whilst it is well known that localised primary breast and prostate cancer 
tumours eventually become much more aggressive and invasive, and that these 
tumour cells migrate to, and thrive particularly well in bone, the reasons for 
this remain only partially understood. The ‘seed and soil’ hypothesis (Paget, 
1889), which is more than 100 years old, describes the early concept of a 
relationship between the tumour cells (seed) and metastatic site (soil) enabling 
the tumour to thrive in a non-native environment, and that certain ‘soils’ are 
better for particular ‘seeds’. But why should breast or prostate cancer cells find 
the bone environment particularly attractive?
Breast cancer metastases in bone tend to be osteolytic, and parathyroid 
hormone-related peptide (PTHrP) is thought to be one responsible factor as 
PTHrP levels are increased in breast cancer metastases o f the bone (Powell et 
al., 1991; Brydon et al., 2002). PTHrP secreted by breast cancer cells acts on
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bone PTH receptors, stimulating RANKL (receptor activator of nuclear factor- 
kB ligand) production which ultimately stimulates osteoclastic bone resorption 
and therefore relinquishes space for breast tumour cells to proliferate (Mundy, 
2002).
Prostate cancer metastases, on the other hand, tend to be osteoblastic 
(osteogenic) and osteoblast proliferation may be stimulated by growth factors 
such as EGF (endothelin growth factor) (Mundy, 2003; Yin et al., 2003), TGF- 
p (transforming growth factor) (Marcelli et al., 1990) and FGF (fibroblast 
growth factor) (Izbicka et al., 1996). Tumour progression from androgen- 
dependence to more aggressive androgen-independence may be mediated by 
interleukin-6 (IL-6) (Wallner et al., 2006).
4.1.2 TRP channels in bone metastases
It is now recognised that a variety of ion channels may have important roles in 
tumour survival and progression, including K A t p  channels (Klimatcheva et al., 
1999), L-type calcium channels (Wang et al., 2000), chloride channels (Shuba 
et al., 2000), IKca channels (Parihar et al., 2003), EAG K channels (Farias et 
al., 2004; Pardo et al., 1999), Kv channels (Wang, Z. et al., 2004), maxi-K 
channels (Bloch et al., 2005) and various others as described in a review by 
Kunzelmann (2005). TRP channels also have putative roles in cancer cell 
function. The cold-sensitive channel TRPM8 is known to be highly expressed 
in early stage androgen-sensitive prostate cancer compared with normal tissue 
and down-regulates in line with androgen receptor expression, and therefore
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androgen-sensitivity, and metastasis (Bidaux et a l , 2005; Tsavaler et at., 2001; 
Zhang & Barritt, 2006). More recently, TRPV6, a highly calcium-selective 
cation channel, has been recognised as playing a part in prostate cancer 
proliferation (Lehen’kyi et al., 2007) and as TRPV6 expression is regulated by 
vitamin D (Taparia et al., 2006), channel expression in bone could have 
implications for calcium regulation. Bianco et al., 2007 show that TRPV6 
appears to play a role in calcium homeostasis of the bone. TRJPV1 has also 
been shown to express differently in prostate and bladder cancers compared to 
normal tissues/cells (Lazzeri et al., 2005; Sanchez et al., 2005) and capsaicin 
appears to inhibit androgen-sensitive prostate cancer progression (Mori et al.,
2006).
Table 4.1 TRP channel expressions in cancers
TRP channel Expression in 
cancer
Changes in expression in 
cancer
References
TRPV1 Prostate, colon, 
pancreas, bladder
Increased expression in 
prostate, colon and pancreatic 
cancers.
Decreased expression in later 
stage bladder cancer.
D om otor et al., 2005 
H artel et al., 2006 
Lazzeri et al., 2005 
S anchez et al., 2005
TRPV6 Prostate, breast, 
colon, thyroid, ovary
G enerally increased 
expression.
F ixem er et al., 2003 
Peng et al., 2000 
Peng et al., 2001 
W issenbach et al., 
2004a
Zhuang et al., 2002
TRPM 8 Prostate, Pancreas Increased expression in later 
stage prostate cancer -  linked 
to androgen receptor 
expression.
B idaux et al., 2005 
Tsavaler et al., 2001 
M ergler et al., 2007 
Zhang & Barritt, 2004
A dapted and updated from Prevarskaya et a l., 2007
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4.1.3 TRP channel expression and activity in osteoclasts
Whilst the literature covering TRP channels in osteoblasts was notably absent 
at the beginning of this thesis (early 2005), there was some new evidence that 
TRP channels had important roles in osteoclasts. The highly calcium-selective 
TRPV5 channel was found to be expressed in osteoclasts and seemingly 
‘essential’ for osteoclastic function (van der Eerden et al., 2005). In 2006, the 
heat-activated channel TRPV1 was shown to be expressed in human 
osteoclasts with a putative role in resorption activity (Brandao-Burch et al.,
2006). Arnett (2008) has extensively researched the effects of pH changes on 
osteoclast and osteoblast activity, and TRPV1 is now emerging as a candidate 
for the sensor of extracellular pH changes in these cells.
4.1.4 Evidence of functional TRP channels in bone
At the start of the work for this thesis in 2005, there were some early 
indications that some members of the TRP channel superfamily might populate 
bone cells and have important roles in the functions of these cells. Mice bred 
with the TRPV5 gene deleted showed reduced bone thickness and 
hypercalciuria (Hoenderop et al., 2003b) which implied that TRPV5 was 
involved in bone cell function. TRPM7 was also emerging as a potentially 
interesting channel in bone, as zebrafish with a mutant TRPM7 channel had 
defective skeletal growth (Elizondo et al., 2005).
Given that there are now 28 known mammalian TRP channels, a selection of 
five TRP channels were chosen for investigation based on the information
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discussed above These were TRPV1, TRPV6 and TRPM8 based on their 
expressions in prostate and breast cancers, TRPV5 as this channel co- 
assembles with TRPV6 and shares many characteristics including its Ca 
selectivity and sensitivity to parathyroid hormone and vitamin D3, and finally 
TRPM7 due to its putative roles in skeletogenesis and cell proliferation 
(Hanano et al., 2004).
4.1.5 Chapter hypotheses, aims and experimental strategies
The first hypothesis of this chapter was that all five of the selected TRP 
channels TRPV1, TRPV5, TRPV6, TRPM7 and TRPM8 would be expressed 
at mRNA level in human osteoblasts, and breast and prostate cancer cell lines, 
for the reasons discussed immediately above.
The second hypothesis, bom from the results o f the first hypothesis, was that 
TRPV1 would be expressed as a channel in the plasma membrane of MG63, 
SaOS-2 and primary human osteoblasts, and meet the criteria set out below.
A number o f essential criteria were used to determine whether channel currents 
recorded were due to TRPV1 activation, based on the channel characteristics 
summarised by Alexander et al. (2004). These four criteria were:
• the channel should be activated by the defining TRPV1 agonist capsaicin 
within the concentration range 1 - 1 0  pM (EC50 has been reported as 0.48 
in HEK cells at pH 7.4 (Ryu et al., 2007)) and blocked by 1 pM 
capsazepine.
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• the activation of the channel by capsaicin should be potentiated by protons 
(by decreasing the extracellular pH with HC1), by measure of increasing 
channel open probability at a particular capsaicin concentration with 
decreasing pH.
• the channel conductance should be around 80 pS in physiological solutions 
at depolarising potentials, as measured from the slope of I/V plots.
• the channel should display voltage-dependent outward rectification around 
0 mV patch potential.
Experimental aims and strategies were: to show the expressions o f the above 
TRP channel messages in MG63, SaOS-2, LNCaP, DU145, MCF-7 and HOB- 
c cells using the Trizol® RNA extraction method, and RT-PCR followed by 
ethidium bromide-stained gel electrophoresis; to use the single-channel patch- 
clamp technique (Hamill et al., 1981) to activate and record the TRPV1 
channel in human osteoblasts; and to use RT-PCR to establish the presence of 
any TRPV1 splice variants.
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4.2 Methods
4.2.1 Electrophysiology
Patch-clamp recording methods and analysis were as described in the methods 
(chapter 2, section 2.3) and the previous chapter (chapter 3, section 3.2.1).
4.2.2 RT-PCR
General RT-PCR methods are detailed in the methods (chapter 2, section 
2.4.1).
4.2.2.1 TRP oligonucleotide primer design
Oligonucleotide primers for five TRP channel mRNA sequences (TRPV1, 
TRPV5, TRPV6, TRPM7 and TRPM8) were designed from human mRNA 
CDS, as described in section 3.2.3.1 of chapter 3 for maxi-K primer design. 
Primers (see table 4.2 and Figure 4.1 for details) were obtained from 
Invitrogen.
Table 4.2 Oligonucleotide primer details for TRP channels.
P rim e r S equence
P ro d u c t
size
L oca tion Acc. No.
TRPV1
F :  G C C T G G A G C T G T T C A A G T T C  
R :  T C T C C T G T G C G A T C T T G T T G
177 2062-2238 N M _ 0 18727
TRPV5
F :  G G A G C T T G T G G T C T C C T C T G  
R :  G A A A C T T A A G G G G G C G G T A G
185 1143-1327 NM  019841
TRPV6
F :  T T G A G C A T G G A G C T G A C A T C  
R :  T C T G C A T C A G G T G C T G A A A C
237 764-1000 NM  018646
TRPM 7
F : T G G G A A G G C T G A A T A T G A G G  
R :  T T C C A T G G G G A T C T C T T C T G
197 2481-2677 N M _017672
TRPM 8
F :  C A T T G T G T G T T T T G C C C A A G  
R :  T T G A C G G C A G A A G A T G T C A G
165 940-1104 NM  024080
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Figure 4.1 TRP channel primers and amplification sequences. Target
primer sequences are shown in red.
TRP VI
1981 c g tc tg a g tc  cacgtcgcac aggtggcggg  
2041 acaacagcct g ta c tc c a c c  t g c c t g g a g c  
2101 tg g a g ttc a c  tg a g a a c ta t g a c ttc a a g g  
2161 t a a t tc tc a c  c ta c a tc c tc  c tg c tc a a c a
2 2 2 1  i i i g a t c g c  a c a g g a y a g c  a a g a a c a tc t  
2281 acacggagaa g a g c t tc c t t  aa g tg c a tg a
TRPV5
1081 c tg a c c tc c a  t tc tc ta c g a  cctcacagag  
1141 c t g g a g c t t g  t g g t c t c c t c  tg a ta a a c g a  
1201 gtgaaggagc tg g tg a g c tt  caagtggaac  
1261 g c tg c c t tg t  a c c tg c tc ta  c a tg a tc tg c  
1321 a a g t t t c g t g  gtggcaaccg c a c tc a t t c t  
1381 ctacaggagg cc ta tgag ac  a c g tg a a g a t
TRPV6
661 g g c a c tg c c t tccgccg tag  tc c c tg c a a c  
721 t t t g c t g c c t  g tg tgaacag  tg ag gag atc  
781 tccgggccc aggactccc t gggaaacaca 
841 a a a a c c t t tg  cc tg ccag a t g ta c a a c c tg  
901 c tg cag cccc  tg g a c c tc g t gcccaatcac  
961 g tg gag g g ta  a c a c tg tg a t g t t t c a g c a c  
1021 a c g ta tg g a c  c a c tg a c c tc  g a c tc tc ta t
TRPM7
2401 c c t t a a g t ta  g c a g t t t c t t  caag a c tta g  
2461 g t t g t t a t c t  g a ta tg tg g a  t g g g a a g g c t  
2521 c a ta c ta a g c  a t t t t a g t t c  c a c c tg c c a t  
2581 a a tg tc c c a t  a tc c c a c a a t c tc a a g a tg c  
2641 c a a c t t tc a g  aacataacag  a a g a g a t c c c  
2701 g g a ta g ta a t gaaggaaaga a tg ag atg ga
TRPM8
841 tc a tg g a c a t  c c c a c tg tc g  aagcaaagct 
901 g c g c a c ta tt  c a a g a ttc c a  a c ta tg g tg g  
961 aggtggaaaa g a g a c tttg a  aagccatcaa  
1021 g g tgg tggaa ggctcgggcc ag atcg ctg a  
1081 tg cc  : ; t g c c g  T ggagaa
1141 c c g g c tg c c t gaggaggaga c tg a g a g ttg
g g c c tg c c tg  caggcccccc g a ta g c tc c t  
t g t t c a a g t t  caccatcggc atgggcgacc  
c t g t c t t c a t  c a tc c tg c tg  c tg g c c ta tg  
tg c tc a tc g c  c c tc a tg g g t gagactg tca  
ggaagctgca gagagccatc  acca tcc tg g  
g g a a g g c c tt ccgctcaggc aag ctg c tg c
a tc g a c tc c t  ggggagagga g c tg tc c t tc  
gaggctcgcc a a a ttc tg g a  acagacccca  
a a g ta tg g c c  g g c c g ta c t t  c tg c a tc c tg  
t t ta c c a c g t  g c tg c g t t a  ccgcc<  
cgagacatca  c c a tc c tc c a  gcaaaaacta  
a tc a tc a g g c  tgg tggggga gctggtgagc
c tc a t c ta c t  ttgg g g ag ca  c c c t t tg tc c  
gtg cgg ctg c  te a  a g c a  t g g a g c t g a c  
g tg tta c a c a  tc c t c a tc c t  ccagcccaac  
t t g c t g t c c t  acgacagaca tggggaccac  
cag g g tc tc a  c c c c t t tc a a  gctggctgga  
c t g a t g c a g a  ageggaagea cacccagtgg  
gacctcacag  a g a tc g a c tc  c tcag g gg at
a c c t t t t g t a  g c tc a c a c c t g ta c a c a a a t  
g a a t a t g a g g  a a a a a t tc c t  gg tacaaggt 
a t t g e t g t t a  g a g ta ta a a a  c taag g ctg a  
tc a tc a g a tg  a c a a tg g a tg  acagcgaaaa  
c a t g g a a g t g  t t ta a a g a a g  t a e g g a t t t t  
g a ta c a a a tg  aaa tc a a a a a  a g c ttc c a a t
ccggaatcag  c ta g a g a a g t a ta tc tc tg a  
caag atccc  it t  f t  f t g t t  t t g c c c a a g g  
ta c c tc c a tc  aaaaa taaaa  t t c c t t g t g t  
tg tg a tc g c t  ag cctg g tgg  aggtggagga 
g e tg g tg eg e  t t t t t a c c c c  g cacggtg tc  
g a tc a a a tg g  c tcaaag aaa  t tc tc g a a tg
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4.2.2.2 TRPV1 splice variant oligonucleotide primer design 
Oligonucleotide primers were designed for TRPV1 channel mRNA using 
methods described above, and by selecting primer sequences that flanked the 
region of interest (exon 7) that was thought to be spliced. In this way, primers 
were selected so that products would be intron-spanning. Primer details are 
given in table 4.3 and Figure 4.2.
Table 4.3 Oligonucleotide primers for TRPV1 splice variants.
P rim e r Sequence P roduc tsizes Location Acc. No.
TRPV lb F :  GGAGCTCACCAACAAGAAGG  
R :  AGAAGATGCGCTTGACGAAT
146 & 326 2062-2238 N M _018727
Figure 4.2 TRPV1 and splice variant primers and amplification sequence.
Target primer sequences are shown in red, and the region expected to be 
spliced out in TRPV1 b is shown in blue.
TRP VI
901 gacaacacga a g t t tg tg a c  g ag ca tg tac  a a tg a g a ttc  tg a tc c tg g g  ggccaaactg
961 cacccgacgc tg aag ctg ga ggagctcacc aacaagaagg gaatgacgcc  g c tg g c tc tg
1021 gcagctggga ccgggaagat c g g g g tc ttg  g c c ta ta t tc  tccagcggga gatccaggag
1081 cccgagtgca  g g cac c tg tc  cag gaag ttc  accgagtggg cctacgggcc c g tg c a c tc c
1141 tc g c tg ta c g  a c c tg tc c tg  catcgacacc tgcgagaaga a c tc g g tg c t ggaggtgatc
1 gcctacag ca  gcagcgagac c c c ta a tc g c  cacgacatgc tc t tg g tg g a  gccgctgaac
1261 c g a c tc c tg c  aggacaagtg g gacag attc  g t c a a g c g c a  t c t t c t a c t t  c a a c ttc c tg
1321 g tc ta c tg c c  tg ta c a tg a t  c a tc t tc a c c  a tg g c tg c c t actacaggcc cg tggatggc
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4.2.2.3 RT-PCR reaction composition and conditions
RT-PCR was carried out using mRNAs from 6 human cell-types: MG63 
(passage number 34) osteoblast-like cells, SaOS-2 (passage number 27) 
osteoblast-like cells, HOB-c (passage number 3) primary osteoblasts, DU 145 
prostate cancer cells, LNCaP (passage number 18) prostate cancer cells, and 
MCF7 (passage number 20) breast cancer cells. The reaction composition and 
conditions were optimised and are detailed in tables 4.4 and 4.5 respectively. 
Reactions o f 12.5 pi were routinely performed and negative controls using 
nuclease-free water or no-RT reaction products from reverse transcription were 
run alongside reactions with cDNA. The PCR amplification products were 
analysed by gel electrophoresis in 2 % or 3 % agarose gels stained with 
ethidium bromide, in 1 x TAE buffer*.
Table 4.4 PCR reaction composition
Components Final concentrations Volumes
5* Green GoTaq® Flexi Buffer 1* 2.5 pi
M gC I2, 25 mM 1.5 mM 0.75 pi
PCR nucleotide (dN TP) m ixture 200 pM  each dNTP 1.25 pi
Forw ard prim er (sense) 0.4 pM 0.5 pi
R everse prim er (antisense) 0.4 pM 0.5 pi
GoTaq® DNA polym erase (5u/|il) 0.3125u 0.0625 pi
cDNA (or H20 ,  or N o-A M V .R T) 0.5 pi
N uclease-free H20 to 12.5 pi
Table 4.5 PCR reaction conditions
Step Tem perature °C Time No. of cycles
Initial denaturation 95 10 min 1
Denaturation 95 30 s
Annealing 55 45 s 40
Extension 72 1 min
Final extension 72 10 min 1
Soak 4 Indefinite
* Tris-A cetate-ED TA
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4.2.2.4 RT-PCR product sequencing
RT-PCR bands were cut from ethidium bromide stained agarose gels under UV 
light. Each cut-out was placed into a separate 0.5 ml microcentrifuge tube and 
a small volume of nuclease-free water was added (typically 10 - 20 pi per tube) 
to keep the product concentrated. The gel was broken up in the water by gently 
mashing with a pipette tip and stored in the refrigerator for at least 24 hours to 
allow the PCR products to leach out of the gel. cDNA eluted into the water was
(fi) •sequenced using the Big Dye Terminator V 3.1 Cycle Sequencing Kit 
(Applied Biosystems, UK) by Central Biotechnology Services at Cardiff 
University.
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4.3 Results
4.3.1 TRP channel expression in osteoblasts and other hormone-sensitive 
cells
Breast and prostate cancers tend to metastasize to the bones, which provide a 
suitable environment for the tumour cells to thrive. These three tissues may 
express similar complements of receptors and signalling factors that allow the 
different cell types to communicate and co-habit. Therefore, the expressions of 
five TRP channels were compared in osteoblastic, breast and prostate cells. 
RT-PCR revealed that the human osteoblast-like cells, prostate cancer cells and 
breast cancer cells have different complements of TRPV5, TRPV6 and TRPM8 
messenger signals (Figures 4.3 and 4.4), but all cells expressed mRNA for 
TRPV1 and TRPM7, and the osteoblasts also expressed a splice variant of 
TRPV1.
Results shown (Figure 4.3) are representative of at least three RT-PCR 
reactions showing the same expressions. Whilst mRNA expressions of TRPV1 
and TRPM7 were consistent across all the cells (MG63 and SaOS-2 
osteosarcoma cells, DU 145 and LNCaP prostate cancer cells, and MCF-7 
breast cancer cells) indicating that these channels may have potentially 
important roles, there were some interesting differences between the messenger 
signals for TRPV5, TRPV6 and TRPM8. Both prostate cancer LNCaP and 
DU 145 cell lines expressed all five TRP channel messengers, including 
TRPM8, whereas the breast cancer cell line MCF7 expressed all except
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TRPM8 Interestingly, The MG63 and SaOS-2 osteosarcoma cells expressed 
different complements of TRP messengers: MG63 cells expressed all except 
TRPM8, whereas the SaOS-2 cells expressed TRPM8, but not TRPV5 or 
TRPV6. Table 4.6 summarizes the different TRP messenger complements in 
the above cells
To confirm the true expression o f the above TRP channels in human 
osteoblasts, RT-PCR was carried out on primary human osteoblasts (passage 
number 3). Figure 4.4, which is representative o f n = 3 PCR reactions, shows 
that the primary osteoblasts expressed mRNA for TRPV1 and TRPM7 only, 
and not TRPV5, TRPV6 or TRPM8. The primary cells are fully functioning 
mineralising osteoblasts (confirmed by PromoCell for 15 passages) which 
appear not to require these latter three TRP channels, but conserve the 
expressions of TRPV 1 and TRPM8, as with all the above cells tested.
4.3.2 Patch clamping: the search for TRPV1 channels in osteoblasts
TRPV1 was shown to be expressed in all three osteoblastic cells by RT-PCR, 
and as the pharmacology o f TRPV1 is well described with various known 
agonists and antagonists, the patch-clamp technique was used to investigate the 
electrophysio logical characteristics o f this channel in human osteoblasts. 
Various physiological solutions were used as described in table 2.1 in chapter 
2. Of more than 100 successfully sealed cell-attached patches with > 1 GQ seal 
resistance, and more than 40 excised inside-out patches in total, most of the 
channel openings observed and recorded were not consistent with reported
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channel conductances 01 other TRP channel characteristics In the few 
recordings where channel openings did begin to match reported characteristics 
for TRPV 1, there was no significant difference (p < 0.05) in open probabilities 
between channels exposed to agonists and controls. This is true for MG63 
cells, SaOS-2 cells and HOB-c primary osteoblasts.
4.3.2.1 Electrophysiology fails to identify TRPV1
The TRPV1 agonists capsaicin ( 1 - 1 0  pM) and resiniferatoxin (100 nM -  1 
pM) did not in general appear to increase channel activity in MG63, SaOS-2 or 
HOB-c cells. There were occasional recordings of channel openings in the 
presence o f capsaicin or resiniferatoxin and of these very few were good 
enough to plot I/V curves. Out of 44 successful seals on MG63 cells with Na 
gluconate TRP solution and 1 pM capsaicin in the electrode, just 2 patches had 
channel activity good enough to enable I/V plots to be constructed from the 
data. The I/V plot for the first channel was linear at both depolarising and 
hyperpolarising potentials and slope conductance was calculated as 24.1 pS, 
with an Erev o f 18.5 mV, which is not consistent with previous reports of 
TRPV1. This channel appeared to display voltage-sensitivity, as channel 
activity increased with depolarising potential. In the second patch, the channel 
was activated by depolarising potentials, had a slope conductance of 72 pS and 
an extrapolated Erev o f around 0 mV (Figure 4.5A). It is not known if this 
channel displayed any degree o f rectification as patch stability was lost during 
recording, but it appeared to display some voltage-sensitivity as measured by 
increased open probability of the channel with increasing depolarising
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potentials With 100 nM resiniferatoxin in the electrode, channel activity was 
observed in 1/16 patches over a range o f potentials. This channel had a slope 
conductance of 189.7 pS at patch potentials > 40 mV, and the I/V slope 
appeared linear with an extrapolated Erev o f 27 mV positive to resting 
membrane potential (Figure 4.5B). Due to very short opening bursts over the 
range o f potentials, the extent of voltage dependency o f this channel is unclear.
Seal success rate for the human primary osteoblasts, HOB-c, with Na gluconate 
TRP solution or Na gluconate Locke in the bath and electrode, with or without 
capsaicin, was 67/75 (89 %). However, many seals became unstable within 2 - 
3 minutes and therefore recordings of channel activity were, in general, o f poor 
quality making data analysis difficult and therefore I/V plots could not be 
constructed. In patches with good seal resistances (> 1 GQ) and low RMS 
noise (< 1.0), I/V plots revealed channels of different conductances, E rev values 
and varying degrees of voltage-sensitivity. Channel activity was 
observed/recorded in the following proportion of patches: control (no agonist) 
15/28 patches; capsaicin in electrode 6/23; 1 pM capsaicin applied to the bath 
3/11; and resiniferatoxin in electrode 0/5.
A small number o f channels in MG63 cells did show some degree of outward- 
rectification, meaning that the inward current is smaller than the outward 
current and is defined by a change in slope conductance around a particular 
patch potential. This is a feature of the TRPV1 channel which outwardly 
rectifies around 0 mV in physiological solutions. The first example (Figure
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4 6A), the only one of its kind out of > 30 cell-attached patches under similar 
conditions, displayed pronounced outward rectification around 0 mV patch 
potential with Na gluconate TRP solution in the bath and electrode (no TRPV 1 
agonist) with a slope conductance o f 174 pS at depolarising potentials, and < 5 
pS at hyperpolarising potentials. The channel current appeared to decrease with 
increasing depolarising potentials greater than 100 mV. The second example 
(Figure 4.6B), observed in 1/17 cell-attached patches with High K solution and 
1 pM capsaicin in the electrode and Na gluconate Locke in the bath, displayed 
pronounced outward rectification around 25 mV patch potential cell-attached. 
Channel conductance was approximately 90 pS at depolarising potentials and 
17 pS at hyperpolarising potentials. As with the channel in Figure 4.6A the I/V 
curve tails off at potentials > 140 mV. The third example (Figure 4.6C), again 
with 1 pM capsaicin and High K solution in the electrode and Na gluconate 
Locke in the bath but in the excised inside-out configuration, showed outward- 
rectification around 10 mV and a slope conductance of 142 pS at depolarising 
potentials and around 6 pS at hyperpolarising potentials.
4.3.2.2 Acidification o f  bathing solution
TRPV1 channel activation by capsaicin or resiniferatoxin is potentiated by 
protons. Therefore, attempts were made to activate the TRPV1 channel in 
MG63 and HOB-c cells by decreasing the pH of the electrode and bathing 
solutions to pH 6.1 with HC1, but this also did not prove fruitful. Seal success 
rate was 13/14 for MG63 cells, and 14/21 for HOB-c cells with Na gluconate 
TRP solutions or Na gluconate Locke and 1 pM capsaicin in the electrode
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pipette In MG63 cells, small conductance channels of < 23 pS were observed 
and recorded from 4/13 cell-attached patches, and similarly recordings from 
HOB-c cell-attached patches (4/14) contained small conductance channels of ~ 
24 pS, each of which had different reversal potentials. None o f these channel 
characteristics matched the criteria for TRPV 1.
4.3.2.3 Electrophysiology finds small conductance channels
O f > 25 successfully sealed patches in MG63 cells in the excised inside-out 
configuration with Na gluconate TRP solution in the electrode and bath, 
channel activity was recorded in 8 patches. The channels seen in each case 
were o f small conductance (22.4 ± 1.26 pS, n = 8) and in all 8 recordings there 
were multiple channels per patch. In 5/8 cases, with 1 pM capsaicin in the 
electrode solution, I/V plots revealed a channel conductance o f 23.96 ± 1.28 pS 
and a mean Erev of 0.64 ± 6.4 mV, calculated from the mean of the I/V slopes 
(Figure 4.7A). In 1/8 recordings, with 1 pM capsaicin and 20 mM TEA in the 
electrode solution, channel conductance was 17.8 pS with an Erev of -5 mV 
(Figure 4.7B). The channel activity in the presence of TEA implies that this is 
not a voltage-gated K+ channel. I/V plots constructed with channel data from 
the final 2/8 control recordings revealed a channel conductance of 20.9 ± 3 pS 
and an Erev o f 2.5 ± 4.1 mV, calculated from the mean o f the two slopes (Figure 
4.7C).
Channel open probability was not increased in patches exposed to capsaicin 
compared to control patches over the range o f depolarising and hyperpolarising
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potentials, indicating that the channel was not capsaicin-activated Figure 4 8 
shows superimposed mean I/V data from the three above scenarios for 
comparison, and the mean I/V slopes are closely matched in conductance and 
reversal potential with no significant differences (p < 0.05).
4.3.2.4 Is the TRPV1 channel active in osteoclasts?
The electrophysiological data collected do not appear to show TRPV1 activity 
in osteoclasts. Rat primary osteoclasts were grown on coverslips and patched 
within two days of seeding. Cells were much larger than osteoblasts (4-5 x 
diameter) and high resistance seals > 1 GQ were difficult to achieve, with a 
success rate of 15/43 with Na gluconate TRP solution in the electrode and bath. 
Only 3/15 patches showed channel activity: cell-attached recordings were 
made in 2/3 cases with the above solutions in the electrode/bath and 1/3 
patches contained 1 p.M capsaicin in the electrode. Channel activity was low in 
the first two patches and channel conductance for one of these was estimated 
(by calculation of I/V) at 45 pS. The patch exposed to capsaicin contained 
active channels with channel currents at +60 mV of 3.05 pA and 5.97 pA, 
corresponding to a single channel conductance of 33.4 pS and a double channel 
conductance o f 60.1 pS, with an Erev of -30 mV (Figure 4.9). The channel was 
voltage-sensitive, and activated by depolarising potentials. However, once 
again, this channel is probably not TRPV1.
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4.3.3 Further molecular biology uncovers a TRPV1 splice variant
Following the failure to identify TRPV1 channel activity using 
electrophysiology, the evidence for expression of this channel was re-explored. 
A splice variant of TRPV1 was found to be co-expressed along with the 
complete receptor, at both messenger and protein level in osteoblast cell 
membranes. RT-PCR was carried out using oligonucleotide primers flanking a 
previously reported splice variant sequence o f the TRPV1 gene, termed 
TRPV lb. Gel electrophoresis revealed three different sized bands each for 
MG63, SaOS-2 and HOB-c mRNA (Figure 4.10). The largest band size at > 
300 bp is the most intense and corresponds to the predicted band size of 326 bp 
for TRPV1. The smallest band size at around 150 bp corresponds to the 
predicted TRPV lb splice variant band of 146 bp. The intermediate band at 
approximately 300 bp was not predicted and the mRNA sequence remains 
unknown.
4.3.3.1 Sequencing o f  suspected TRPV1 and splice variant gel bands
Sequencing confirmed that the identity of the largest band was TRPV1 (Figure 
4.11). The sequence of the smallest 150 bp band was short of 180 base pairs 
from the full TRPV1 sequence, which matched the mRNA sequence for exon 7 
of this gene. Therefore the smallest band is confirmed as the splice variant 
TRPV lb  (Figure 4.11). For confirmation, the deleted sequence also matches 
that reported by Lu et al. (2005) (Figure 4.12). The intermediate band remains 
unidentified despite attempts to sequence due to poor quality/small quantity of 
PCR product. Occasional point mutations appear to occur in the TRPV1
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sequence, particularly either side of the exon 7 sequence shown by dashed red 
underline in Figure 4.11, and one point mutation within exon 7 (adenine 
instead of guanine). This mutation therby formed the amino acid triplet code 
GAA instead of GAG. Both these triplets code for glutamic acid, so the point 
mutation is silent.
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4.4 Discussion
4.4.1 TRP channel expression in hormone-sensitive cells
The RT-PCR data enable a partial expression profile to be built for TRP 
channel proteins in sex hormone-sensitive cells. Interestingly, TRPV1 and 
TRPM7 messenger signals were expressed in all cells, supporting an argument 
for putative roles for these channels in important cellular processes such as
j0\  i i
proliferation, and in carrying Ca and Mg currents across the plasma 
membrane. In support of these findings, there have been a number of key 
reports within the last three years on the importance o f TRPM7 and TRPV1 
expression. TRPM7 is considered a key regulator of cell Mg2+ levels 
(Schlingmann et al., 2007) and possibly other divalent cations (Wei et al.,
2007) in a variety o f cells, and is essential for mast cell survival (Wykes et al.,
2007) and the proliferation of some cancers (Jiang et al., 2007). The messenger 
signal has also been detected in rat prostate tissue (Wang et al., 2007). In bone 
the links between TRPM7 channel expression and human osteoblast 
proliferation (Abed & Moreau, 2007) and MG63 cell Ca2+ and Mg2+ regulation 
(Levesque et al., 2008) have been further strengthened from the early work by 
Elizondo et al. (2005) in zebrafish skeletogenesis. Similarly, evidence is 
beginning to emerge o f important roles for TRPV1 in non-excitable cells, 
including putative functional roles in prostate, pancreatic, colon and bladder 
cancers (Sanchez et al., 2005; Hartel et al., 2006; Domotor et al., 2005; Lazzeri 
et al., 2005) and in the regulation of fat metabolism (Motter et al., 2008) and 
adipocyte differentiation (Zhang et al., 2007). In bone, TRPV1 may have a
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putative functional role as a pH detector and regulator of osteoblastic and 
osteoclastic activity (Arnett, 2008).
The different expressions of the other three TRP channels must be due to 
tissue-dependent requirements for the channels. Both prostate cancer cell lines 
(LNCaP and DU 145) express all five of the TRP mRNAs including TRPM8. 
As described in the introduction to this chapter, TRPM8 expression has been 
reported to be linked with androgen receptor expression in prostate tissue 
(Bidaux et al., 2005; Tsavaler et al., 2001) and for this reason TRPM8 
expression would be expected in androgen-sensitive tissues such as prostate 
and possibly bone, and may be a diagnostic marker for androgen-sensitive 
early-stage prostate cancer. The absence of TRPM8 expression in MCF7 breast 
cancer cells could be explained by the relative androgen insensitivity o f this 
cell type. The TRPV6 channel also shows increased expression in some 
cancers, including prostate and breast cancers (Fixemer et al., 2003; Bolanz et 
al., 2008) and is known to heteromultimerise with TRPV5 to form channels 
with different characteristics (Weber et al., 2001).
In the osteoblast cells, the apparent expressions o f TRPV5, TRPV6 and 
TRPM8 are curiously different in each of the cell lines. It is worthy o f note that 
MG63 and SaOS-2 cells are, o f course, human osteosarcoma cell lines and not 
primary osteoblast cells and functional characteristics may be slightly different 
(Pautke et al., 2004). For example, MG63 cells do not mineralise in culture, 
whereas SaOS-2 cells will extensively mineralise under the correct conditions
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(McQuillan et a l , 1995) Therefore, SaOS-2 cells may be considered more 
mature osteoblasts (Rodan et al., 1987), phenotypically closer to true 
osteoblasts than MG63 cells with more similar gene and protein expressions. 
But from the RT-PCR data, it is clear that the messenger RNA expressions do 
not support this argument for the TRP channels. The Ca2+ selective channels 
TRPV5 and TRPV6 are targets for calciotropic hormones such as parathyroid 
hormone and vitamin D3 (Schoeber et al., 2007; van der Graaf et al., 2004; 
Meyer et al., 2006), and therefore these channels would be expected to be 
found in bone cells. However, the primary osteoblast cells apparently do not 
require these channels to function and instead presumably rely more heavily on 
the parathyroid hormone receptor (e.g. Ahlstrom et al., 2008) and vitamin D3 
receptor (Jurutka et al., 2007) for signalling by these hormones.
In summary, TRPV1 and TRPM7 stand out as potentially important channel 
proteins in these hormone-sensitive cells, whereas TRPV5, TRPV6 and 
TRPM8 appear to have heterogeneous roles that may relate to the malignant or 
non-malignant status o f the cells.
4.4.2 Electrophysiology fails to detect TRPV1 in osteoblasts
The search for TRP channels in osteoblasts using the patch-clamp technique 
concentrated on TRPV 1 given its ubiquitous expression and the availability of 
pharmacological tools. However, despite this expression at messenger level the 
electro physio logy did not find functionally active TRPV1 channels in MG63, 
SaOS-2 or HOB-c osteoblastic cells, none of the criteria for identification of
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TRPV 1 channels were met and therefore the chapter hypothesis was deemed 
false.
Recordings were made ffom all three osteoblast cell-types, but the number of 
patches with active channels was low and ion channel characteristics were 
disparate with no conformity even on attempts to activate TRPV1 with well- 
recognised and documented channel openers. Agonist applications were made 
external to the channel/cell as the evidence shows this is effective: 
resiniferatoxin has been found to bind and activate at an extracellular site 
(Chou et al., 2005), whereas capsaicin appears to bind to an intracellular 
domain o f the channel. However, due to the lipophilic nature of capsaicin, the 
molecule readily crosses through the cell membrane to act intracellularly (Jung 
et al., 1999). It has been shown by others (Jordt et al., 2000) that acidification 
of the extracellular environment can potentiate the agonistic effect of capsaicin 
to greatly increase activity of TRPV1, but in MG63 and HOB-c cells the 
evidence in this thesis for this is lacking. There is no clear evidence that any of 
the channels recorded are TRPV 1 (or any other TRP channel) but they could be 
non-selective channels. This is in stark contrast to the wealth o f K+ channel 
data collected and presented in chapter 3, some of the experiments for which 
were run in parallel demonstrating that the cells were viable and ion channel 
rich.
Due to the difficulty in activating TRPV1 in osteoblasts, experiments were 
carried out in an attempt to activate the channel in rat osteoclasts. TRPV 1 has
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been reported to be expressed in human osteoclasts where it may function as a 
pH sensor and regulator of osteoclastic activity (Brandao-Burch et al., 2006). 
However, in the experiments here the single example o f ion channel activity in 
rat osteoclast cells in the presence o f capsaicin does not display the classical 
channel rectification that would be exected of TRPV1, and single channel 
conductance is much lower than reported TRPV1 conductances in other cell 
types under similar conditions (see for example, Premkumar et al., 2002; 
Raisinghani et al., 2005). Therefore, despite being the only truly active channel 
observed over a wide range of potentials in the presence o f capsaicin, this 
channel is probably not TRPV1, but could be a non-selective cation channel. 
Whether or not this channel is capsaicin sensitive requires future attention, but 
as n = 1 only (1/43), the activity in the presence o f capsaicin may well be 
coincidental.
4.4.3 TRPV1 splice variant expression. A possible explanation for 
channel inactivity?
The lack of evidence for functional TRPV1 channels from the 
electrophysiology prompted a return to the molecular biology in search for an 
emerging splice variant of mammalian TRPV1 protein, which is reportedly 
insensitive to capsaicin, protons and heat (Schumacher et al., 2000; Xue et al., 
2001). The RT-PCR data and sequencing of the PCR gel bands showed the co­
expression at messenger level o f TRPV 1 and the splice variant of this channel 
now known as TRPV lb  in human osteoblasts. A recent report of this splice 
variant supports the findings o f Schumacher and Xue (ibid.) and shows that
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TRPV lb has a total deletion of exon 7 forming part of the N-terminus, thought 
to be the location of the capsaicin-binding site (Lu et al., 2005). Importantly, 
the TRPV lb  splice variant subunit is thought to be dominant over the full 
TRPV1 subunit, and therefore TRPV1 channels comprising heteromultimers of 
TRPV1 and TRPV lb  may be less sensitive to capsaicin and other TRPV1 
agonists, and protons (Vos et al., 2006; Wang, C. et al., 2004). This could 
explain the difficulty in finding any active TRPV 1 channels in the osteoblasts 
with patch-clamping. Whilst the largest and smallest amplicons have been 
confirmed by sequencing, the unidentified band (at around 300 bp) is possibly 
due to non-specific amplification, and therefore primers should be redesigned 
to eliminate this, and/or further sequencing should be carried out to identify 
this product.
4.4.4 Chapter conclusions and future work
The first hypothesis in this chapter that the osteoblasts, breast and prostate 
cancer cells would share the same expression of selected TRP channels was 
shown to be false. However, TRPV1 and TRPM7 are expressed by all cell 
types and are potentially important players in key functions o f these cells. The 
unexpected findings o f mixed TRPV5 and TRPV6 channel expressions in the 
osteoblasts raises questions which would be worthy of address in future work 
(see below).
The second hypothesis, bom from the RT-PCR findings, that the TRPV1 
channel would active in osteoblasts and sensitive to capsaicin, also tested false.
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Despite the osteoblasts being richly decorated with K+ channels (see chapter 3) 
proving the patch-clamp setup was established and working well, and despite 
the RT-PCR evidence for TRPV1 expression, TRPV1 channel activity was not 
seen in these cells. However, the apparent co-expression of the functionally 
dominant-negative splice variant TRPV lb  may explain this inactivity. It is 
likely that heteromultimers of TRPV 1 and TRPV lb  co-assemble in the plasma 
membrane of osteoblasts and that TRPV lb  negatively modulates the activity of 
the channel in response to the classical agonists. This raises another question: if 
the TRPV 1 /TRPVlb protein is not active as an ion channel in osteoblasts, is 
the protein functional and if so, what does it do? In summary, this chapter 
shows for the first time the various expressions of a number o f TRP channels in 
osteoblast, breast-cancer and prostate-cancer cells, and that TRPV1 and 
TRPM7 are commonly expressed in all o f these cell-types. Also shown for the 
first time is the mRNA expression of the splice variant TRPV lb  in osteoblasts, 
including primary human osteoblasts, which may have important consequences 
for channel (unction in these cells.
These findings raise a number o f interesting questions which require 
addressing. Some suggestions for points requiring more immediate attention in 
future work include:
• Further investigations into the reasons for the different expressions of TRP 
channels, particularly TRPV5 and TRPV6, in the osteosarcoma cell lines 
and primary osteoblasts.
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• Whole-cell patch clamp experiments to try to activate whole membrane 
TRPV 1 currents using capsaicin, acid conditions and heat > 44 °C.
• Cloning and transfection of the osteoblast TRPV1 channel into (for
example) HEK-293 cells in large quantities, in TRPV1 homomultimers,
TRPV lb homomultimers and TRPV 1/TRPVlb heteromultimers to 
determine the electrophysio logical characteristics o f these channels.
• Identification of the ‘unknown’ 300 bp amplicon identified in MG63, 
SaOS-2 and HOB-c cells by sequencing, and primer redesign to establish if 
this amplicon is a true variant of TRPV1 or due to non-specific 
amplification.
• Western blotting and immunocytochemistry to find if TRPV1 and any 
splice variants are expressed as proteins in the cell plasma membrane, or 
other fractions of the cytoskeleton.
• The recent reports of functional roles for TRPM7 in bone are very
interesting, and channel expression in human osteoblasts was shown by the
findings o f this thesis. Future work on the functions o f TRPM7 in human 
osteoblasts or osteoclasts would be beneficial to the story o f TRP channels 
in bone.
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Figure 4.3 RT-PCR for several TRP channel mRNAs 
in various hormone-sensitive cell-types. TRPM8 band 
is absent for MG63 cells but not for SaOS-2, whereas 
bands for TRPV5 and V6 are absent for SaOS-2 cells. 
Prostate cancer derived LNCaP and DU 145 cells have 
the full complement of TRP mRNAs tested for, whereas 
MCF-7 breast cancer cells do not contain TRPM8 
mRNA.
Product sizes
p-actin 126 bp 
TRPV1 177 bp 
TRPV5 185 bp 
TRPV6 2 37  bp 
TRPM7 197 bp 
TRPM8 165 bp
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Figure 4.4 RT-PCR shows HOB-c human primary osteoblasts have 
only a partial complement of TRP channel mRNAs. (A) TRPV1 and (B) 
TRPM7 are present, as in both MG63 and SaOS-2 osteoblast-like cells 
(Figure 4.4), but TRPV5, V6 and M8 are not expressed.
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Table 4.6 TRP channel mRNAs identified in various cell- 
types by RT-PCR.
TRPV1 TRPV5 TRPV6 TRPM7 TRPM8
MG63 ✓ S X
SaOS-2 ✓ X X S ✓
HOB-c V X X V X
LNCaP S ✓ S V
DU 145 S ✓ S V
MCF7 V X
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Figure 4.5 MG63 cell-attached I/V plots in the presence of capsaicin or 
resiniferatoxin, with Na gluconate TRP solutions in the bath and 
electrode. (A) With 1 pM capsaicin in the electrode, y = 72 pS (R2 = 
0.9954), and Erev = 0 mV. (B) With 100 nM resiniferatoxin in the electrode, 
y = 189.7 pS (R2 = 0.9821), and Ere, = +27 mV.
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Figure 4.6 MG63 cell outwardly rectifying channel I/V plots. (A) Cell 
attached, with Na gluconate TRP solution in the bath and electrode, y = 
174.3 pS (R2 = 0.97776) at depolarising potentials and Erev = +2.5 mV. (B) 
Cell-attached, with High K solution and 1 pM capsaicin in the electrode, 
and Na gluconate solution in the bath, Erev = +26 mV. (C) Inside-out, with 
High K solution and 1 pM capsaicin in the electrode and Na gluconate 
solution in the bath, Erev = +9.7 mV.
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Figure 4.7 Exemplar I/V plots and single channel data from excised 
inside-out patches of MG63 cells. Recordings were with Na gluconate TRP 
solution in the bath and electrode. (A) 1 pM capsaicin in the electrode, y = 21 
pS (R2 = 0.998) and 41.5 pS (R2 = 0.999). Ere, = 0 mV. (B) 1 pM capsaicin 
and 20 mM TEA in the electrode, y = 17.8 pS (R2 = 0.991), 35.4 pS (R2 = 
0.997) and 51.6 pS (R2 = 0.996). Erev = -5 mV. (C) Control, y = 17.9 pS (R2 = 
0.995), 34.6 pS (R2 = 0.998) and 52.2 pS (R2 = 0.997). Erev = +6.7 mV.
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Figure 4.8 Mean data from recordings exemplified in figure 4.7 of 
excised inside-out patches of MG63 cells.
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Figure 4.9 Data from cell-attached recording of rat osteoclast. Na
gluconate solution in bath and electrode, with 1 pM capsaicin in the 
electrode. (A )  Single channel data shows channel activity at + and -  
potentials. (B) Current distribution histogram, with Gaussian fits over 
peaks giving mean currents of 3.05 pA and 5.968 pA. (C) I/V plot showing 
slopes for single and double openings. Single channel y = 33.4 pS and 
double channel y = 60.1 pS. (D) NPo/V plot showing channel is voltage 
dependent and activity increases markedly with depolarising potentials.
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1----------------------TRPV1 spl. var.---------------------- 1
Predicted band sizes:
C om p lete T R PV 1: 326  bp 
TR PV Ib: 146  bp
Figure 4.10 Osteoblasts and osteoblast-like cells express TRPV1 and 
TRPV1 splice variants. Bands correspond well to expected band sizes for 
TRPV1 and the splice variant TRPVIb. The intermediate band (~ 300 pS) 
is unidentified. Negative controls contain no-RT reaction products.
161
TRPV1 sequence
B
Figure 4.11 
Red dashed
RNA sequencing of TRPV1 bands (from figure 4.11) confirms expression of (A) TRPV1 and (B) TRPVIb. 
line indicates sequence missing from TRPVIb splice variant.
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Figure 4.12 TRPV1 amino acid sequence. The osteoblast TRPV1 splice 
variant identified in figure 4.12 has the same 60 amino acid deletion in the 
N terminus (shown here in yellow) as reported for the human TRPVIb 
receptor (figure from Lu et al., 2005).
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5 FUNCTIONAL PROPERTIES OF THE TRPV1 
RECEPTOR IN OSTEOBLASTS
5.1 Introduction
In the previous chapter, the case was presented for the differential expressions 
of five TRP channels in hormone-sensitive prostate, breast and osteoblast cells 
and showed that one TRP channel, TRPV1, expresses in osteoblasts in at least 
two variant forms: the ‘conventional’ TRPV1 subunit, and a shorter splice 
variant which is known as TRPVIb. The lack of evidence in chapter 4 for 
TRPV 1 ion channel activity was possibly due to the expression o f the dominant 
negative TRPV 1 b subunit which confers capsaicin insensitivity to the channel. 
The work presented in this chapter will seek to determine any longer-term 
effects of various TRP ligands on osteoblast cell growth and function, to begin 
to map out the role o f TRPV1 in osteoblasts.
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5.1.1 Evidence of putative functional roles for TRP channels in bone
Several members of the TRP channel superfamily are beginning to attract 
increasing interest in the field of bone function research due to emerging 
putative roles in osteoblast proliferation, mineralisation and differentiation.
The highly calcium-selective channels TRPV5 and TRPV6  are involved in 
bone growth. TRPV5 appears to be essential for normal bone turnover and it 
has been shown that TRPV5 knockout (TRPV5_/~) mice have ‘reduced bone 
thickness’ (Hoenderop et al., 2003b) due to the diminished active Ca2+ 
resorption by the kidney nephrons, for which TRPV5 has been called the 
‘gatekeeper’ of transepithelial renal Ca transport. The same knockout mouse 
model shows increased osteoclast cell numbers and cell size, but much 
diminished resorptive activity compared to TRPV5+/+ mice (van der Eerden et 
al., 2005). Therefore TRPV5 is required in the kidney for renal Ca2+ resorption 
and in osteoclasts for bone resorption. The second highly Ca2+ selective TRP 
channel, TRPV6 , which shares more than 70% homology with TRPV5, has 
been shown to have a role in cell proliferation, and is upregulated particularly 
in later stage prostate and breast tumours that are metastasising (Schwarz et al., 
2006; Prevarskaya et al., 2007). It has been implied by Nijenhuis et al. (2003a) 
that as TRPV6  expression has been identified in osteoblasts, this channel might 
play a role in mineralisation. TRPV5 and TRPV6  channels may be targets for 
the well-known bone regulator l,25(OH)2D3 or vitamin D3 (Hoenderop et al., 
2002; Weber et al., 2001), and possibly also targets for oestrogens (Van Abel
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et al.. 2002) as TRPV5 expression was stimulated by 17p-oestradiol in 
ovariectomised rats.
TRPM7 has been shown by Elizondo et al. (2005) to be important for normal 
skeletogenesis in the dwarf zebrafish model, in which the mutant nutria!12462 
has different tissue expressions of TRPM7 compared to wild-type. 
Consequently the nutria112462 mutant zebrafish is phenotypically much smaller 
and differently shaped to the wild-type dwarf zebrafish. Abed and Moreau 
(2007) found that in human osteosarcoma cell lines MG63, SaOS-2 and U- 
20S, TRPM7 was important for osteoblast proliferation. Cells treated with 
siRNAs targeted at TRPM7 showed 60 -  75% reduction in proliferation 
compared to untreated TRPM7-4normal’ cells.
The cold-sensitive channel TRPM8 is upregulated in a variety o f malignant 
tumours including prostate, breast, colon, lung and skin (Tsavaler et al., 2001; 
Zhang et al., 2004; Zhang et al., 2006), many o f which metastasize to bone. In 
chapter 4, the expression o f TRPM8 in human osteoblast-like cell lines was 
shown to be low. The expression of TRPM8 in prostate cancer is known to be 
linked to androgen receptor expression -  the tumour becomes more aggressive 
and begins to metastasize at the same time as androgen-sensitivity o f the 
tumour is lost, and TRPM8 expression is down-regulated (Zhang et al., 2004). 
The transition from TRPM8 high-expression to low-expression may be 
necessary for tumour seeding and proliferation in the bone environment.
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5.7. /. /  Current evidence fo r  TRPV1 function in bone
TRPV1 has been shown to be expressed in osteoblasts and osteoclasts and 
appears to have several functional roles:
Proliferation and mineralisation
TRPV1 activation is known to be sensitive to pH and reduced pH (increased 
number o f protons) increases the activity of this channel by potentiation (Ryu 
et al., 2003). Bone is a pH sensitive tissue and small changes in pH may have 
consequences for bone mineralisation or absorption. A decrease in extracellular 
pH in vitro from 7.4 to 6.9 abolishes mineralisation by osteoblasts, and is 
associated with an 8X reduction in osteoblast alkaline phosphatase production 
(a marker for mineralising osteoblasts) and a significant rise in the expression 
of matrix Gla protein, which is a calcium-binding protein that inhibits 
mineralisation (Brandao-Burch et al., 2005). The same change in conditions 
stimulates osteoclasts to maximum resorptive activity, whereas at pH 7.4 
resorptive activity is minimal (Arnett, 2008). The author (ibid) argues that 
TRPV 1 might well be the cellular sensor for pH in osteoblasts and osteoclasts, 
and therefore has a vital role in normal bone turnover.
Differentiation
The association between decreased bone mineral density and increased bone 
marrow or trabecular bone adipocyte content is well known, and occurs with 
aging (Parfitt et al., 1992; Rozman et al., 1989), non-weight bearing 
osteoporosis (Jee et al., 1983), glucocorticoid-induced osteoporosis (Kwai et
168
C H A PTER  5:
FUN CTIO NA L PR O PER TIES OF THE TRPV1 REC EPTO R IN O STEO BLA STS
al., 1985), ovariectomy-induced osteoporosis (Martin & Zissimos, 1991) and 
general osteoporosis o f all ages (Gimble et al., 1996; Meunier et a l 1971; 
Nuttall et al., 1998). It is presumed that adipocyte formation takes place at the 
expense o f osteoblast maturation and that these cell types have a common 
ancestor (Gimble et al., 1996; Thompson et al., 1998). The mechanisms that 
control the differentiation of osteoblast and adipocyte precursors are poorly 
understood, but clearly pharmacological intervention could provide a future 
treatment for pathologies.
An emerging putative role for TRPV 1 in bone is in differentiation. It has been 
shown that TRPV1 activation by capsaicin prevents adipogenesis in 3T3-L1- 
preadipocytes (a non-bone precursor) and that this effect is lost when TRPV 1 is 
knocked-down (Zhang et al., 2008). Furthermore, the authors also showed that 
during regular adipogenesis in 3T3-LI-preadipocytes, TRPV1 expression is 
downregulated, but exposure to capsaicin maintains TRPV 1 expression levels. 
Therefore, it is clear that TRPV1 expression and activation is pivotal in 
determining whether precursor cells differentiate into adipocytes. These very 
interesting findings o f the above two studies beg further investigation, with the 
obvious and important next step being to determine whether TRPV 1 activation 
in osteoblastic-precursors can discourage adipogenesis and promote 
osteoblastogenesis. Osteoblast-precursor differentiation has clear implications 
for osteogenesis and diseases such as osteoporosis (Griffith et al., 2008; 
Griffith et al., 2005; Justesen et al., 2001; Kha et al., 2004).
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5.1.2 Cannabinoids as TRPV1 ligands
5.1.2.1 Cannabinoid receptors are functional in bone
Firstly, it is pertinent to recognise that the expression of cannabinoid receptors 
CBj or CB2 influences bone cell function. CBi receptors have been shown to 
be involved in the regulation o f bone mass and bone turnover, but CB] 
receptors are expressed only at low levels in osteoblastic precursors, mature 
osteoblasts and in osteoclasts (Tam et al., 2006) but high expression is found in 
trabecular bone sympathetic nerve fibres. As noradrenaline release from these 
nerve fibres decreases osteoblastic activity but increases osteoclastic bone 
resorption, the likely mechanism o f bone regulation by CBi receptor 
stimulation is downstream sympathetic signalling (Bab et al., 2008; Bab & 
Zimmer, 2008; Tam et al., 2008). In contrast, CB2 receptors, which are also 
expressed only at very low levels in osteoblast precursors, increase in 
expression as cells mature into true osteoblasts in line with increasing 
expressions o f markers of osteoblast activity including alkaline phosphatase 
(Zhou et al., 2004), parathyroid hormone receptor (Zhang et al., 1995) and 
runt-related transcription factor 2 (RUNX2) (Araujo et al., 2004; Bab & 
Zimmer, 2008). CB2 also shows high expression in osteoclasts (Bab et al., 
2008; Ofek et al., 2006). CB2 stimulation by the endogenous cannabinoid 
anandamide results in increased osteoblastic activity and reduced osteoclastic 
absorption, both directly and by increased osteoblastic RANKL expression, 
thereby increasing bone mass, whereas CB2 ; mice display significantly 
decreased bone mass (Ofek et al., 2006).
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5.1.2.2 Cannabinoid ligands as TRPV1 channel agonists 
It is evident that the endocannabinoid system plays an important part in the 
regulation of bone mass and metabolism, but it is becoming clear that 
endocannabinoids -  in particular anandamide -  can be endogenous activators 
o f TRPV1 and may therefore partake in a different mechanism for bone 
regulation. Smart et al. (2000) recognised that anandamide is a full agonist of 
TRPV1 producing similar inward currents to those induced by capsaicin, and 
evoking [Ca2+]j increases in the same manner. The potency o f anandamide at 
the TRPV 1 receptor was weaker than that of capsaicin, and was approximately 
20x weaker than its binding affinity at the cannabinoid receptor (Smart et al., 
2000; Devane et al., 1992).
The chemical structure of anandamide resembles that o f many vanilloids 
(Pertwee, 1997; Szallasi & Blumberg, 1999) and one of the vanilloids, olvanil, 
has been shown to inhibit the facilitated diffusion of anandamide via carrier 
proteins, thus maintaining high levels of anandamide for CB receptor 
activation (Di Marzo et al., 1998). In addition to TRPV1 activation by 
anandamide, a second endocannabinoid ligand, palmitoylethanolamide 
(Pertwee, 1997), has been shown to activate TRPV1, but is less potent than 
anandamide at the same receptor site (Smart et al., 2000). Figure 5.1 shows the 
structural similarities between some selected vanilloids and an 
endocannabinoid as an example.
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Capsaicin
Olvanil
A nandam ide
Figure 5.1 Chemical structures of vanilloids and an endocannabinoid 
for comparison.
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5.1.3 Chapter hypothesis, aims and experimental strategies
Given the evidence, the hypothesis of this chapter is that the TRPV1 channel
has a functional role in (i) the proliferation, (ii), mineralisation and (iii)
differentiation of osteoblasts.
The aims of this chapter are:
• to test whether known TRPV1 agonists and antagonists, and also
cannabinoid ligands, have any effect on the growth (proliferation) of 
MG63 cells, using haemocytometry and MTS dye absorption 
measurements.
• to test whether TRPV 1 agonists and antagonists affect the mineralisation
o f human SaOS-2 and mouse 7F2 osteoblasts.
• to test whether the differentiation o f mouse 7F2 osteoblast precursors into
either mature osteoblasts or adipocytes is affected by TRPV1 and 
cannabinoid ligands.
• to investigate the effects of capsaicin and other TRPV1 ligands on the
isolated guinea pig ileum, as a model for the short-term effects of 
capsaicin and other TRPV1 ligands, including anandamide and other 
cannabinoids.
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5.2 Methods
5.2.1 Cell culture and counting
Cells were cultured and numbers counted as described in chapter 2, sections
2.1 and 2.2 respectively.
5.2.2 Drug solutions
Drugs and chemicals used in experiments were obtained from Sigma (Sigma- 
Aldrich Co. Ltd., Dorset, UK) unless otherwise stated. Anandamide, 
methanandamide and abnormal cannabidiol were obtained from Tocris (Tocris 
Cookson Ltd., UK). Stock solutions of menthol, capsaicin, capsazepine, 
anandamide, methanandamide, abnormal cannabidiol, thapsigargin, SB366791, 
resiniferatoxin and pinacidil were prepared in absolute ethanol (99.8% certified 
AR grade) (Fisher Scientific, Ltd.). Stocks of ruthenium red and all other 
chemicals were prepared in in-house distilled H2O, unless explicitly stated for 
each drug/chemical.
5.2.3 RT-PCR: Mouse TRPV1
General RT-PCR methods are detailed in Chapter 2: Materials and Methods, 
section 2.4.1. Products obtained from RT-PCR with mouse 7F2 cells have not 
been sequenced to confirm identity.
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5.2.3.1 Oligonucleotide primer design
Oligonucleotide primers for mouse TRPV1 and p-actin mRNA sequences were 
designed from Mus musculus mRNA coding sequence, as described in section
3.2.3.1 of chapter 3 for maxi-K primer design. Primers (see table 5.1 and 
Figure 5.2 for details) were obtained from Invitrogen.
Table 5.1 Oligonucleotide primer details for TRP channels.
P rim e r Sequence
P roduc t
size Location Acc. No.
TRPV 1 F: a g c g a g t t c a a a g a c c c a g a  R: t t c t c c a c c a a g a g g g t c a c 233 4 3 9 -6 7 1 N M _001001445
P-actin
F: t g t t a c c a a c t g g g a c g a c a  
R: t c t c a g c t g t g g t g g t g a a g 392 304 - 695 NM 007393
Figure 5.2 TRPV1 and p-actin primers and amplification sequences.
Target primer sequences are shown in red.
TRPV1
361 g c tg tg g c tc  agagcaactg  ccaggagctg gagagcctgc t g t c c t t c c t  gcagaagagc
421 aagaagcgcc tg a c tg a c a g  c g a g t t c a a a  g a c c c a g a g a  cgggaaagac c tg tc tg c tc
481 aaag ccatg c  tc a a tc tg c a  caatgggcag aacgacacca t t g c t c t g c t  c c tg g a c a tt
541 gcccggaaga c a g a ta g c c t g a a g c a g ttt g tc a a tg c c a  g c tacacag a  c a g c ta c ta c
601 aagggccaga c a g c a tta c a  c a t tg c c a t t  gaaaggcgga a c a tg g c a c t g g t g a c c c t c
661 t t g g t g g a g a  atggagcaga tg tc c a g g c t g c tg c ta a c g  g g g a c t tc t t  caagaaaacc
721 aaagggaggc c tg g c t tc ta  c t t tg g tg a g  c tg c c c c tg t c c c tg g c tg c  gtgcaccaac
p-actin
241 gggtgacgag gcccagagca agagaggtat c c tg a c c c tg  a ag tacccca  ttg a a c a tg g
301 c a t t g t ta c c  aactgggacg acatggagaa g a tc tg g c a c  c a c a c c t tc t  acaatg ag c t
361 g c g tg tg g cc  cctgaggagc a c c c tg tg c t gctcaccgag g cccccctg a  accctaaggc
421 caaccg tg aa  aagatg accc  a g a tc a tg t t  tg a g a c c ttc  aacaccccag c c a tg ta c g t
481 ag ccatccag  g c tg tg c tg t  c c c tg ta tg c  c tc tg g tc g t  accacaggca t tg tg a tg g a
541 c tccggagac ggggtcaccc a c a c tg tg c c  c a tc ta c g a g  g g c ta tg c tc  tc c c tc a c g c
601 c a tc c tg c g t c tg g acc tg g  ctggccggga cctgacagac ta c c tc a tg a  ag a tc c tg a c
661 cgagcgtggc ta c a g c ttc a  ccaccacagc tgagagggaa a tc g tg c g tg  acatcaaaga
721 g a a g c tg tg c  t a t g t t g c t c  ta g a c ttc g a  gcaggagatg gccactgccg  c a tc c t c t tc
781 c tc c c tg g a g  a a g a g c ta tg  ag ctg cctg a  cggccaggtc a tc a c t a t tg  gcaacgagcg
841 g ttc c g a tg c  c c tg a g g c tc  t t t tc c a g c c  t t c c t t c t t g  g g ta tg g a a t c c tg tg g c a t
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5.2.3.2 RT-PCR reaction compositions and conditions
RT-PCR was carried out using 7F2 (passage number 24) mRNA and the 
reaction compositions and conditions were optimised and are detailed in tables
5.2 and 5.3 respectively. Reactions o f 25 pi were routinely performed and 
negative controls using no-RT reaction products from reverse transcription 
were run alongside reactions with cDNA. The PCR amplification products 
were analysed by gel electrophoresis in 2 % agarose gels stained with ethidium 
bromide, in 1 x TAE buffer*.
Table 5.2 PCR reaction composition (mouse TRPV1 & p-actin)
Components Final concentrations Volumes
5* Green GoTaq® Flexi Buffer 1* 5 pi
M gC l2, 25 mM 1.5 mM 1.5 pi
PCR nucleotide (dN TP) m ixture 200 pM  each dN TP 2.5 pi
Forw ard prim er (sense) 0.4 pM 1 pi
R everse prim er (antisense) 0.4 pM 1 pi
GoTaq® DNA polym erase (5u/|il) 0.625 u 0.125 pi
cDNA (or H20 ,  or N o-A M V .RT) 1 pi
N uclease-free H20 to 25 pi
Table 5.3 PCR reaction conditions (mouse TRPV1 & p-actin)
Temperature °C______ Time_______No. of cycles
Initial denaturation 95 10 min
Denaturation 95 30 s
Annealing 55 45 s
Extension 72 1 min
Final extension 72 10 min
Soak 4 Indefinite
* Tris-A cetate-ED TA
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5.2.4 Statistics and graphing
Statistical significance at the 0.05 level was determined by one-way analysis of 
variance, with post hoc comparisons of means by the Bonferroni method. 
Graphs were plotted using Origin® 7 software (OriginLab Corp.). Data are 
presented as mean ± SEM. Graph bars marked with * indicates a statistically 
significant difference to the control at the 0.05 level.
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5.3 Results
5.3.1 Effects of TRP channel ligands on MG63 cell numbers
MG63 cells were incubated in various known TRPM8 and TRPV 1 ligands and
9 + *Ca channel ligands, including the SERCA pump inhibitor thapsigargin, for a 
period of 72 hours to investigate the chronic effects of these drugs on 
osteoblast cell numbers, in a preliminary attempt to elucidate roles for these 
channels in osteoblast proliferation or cell death. While many of the drugs 
tested caused a concentration-dependent decrease in cell numbers following the 
treatment period, none of the compounds tested induced proliferation of the 
MG63 cells within the experimental time limits. In addition, osteoblast cell 
proliferation is shown to be pH-dependent.
The cold-sensitive TRPM8 agonist menthol had no significant effect on MG63 
cell number within the concentration range 10 pM -  1 mM after 72 hours 
exposure (n = 3) and the application of the TRPV1/TRPM8 antagonist 
capsazepine at a concentration of 1 pM did not make any difference to the cell 
number after exposure of the cells to the same concentration range of menthol 
(n = 3) (Figure 5.3). These initial findings do not indicate a role for TRPM8 in 
osteoblast proliferation.
The TRPV1 agonist capsaicin caused a concentration dependent (0.3 pM -  100 
pM) reduction in MG63 cell numbers after 72 hours exposure, and the effects 
of the highest concentrations 30 pM and 100 pM capsaicin were significantly
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reduced cell numbers (p < 0 05; n = 3) Similarly, the TRPV1 antagonist 
capsazepine caused a concentration-dependent reduction in cell numbers (0.1 
pM -  100 pM), with the effects of 30 pM and 100 pM capsazepine being 
statistically significant (p < 0.05; n = 4) (Figure 5.4). 1 pM capsazepine, which 
did not cause a change in cell numbers (Figure 5.4), curiously prevented the 
effects o f the higher concentrations of capsaicin (30 pM and 100 pM) resulting 
in a much smaller effect on cell numbers by capsaicin, which was statistically 
insignificant (p > 0.05; n = 3) (Figure 5.5). Therefore 1 pM capsazepine may 
be blocking the effects of higher concentrations o f capsaicin on MG63 cell 
numbers, which points towards TRPV1 -channel mediated cell death.
MG63 cell number was not increased by any of the three cannabinoids (1 -1 0 0  
pM anandamide and 0.1 -  100 pM methanandamide or abnormal cannabidiol), 
but was significantly decreased after 72 hours exposure by > 10 pM 
anandamide (p < 0.05; n = 3), > 10 pM methanandamide (p < 0.05; n = 3), and 
> 30 pM abnormal cannabidiol (p < 0.05; n = 3) (Figure 5.6). These effects are 
likely attributable to cannabinoid receptor stimulation, but this has not been 
systematically explored in this thesis.
Thapsigargin, the SERCA pump inhibitor, caused a concentration-dependent 
decrease in MG63 cell numbers after 72 hours exposure over the concentration
range 10 -  1000 nM, which was statistically significant over this range (p <
• 2+0.05; n = 4) (Figure 5.7). Ruthenium red, a non-specific Ca -channel blocker,
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also caused a significant concentration-dependent decrease in MG63 cell 
numbers at 30 pM and 100 pM (p < 0.05; n = 2) (Figure 5.8).
A short pilot study investigating the effects of pH on osteoblastic cell number 
revealed a significant decrease in cell number at pH 6.91 compared to control 
pH 7.4 (n = 1). This was not explored further, but could be investigated in 
future experiments.
5.3.2 The effects of TRPV1 ligands on the mineralisation of SaOS-2 and 
7F2 osteoblast-like cells
Induction o f true osteoblast mineralisation in the human SaOS-2 osteoblasts 
was inconclusive. Up to 14 days after initiation o f the mineralisation treatment 
in SaOS-2 osteoblast-like cells, the alizarin red-stained wells appeared to show 
saturation of mineralisation, possibly due to non-specific (non-osteoblast-like) 
mineralisation, excessive cell number, or time-scale of the assay, in all 
controls, 1 and 10 pM capsaicin, and 1 and 10 pM capsazepine (Figure 5.9). 
True osteoblastic mineralisation of mouse 7F2 cells appeared to be more 
successful as shown in Figure 5.10. However, although there appears to be 
little visual difference in mineralisation with 10 pM capsaicin or 100 pM of the 
K At p  opener pinacidil after 1 0  days treatment, elution o f the dye to quantify 
mineral deposition would be required to draw any firm conclusions from these 
experiments.
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5.3.3 The effects of TRPV1 ligands on the differentiation of osteoblast 
precursors into adipocytes
Results show that 7F2 osteoblast precursors can be prevented from 
differentiating into adipocytic cells, and persuaded along the osteoblastic 
pathway, by stimulation of TRPV1 with known TRPV1 agonists and the 
cannabinoid anandamide. TRPV1 antagonists do not prevent differentiation. 
Therefore, TRPV1 appears to have an important role in osteoblast precursor 
cell differentiation.
Control wells showed that induction of adipogenesis in 7F2 cells was 
successful. Lipid droplets were visible in induced cells after approximately 3 
days, and the differentiation of 7F2 cells appeared to slow cell division as can 
be seen when comparing the control wells of induced and non-induced cells 
(10 days) in Figure 5.11. Non-induced cells appear much more densely packed, 
whereas induced adipogenic cells are more sparse with visible lipid droplets 
(stained red). After 10 days treatment and oil red O staining, the TRPV1 
agonists capsaicin (1 pM) and resiniferatoxin (100 nM) both appeared to have 
reduced adipogenesis compared to control wells, whereas the non-specific 
TRPV1 antagonist capsazepine (1 pM) and the selective TRPV1 antagonist 
SB366791 (100 nM) each had no apparent effect on adipogenesis compared to 
controls. Also interestingly, the endocannabinoid anandamide (1 pM) appeared 
to have reduced adipogenesis compared to controls, in a similar fashion to 
capsaicin and resiniferatoxin. The TRPV1 antagonists were able to block the 
preventative effects o f capsaicin, resiniferatoxin and also anandamide resulting
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in differentiation to adipogenic cells Figure 5 11 shows representative images 
from 1 of 3 experiments
5.3.4 RT-PCR confirms expression of TRPV1 in mouse osteoblast 
precursors
30 cycles of RT-PCR showed that TRPV1 is expressed in mouse 7F2 
osteoblastic cells at the mRNA level, revealing a band between 200 and 300 
bp, corresponding well with an expected band size of 233 bp (Figure 5.12).
182
C H A PTER  5:
FUN CTIO NA L PR O PER TIES OF THE TRPV1 REC EPTO R IN O STEO BLA STS
5.4 Discussion
5.4.1 TRP and Ca2+ channel ligands on osteoblast cell number
The results show that after a 72-hour treatment, none o f the TRP ligands tested 
promoted proliferation of MG63 cells. The insignificant effects of up to 1 mM 
menthol on MG63 cell numbers is not surprising given the very low expression 
o f TRPM8 in these cells, as shown by RT-PCR in chapter 4. Others have 
shown that 100 pM menthol activates TRPM8 channel currents in transfected 
HEK-293 cells (Thebault et al., 2005) so the concentration range used is 
presumably appropriate. Given these results, and the low expression of TRPM8 
in osteoblasts, it is likely that these cells do not utilise TRPM8 in a major role 
in cell proliferation.
Hui et al. (2003) have reported that the binding o f capsaicin at the TRPV1 
receptor occurs with a A'j of around 0 6 pM with the increase in channel 
activity peaking at around 3 pM in TRPV1-tranfected Xenopus oocytes. In 
MG63 osteosarcoma cells, 0.3 - 10 pM capsaicin did not significantly affect 
the number o f cells after 72 hours, but 30 pM and 100 pM capsaicin 
significantly reduced cell numbers with signs of cell death. Caterina et al. 
(1997) showed that TRPV 1-transfected HEK-293 cells were killed by 
prolonged (7 hours) exposure to 3 pM capsaicin whilst non-transfected cells 
remained healthy, and suggested that TRPV1 mediates capsaicin-induced 
necrosis rather than apoptosis due to the absence of nuclear fragmentation in 
the dead cells. As demonstrated in previous chapters, TRPV1 expressed in
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MG63 cells is seemingly much more difficult to activate, arguably due to the 
expression o f the dominant negative TRPVlb splice variant which renders 
TRPV lb  subunit-containing channels much less sensitive to capsaicin. 
Therefore, it would seem reasonable that higher concentrations of capsaicin 
may be required to have the same effect, which may be TRPV 1-mediated 
necrosis, in MG63 cells. However, it is most likely that death of MG63 cells by 
high concentrations of capsaicin may be due to necrotic non-specific toxicity. 
Interestingly, the fact that the capsaicin-induced effects at 30 and 100 pM were 
blocked by 1 pM capsazepine confuses the matter by indicating that these 
effects were specific and mediated by capsaicin on the TRPV1 channel, but 
this should be further repeated for confirmation. Future work such as apoptosis 
assays are suggested to determine the mechanism o f cell death.
The growth-arresting and apoptotic/necrotic effects of the cannabinoids 
anandamide, methanandamide and abnormal cannabidiol at micromolar 
concentrations have been shown previously in various cells, and these effects 
occur either via the cannabinoid CBj and CB2 receptors and the TRPV1 
channel (Ligresti et al., 2003; McKallip et al., 2002; Maccarrone et al., 2000; 
Siegmund et al., 2005), or independently o f these receptors (Biswas et al., 
2003; Sarker et al., 2003). Siegmund et al. (2005) report that 1 - 1 0  pM 
anandamide blocked proliferation o f human hepatic stellate cells and dose- 
dependently induced cell death at concentrations > 25 pM. This is consistent 
with the effects of anandamide on MG63 cells reported in this thesis. 
Siegmund et al. (2005) also showed that the growth-arresting and cell death
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effects of anandamide were unaffected by selective blockade of CBi and CB: 
receptors or TRPV1 receptors. Although untested here, this may mean that in 
MG63 cells the cannabinoid agonists cause growth-arrest and cell death by 
non-specific means.
Thapsigargin, a selective inhibitor of the sarcoplasmic/endoplasmic reticulum 
Ca2+-ATPase (SERCA) pump, prevents replenishment o f the ER with Ca2+ and
2+ t 2 |
leads to cytosolic [Ca ] increases as Ca leaks out of the ER. Cells 
undergoing apoptosis are known to have depleted thapsigargin-sensitive Ca2+ 
stores, suggesting Ca movement within the cell (Jan et al., 2000; Distelhorst 
et al., 1996; Baffy et al., 1993). In osteoblasts, thapsigargin-induced apoptosis 
has been previously reported (Labelle et al., 2007; Jan et al., 2000; Mentaverri 
et al., 2003) and the dose-dependent thapsigargin toxicity on MG63 cells 
presented in this thesis is consistent with the dose-dependent apoptosis of 
MC3T3E1 osteoblast cells over the range 1 - 1 0 0  nM reported by Chae et al. 
(1999), although apoptosis was not systematically confirmed in this thesis. 
Labelle et al. (2007) also show that thapsigargin-induced ER depletion o f Ca2+ 
causes capacitative Ca entry (CCE) through the plasma membrane, which is 
associated with osteoblast proliferation and may involve TRPC channels, as 
observed in other tissues (Golovina et al. 2001; Sweeney et al. 2002; Liu et al. 
2003; Wang, X. et al. 2004), but not TRPV1 (Wisnoskey et al., 2003).
The Ca2+ channel blocker ruthenium red caused growth arrest but not cell death 
at 30 and 100 pM, which is consistent with reports of similar effects at the
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same concentrations in cerebella astrocytes and neurons, and in cortical 
neurons (Tapia & Velasco, 1996). The presumed mechanism o f cell death by 
ruthenium red is by inhibiting Ca movement within the cell from ER stores 
and via mitochondrial ryanodine receptors, and by inhibiting mitochondrial 
Ca2+ uptake (Hajnoczky et al., 2006).
Much o f the reduced MTS absorbance signals from the highest concentrations 
o f compounds used in these experiments are probably due to necrotic, rather 
than apoptotic cell death. In contrast to the majority o f data shown, the 
thapsigargin concentration-effect is perhaps more likely to be due to apoptosis 
rather than necrosis due to the nature of the concentration dependence within 
an appropriate concentration range for SERCA pump antagonism. Cells 
observed under the microscope appeared healthy at all concentrations of 
thapsigargin, although numbers were reduced at higher concentrations, whereas 
for many of the other compounds the cells at the highest concentrations had 
detached from the plates.
5.4.2 Mineralisation experiments
The mineralisation o f SaOS-2 osteosarcoma cells was unsuccessful as the 
alizarin red stain showed saturation, as described in the results. Future 
experiments with these cells should use a lower cell density, a reduced assay 
time-scale and/or possibly a reduced supplementation o f P-glycerophosphate, 
although ideally a true osteoblastic cell-type should be employed, rather than a 
sarcoma to reduce the possibility o f non-specific mineralisation. The data from
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7F2 cells are inconclusive and these assays should be repeated in future studies 
followed by elution of the dye to quantify mineral deposition, and establish 
whether or not there are any differences in mineral deposition due to the 
compounds used. Edge-effects, due to the exposure of those wells around the 
perimeter of plates to gaseous exchange during incubation, could be avoided in 
future experiments by either avoiding perimeter wells in multiwell plates, or by 
using 6-well plates where the bias is removed from the experiments.
5.4.3 The effects of TRPVI ligands on 7F2 osteoblast differentiation
The results presented here are further evidence o f the remarkable ability of this 
cell line, which otherwise displays all the markers o f mature osteoblasts, to 
differentiate and divert from the osteoblast pathway into lipid-producing 
adipocytes. The novel data presented here are a beginning in closing the link 
between this phenomenon, as originally described by Thompson et al., (1998), 
and the role TRPV1 plays in the differentiation o f 3T3-L1-preadipocytes into 
mature adipocytes (Zhang et al., 2007) showing for the first time that the 
TRPV1 channel appears to play a role in regulating the differentiation of 
immature osteoblasts either into mature osteoblasts or into adipocytes.
Whereas Zhang et al. (2007) recently showed that capsaicin as an agonist of 
TRPV1 prevented differentiation along the adipocyte pathway, the results 
shown in this thesis demonstrate that both capsaicin and resiniferatoxin have 
the same effect on immature osteoblasts, and of further interest are the data 
showing that anandamide also has the same effect. This adds strength to the
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suggestion that anandamide is a putative endogenous agonist of human TRPV1 
(Smart et al., 2000). The TRPV1 antagonists capsazepine and the specific 
ligand SB366791 did not prevent differentiation to adipocytes, which is 
consistent with the reports by Zhang (op. cit.) that capsazepine does not 
prevent adipogenesis and that TRPV1 is downregulated along the pathway to 
adipocyte differentiation. In support o f this, it is interesting to note that 
capsazepine and SB366791 were each separately able to antagonise the anti- 
adipogenic effects of capsaicin, resiniferatoxin and anandamide, in each case 
resulting in differentiation along the adipocyte pathway. These 
pharmacological data show that the apparent anti-adipogenic (or pro- 
osteoblastic) effects of anandamide are mediated by TRPV1 and not the 
cannabinoid receptors.
The consequences o f osteoblast differentiation into adipocytic cells are 
pathologically important and the data presented here highlight a target for 
pharmacological intervention in the TRPV1 channel, and bring to our attention 
a very interesting functional role for TRPV 1 in bone.
5.4.4 RT-PCR confirms TRPV1 expression in mouse 7F2 osteoblasts
Confirmation that the TRPV 1 channel is expressed in 7F2 cells is given by the 
RT-PCR data. The results discussed above are indicative o f a functional 
channel that is receptive and responsive to capsaicin. Human TRPV1 and 
mouse TRPV1 share 86.5% sequence identity and as with the human TRPV1 
channel, a splice variant o f mouse TRPV1 (mTRPVl) has been identified
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which is unresponsive to capsaicin, protons or heat, and has been termed 
mTRPVip (Wang, C. et al., 2004). The variant form has a deletion of 10 
amino acids from exon 7 forming part of the N terminus and is dominant / 
negative when heteromultimers o f mTRPVl and mTRPVip are expressed. 
Along with human TRPV lb  expression, this is also consistent with reports of 
N terminal exon 7 deletions in rat TRPV1 sequences, forming splice variants 
known as SIC, VR.5’sv and VR1L2, each o f which are unresponsive to 
capsaicin and form non-functional channels (Sharif Naeini et al., 2006; Eilers 
et al., 2007; Tian et al., 2006). However, Wang, C, et al. (2004) have shown 
that the tissue expression of mouse mTRPVip is heterogeneous, and largely 
confined to brain, skin, DRG, stomach and tongue. The expression of a mouse 
TRPV 1 splice variant has not been systematically tested in this thesis.
5.4.5 Chapter conclusions and future work
The chapter 5 hypothesis was that the TRPV1 channel has a functional role in 
(i) the proliferation, (ii), mineralisation and (iii) differentiation o f osteoblasts. 
The data presented in this chapter show that part (iii) o f the hypothesis appears 
to be true, but parts (i) and (ii) appear false. The proven part of the hypothesis 
is very interesting: if the functional role o f TRPV 1 in osteoblast differentiation 
is real, as evidenced in this thesis, TRPV1 could become an important target 
for new drugs, or novel indications for drugs currently under investigation, in 
the battle against osteoporosis and particularly glucocorticoid- and age-related 
osteoporosis where osteoblast production is seemingly sacrificed for 
adipocytes.
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Some of the data presented in this chapter are preliminary and were intended to 
be exploratory in nature in the search for TRPV1 receptor functions in 
osteoblasts, and to create dose-response curves in order to select appropriate 
drug concentrations for experimentation. Some of these preliminary data 
require future attention, including further work on the growth-arresting effects 
o f pH on MG63 cells which contrasts with data in the literature, and
development of the findings o f the effects o f thapsigargin and ruthenium red,
and the use of these drugs as pharmacological tools in the characterisation of 
TRPV 1 and its functions in osteoblasts. Recommendations for more immediate 
investigation include:
• further evidence of the anti-adipogenic effects o f TRPV 1 activation with
the use of a larger pharmacological artillery, to include adenosine as a
putative TRPV1 antagonist and cannabinoids (agonists and antagonists) to 
further investigate the action o f anandamide and more conclusively 
distinguish its effects of TRPV 1 from cannabinoid receptors.
• the effects of acidification on the differentiation o f 7F2 cells, both alone 
and in combination with TRPV 1 agonists.
• further work on the protective effects o f capsazepine on capsaicin toxicity 
in osteoblasts, to determine whether TRPV 1 antagonist by other ligands has 
the same protective effect, and whether this can also protect against the 
toxic effects of other TRPV 1 agonists.
• proliferation, apoptosis, mineralisation and differentiation assays using 
primary human osteoblasts as the gold standard.
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Control 1% EtOH 10 100
Menthol concentration (^M)
Menthol & capsazepine (CPZ) concentrations (nM)
Figure 5.3 (A) The TRPM8 agonist menthol had no significant effect 
on MG63 cell number after 72 hours treatment (p < 0.05) either (A) alone 
over the range 10 pM to 1 mM (n = 3), or (B) in combination with 1 pM 
capsazepine over the same menthol concentration range (n = 3).
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B
Capsaicin concentration (nM)
1 2 0 -
Capsazepine concentration (^M)
Figure 5.4 Effects of capsaicin and capsazepine on MG63 cell 
numbers. After 72 hours treatment, (A) the TRPV1 agonist capsaicin 
caused a significant decrease (p < 0.05) in MG63 cell numbers at 30 pM 
and 100 pM (n = 3), and (B) the non-specific TRPV1 antagonist 
capsazepine also caused a significant decrease (p < 0.05) in MG63 cell 
numbers at 30 pM and 100 pM (n = 4). * indicates significant difference 
from control.
192
C H A PTER  5:
FUNCTIONAL PR O PER TIES OF T H E  TRPV1 REC EPTO R IN O STEO BLA STS
Capsaicin / Capsazepine (CPZ) concentration (jiM)
Figure 5.5 Effects of capsaicin vs. capsazepine on MG63 cell numbers.
After 72 hours treatment, 1 pM capsazepine (which had no significant 
effect on MG63 cell number) prevented the cell number decreases caused 
by 30 pM and 100 pM capsaicin, seen in figure 5.4 (n = 3).
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0.1%  EtOH 1 3 10 30  100
Anandamide concentration (nM)
120
Methanandamide concentration (nM)
*5^o Abnormal cannabinoid concentration (^M)
Figure 5.6 Effects of different cannabinoids on MG63 growth. All 3
agonists caused concentration-dependent reduction of cell numbers after 72 
hours treatment, which were significantly different from controls at (A) 10, 
30 and 100 pM anandamide (n = 3), (B) 10, 30 and 100 pM 
methanandamide (n = 3), and (C) 30 and 100 pM abnormal cannabinoid (n 
= 3). * indicates significant difference from control (p < 0.05).
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Thapsigargin concentration (nM)
Figure 5.7 Effects of thapsigargin on MG63 cell numbers. The SERCA 
pump inhibitor thapsigargin caused a concentration-dependent decrease in 
MG63 cell numbers after 72 hours treatment over the concentration range 
10 -  1000 nM, which was statistically significant from control over this 
entire range (p < 0.05; n = 4).
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Control
Ruthenium red concentration (^M)
Figure 5.8 Effects of ruthenium red of MG63 cell numbers. The non-
2+
specific Ca -channel blocker ruthenium red caused a concentration- 
dependent decrease in MG63 cell numbers at 30 pM and 100 pM, which 
was significantly different from control (p < 0.05; n = 2).
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Figure 5.9 Mineralisation assay of SaOS-2 human osteosarcoma cells.
Mineralisation appears to be saturated, and therefore results are 
inconclusive (n = 2).
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C Control
E Ethanol vehicle control
Caps Capsaicin (10 pM)
P Pinacidil (100 pM)
Figure 5.10 Mineralisation assay of 7F2 mouse osteoblasts. Alizarin red 
staining shows osteoblastic mineralisation appears successful after 10 days 
treatment (n = 3). However, dye elution is required in future repeats to 
quantify mineral deposition and allow any differences to be measured.
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Adipogenesis
Not induced Induced
Control
1 pM C apsaicin
1 pM C a p sa z ep in e
1 pM A nandam ide
100 nM Resiniferatoxin
100 nM S B 366791
C apsaicin  + 
C a p sa zep in e
C apsaicin  + 
S B 366791
A nandam ide + 
C a p sa zep in e
A nandam ide + 
S B 366791
R esiniferatoxin + 
C a p sa zep in e
R esiniferatoxin + 
S B 366791
Figure 5.11 Adipogenesis assays (n = 3) with lipids stained red, showing that 
TRPV1 agonists capsaicin (1 pM) and resiniferatoxin (100 nM) prevented 
adipogenesis o f induced 7F2 cells, and anandamide (1 pM) also appeared to do 
the same. The TRPV1 antagonists capsazepine and SB366791 did not prevent 
adipogenesis, but did appear to block the effects of the above agonists.
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Figure 5.12 RT-PCR confirms mRNA expression of TRPV1 in mouse 
7F2 osteoblasts. (3-actin = 392 bp and TRPV1 = 233 bp.
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6  CAPSAICIN-INDUCED CALCIUM
SIGNALLING IN MG63 CELLS VIA THE 
TRPV1 CHANNEL
6.1 Introduction
In chapter 4, it was shown that the TRPV1 channel is expressed at the 
messenger level in MG63 osteosarcoma cells and other human osteoblasts 
(including primary osteoblasts) and at the protein level in MG63 cell 
membranes. Importantly, the splice variant TRPV lb  was also shown to be 
expressed at both messenger and protein level, which may, at least in part, 
account for the difficulty in gathering electro physio logical data of TRPV1 
activation (chapter 4) as TRPV lb is a putative inhibitory subunit, meaning that 
any TRPV1 channel which contains TRPVlb subunits (homologous or 
heterologous) is insensitive to capsaicin (1 pM), protons (pH 5.0) and heat (50 
°C) (Vos et al., 2006). However, in chapter 5, TRPV1 was found to be 
functional in mouse 7F2 osteoblasts, specifically being important in 
differentiation, regulating progression o f osteoblast-precursors to mature 
osteoblasts or to adipocytes, despite the expression o f TRPVlb. Another
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demonstrable criterion of TRPV 1 functionality is channel activation by known
agonists (e.g. capsaicin, protons) in order to cause an increase in intracellular
Ca2+ concentration via the TRPV 1 channel.
This chapter aims to address this final point to further confirm the presence and 
functional status of the TRPV1 channel in osteoblasts, and to show whether or 
not TRPV1 channel activation by capsaicin induces a Ca2+ signal in these cells.
6.1.1 Calcium signalling
Calcium signalling is the term given to the process by which cytoplasmic free
'yi # .
Ca ions act in a signal transduction cascade either following influx from 
extracellular fluid via plasma membrane ion channels, or as second messengers 
following activation o f an indirect pathway, such as G protein-coupled receptor 
activation (Campbell, 1983). Intracellular sources of Ca2+ are the endoplasmic 
reticulum (ER) and mitochondria, which act as internal Ca2+ stores, although 
mitochondrial stores are transient. Ca2+ ions are pumped against their 
concentration gradient into these stores to maintain a ‘resting’ cytosolic [Ca2+] 
of around 100 nM (Campbell, 1983; Baker, 1972). Activation of specific 
receptors on the ER, the vast majority of which are ryanodine receptors and 
inositol triphosphate (IP3) receptors, allows release o f Ca2+ ions into the 
cytoplasm, increasing free [Ca2+]i to as much as 5 -  10 pM (as much as 50 pM 
Ca may actually be released, but the majority is bound to cytoplasmic 
proteins and organelles) (Campbell, 1983). This cytosolic Ca2+ regulates an
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array of important physiological processes, including enzyme activity and ion
channels/pumps.
On the plasma membrane, ion channels which allow Ca2+ influx to the cytosol
2d" •include the voltage-gated Ca channels, which are generally associated with 
excitable tissue (neurons, myocytes, etc.) but are also found in non-excitable 
cells such as osteoblasts (L-type) (Grygorczyk et al., 1989; Meszaros et al.,
•y j
1996), and ligand-gated Ca channels, including TRP channels (Clapham et 
al., 2005; Harteneck et al., 2000) and store-operated channels (Clapham et al., 
2005; Parekh & Putney, 2005). TRP channel signalling has already been 
reviewed (section 1.6.4.1), and store-operation may be a mechanism featured 
by some TRP channels (such as the TRPC channels: see below). However, the 
general theory that all TRP channels are store-operated channels is now widely 
accepted as wrong.
6.1.1.1 Store-operated channels
2 “bThe idea that cellular Ca entry across the plasma membrane could be, at least 
in part, controlled by intracellular Ca2+ store depletion following signalling in 
order to replete these stores has been building for over more than 20 years 
(Putney, 1986; Putney, 1990). This is now known as store operated Ca2+entry 
(SOCE) and the best described of the SOCE currents is that which is known as 
the Ca2+ release activated Ca2+ current, I c r a c  (Lewis & Cahalan, 1989; 
Matthews et al., 1989; Penner et al., 1988). However, there is now evidence to 
show that SOCs do more than simply replete internal stores, but also create
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Ca2+ signals which regulate cellular processes such as gene expression, cell 
metabolism and exocytosis (Parekh & Putney, 2005; Lewis, 2007).
2+
The best described, by far, of the store-operated channels (SOCs) is the Ca 
release activated Ca2+ (CRAC) channel which carries I c r a c  (Hoth & Penner,
1992). The messenger linking intracellular Ca2+ release and plasma membrane 
(PM) SOCs has long been unknown, but recent breakthroughs have identified 
STIM1, a primarily ER-bound transmembrane protein, as the Ca2+ store sensor, 
and CRACM1 (also known as Orail), a plasma transmembrane protein, as the 
putative CRAC channel pore-forming subunit (Feske et al., 2006; Li et al., 
2007; Vog et al., 2006; Zhang et al., 2005; Zhang et al., 2006; Potier & 
Trebak, 2008). Verification occurs with artificial co-expression of STIM1 and 
CRACM1, which results in CRAC-like currents exhibiting all the features of 
CRAC (Mercer et al., 2006; Peinelt et al., 2006; Soboloff et al., 2006). The 
proposed mechanism of interaction is that on store-depletion, STIM1 
accumulates in regions of the ER close to the PM (Wu et al., 2006), but 
whether there is direct protein-protein interaction between STIM1 and 
CRACM1 (Muik et al., 2008; Yeromin et al., 2006), or whether there are 
intermediate signalling proteins (Csutora et al., 2008; Wu et al., 2006), is 
currently an issue of contention.
6.1.1.2 Is there a role fo r  TRP channels in store-operated Ca2+ entry?
Whether or not some TRP channels have a role in SOCE remains a hot topic, 
but TRPC channels remain controversial candidates (Parekh & Putney, 2005;
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Smyth et al., 2006; Alicia et al., 2008). TRP channels began to emerge as 
candidates for SOCs due their Ca2+ permeability and selectivity, and the 
predicted topology of TRP channels was similar to that of VDCCs (Hardie & 
Minke, 1993). But as it emerged that the Drosophila TRP channel was 
activated by downstream products of PLC, such as diacyl glycerol (DAG) or 
polyunsaturated fatty acids (PUFAs) (Hardie, 2003; Montell, 2003) the notion 
that all TRPs and SOCs were one and the same suffered a setback. However, it 
should be noted that whilst understanding of the CRAC channel (see above) 
signalling mechanism may be progressing fruitfully, CRAC is just one 
component of SOC currents, the remainder of which are poorly understood. 
Whilst TRPC channels may not be CRAC channels, some authors believe 
TRPC channels may yet reveal themselves as SOCs. Worley et al. (2007) 
propose in one article that TRPC1 is a STIM1-regulated SOC, whilst in another 
the authors go further and believe all TRPC channels (except TRPC7) to be 
SOCs which are heteromultimerised by STIM1 (Yuan et al., 2007). Therefore 
the answer to the above question is: possibly, but there is a lot to do before a 
definite answer can be given. In addition to the TRPC subgroup, TRPV6 (Den 
Dekker et al., 2003; Vennekens et al., 2000; Voets et a l,  2001) has shown 
some early promise as a SOC, but is not the I c r a c  channel as this has a Ca2+ 
selectivity over Na+ {PcJPn&) of > 1000:1 and a conductance o f < 1 pS (Broad 
et al., 1999), compared to PcJPn& > 130:1 and 58 - 79 pS conductance for 
TRPV6 (Alexander et al., 2004).
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6.1.1.3 The calcium-sensing receptor (CaR)
The extracellular calcium-sensing receptor was first cloned from bovine 
parathyroid by Brown et al. (1993) and is a PM-bound non-ion channel
receptor, characteristic of the GPCR family. The receptor is particularly
2  |
sensitive to extracellular Ca and other polyvalent cations and therefore the 
authors (ibid) proposed that the CaR on parathyroid and other calcium-
2 “hsensitive tissues is the extracellular calcium-sensor in the regulation of Ca 
metabolism, and report that the receptor responds to changes of [Ca2+]0 in the 
millimolar range. The receptor is a 7-transmembrane protein receptor with a 
large extracellular domain, containing multiple Ca2+-binding sites (Brown et 
al., 1993). [Ca2+]0 changes are detected by the CaR, which then modulates 
multiple signalling pathways of G-protein coupling via Gj (inhibiting adenylate 
cyclase) (de Jesus Ferreira et al., 1998), Gq (activating phospholipase C) (Kifor 
et al., 1997) and possibly G 12/13 (activating Rho-mediated phospholipase D) 
(Huang et al., 2004), to alter [Ca2+],. However, there is also good evidence for 
CaR responses via non-G-protein coupling pathways, including direct CaR- 
induced phospholipase induction (Kifor et al,. 1997), CaR-induced Ca2+j 
oscillations (Breitwieser et al., 2001; Miki et al., 2005), and PKC-mediated 
CaR phosphorylation (Bai et al., 1998; Meggio et al., 1995). However, the full 
detail o f the CaR downstream signalling mechanisms remain unresolved to 
date (van den Hurk et al., 2008).
Detection of changes in [Ca2+]0 by the parathyroid gland is presumably the 
mechanism by which the parathyroid regulates the secretion o f parathyroid
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hormone (PTH) Parathyroid hormone action on bone ceils results in calcium 
resorption into the blood from the bone by stimulating osteoblasts to increase 
their release of RANKL, which stimulates osteoclast development. The CaR 
has also been identified in osteoblasts (Dvorak et al., 2004; Chattopadhyay et 
al., 2004) and osteoclasts (Kameda et al., 1998) and may directly regulate bone 
turnover. Osteoblasts have been shown in this Thesis (see section 3.3.2, and 
Figure 3.17) to detect and respond to small changes in extracellular calcium 
concentration within the physiological range 0.6 -  3.0 mM, which is likely due 
to CaR sensing.
6.1.2 The role of TRPV1 in modulating intracellular free Ca2+ 
concentration
The TRPVI channel has for some time been recognised as a Ca2+-permeable 
ion channel with high expression in peripheral sensory neurones and dorsal 
root ganglia (Caterina et al., 1997). Plasma membrane TRPV1 activation is a
known means of Ca2+ influx from extracellular free Ca2+, and also [Ca2+]i
* 21elevation by Ca release from internal stores in dorsal root ganglia (Savidge et 
al., 2001) and various other non-excitable tissue- and cell-types (e.g. Liu et al., 
2000; Sanchez et al., 2005), and is outwardly rectifying with a conductance of 
around 80 pS and a PcJPn* o f around 10: 1. The relatively defined 
pharmacology of the TRPV1 channel compared to other TRP channels has 
enabled the elucidation of mechanisms o f activation o f Ca2+ entry. The channel 
is directly activated by the specific agonist capsaicin (Caterina et al., 1997) and 
the endocannabinoid anandamide (Smart et al., 2000) which evoke [Ca2+]j
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increases in various cell types, and blocked by the synthetic compound
capsazepine (Bevan et al., 1992). Perhaps rather surprisingly, the TRPV1 
antagonist capsazepine on its own evokes a rise in [Ca2+]i in MG63 cells 
similar to that seen with capsaicin in other cell types (Teng et al., 2004. 
Capsazepine in other cell types inhibits Ca2+ signals (Piper et al., 1999),
although recently another group has reported [Ca2+]j increases in prostate
cancer cells in response to capsazepine (Huang et al., 2006). Teng et al. (2004)
'y I
speculate that the capsazepine-induced [Ca ]j rise in MG63 cells may be via a 
separate mechanism exclusive of TRPV1. Capsazepine is now well
documented to be non-selective for TRPV1; it also blocks voltage-dependent
2+
Ca channels (VDCCs) (Docherty et al., 1997), and interestingly capsazepine 
activates the amiloride-sensitive epithelial Na+ channel (ENaC) in human 
epithelial cells (Yamamura et al., 2004).
More recently, the nucleoside adenosine has been shown to block the Ca2+ 
signalling effect o f capsaicin (Puntembekar et al., 2004) and therefore is a 
putative endogenous antagonist of TRPV1, and interestingly Zhang et al. 
(2007) have shown the importance of the Ca2+ signal by capsaicin-induced 
TRPV1 activation in adipocyte cell differentiation. What appears lacking in the 
literature is evidence o f [Ca ]j signals in human osteoblasts in response to 
capsaicin and other TRPV 1 agonists.
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6.1.3 Is TRPV1 involved in SOCE?
TRPV 1 does not have any of the characteristics that could realistically make it 
a SOC, other than the fact that as a Ca2+ permeable channel it allows Ca2+ entry 
across the plasma membrane which may contribute to Ca2+ store repletion. 
There is plenty of evidence against TRPV1 being the CRAC channel. For 
instance, 2-aminoethoxydiphenylborane (2-APB), a ligand that was used to 
discriminate I c r a c  as a selective blocker (although now known not to be 
selective at all) activates TRPV1, TRPV2 and TRPV3 channels (Hu et al., 
2004; Chung et al., 2004). Also, and importantly in this argument, capsaicin 
blocks I c r a c  in Jurkat T-cells (Fischer et al., 2001) whereas capsaicin is the 
defining TRPV1 agonist (Cahalan et al., 1997). TRPV1 agonists have been 
shown to release Ca2+ from internal stores via activation of endoplasmic 
reticulum TRPV1 channels, but this failed to activate SOCs on the plasma 
membrane, which indicates that TRPV1 is also not involved in SOCE 
signalling (Wisnoskey et al., 2003).
6.1.4 Desensitisation of capsaicin-induced Ca2+ flux in excitable cells
• 94-The capsaicin-induced influx of Ca ions into excitable cells (dorsal root 
ganglionic neurones, peripheral sensory neurones) has been shown to be 
desensitising resulting in reduced inward currents on further challenges with 
capsaicin and that this desensitisation is capsaicin-, [Ca2+]0- and voltage- 
dependent (Piper et al., 1999; Cholewinski et al., 1993; Koplas et al., 1997). A 
number of mechanisms of action of desensitisation have been proposed: one is 
that TRPV1 is dephosphorylated by calcineurin (protein phosphatase 3 CA -
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formerly called protein phosphatase 2B) (Novakova-Tousova et al., 2007) and 
another is that desensitisation may be regulated by protein kinase A activation 
and calmodulin binding (Bhave et al., 2002; Mohapatra & Nau, 2003; 
Numazaki et al., 2003; Rosenbaum et al., 2004). A possible third mechanism 
of desensitisation (shown in Figure 6.1) is that Ca2+ influx via TRPV1 causes 
hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2) which deactivates 
the channel, as PIP2-binding is thought to be essential for TRPV1 activation 
(Liu et al., 2005). Re-synthesis of PIP2 by phosphatidylinositol-4-kinase 
(PI4K) rephosphorylates TRPV1 and reverses the capsaicin-desensitisation 
(Liu et al., 2005). The authors of this proposed mechanism do not agree with 
Mandadi et al. (2004) who propose that resensitisation is probably mediated by 
protein kinase C, and Liu et al. (Ibid) suggest that the ‘re-sensitisation’ seen by 
Mandadi et al. is due to incomplete desensitisation o f TRPVI following short 
bursts of capsaicin exposure, and therefore Ca2+ responses were due to 
activation of non-desensitised channels following PKC activation.
Much o f the evidence for capsaicin-desensitisation is based on experiments 
with excitable cells although the same mechanism is presumably responsible 
for any TRPV 1 desensitization in non-excitable cells, including osteoblasts.
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Figure 6.1 Possible mechanism of desensitisation of TRPV1 by capsaicin.
Ca2+ influx may promote Ca2+-dependent PIP2 hydrolysis by phospholipase C 
(PLC), leading to desensitisation of the channel. Resynthesis of PIP2 allows 
recovery and resensitisation of TRPV 1 to capsaicin.
6.1.5 Chapter hypothesis, aims and experimental strategies
The hypothesis in chapter 6 is that applications of TRPV 1 agonists, such as 
capsaicin and protons, to MG63 osteosarcoma cells will cause intracellular free 
Ca2+ to rise due to activation of the TRPV 1 channel, thus fulfilling the 5th key 
aim of the thesis, as listed in the introduction (section 1.7).
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The chapter aims are to use fluorescence imaging technology to show that 
TRPV1 is indeed a functional channel that induces a Ca2+ signal when 
activated by specific TRPV1 agonists, and that this activation can be 
potentiated by decreasing the extracellular pH from physiological levels (pH
7.4).
For any Ca2+ signal to be due to TRPV1 activation beyond any reasonable 
doubt, several criteria are included in this thesis which should be satisfied. 
These are as follows:
1 The Ca2+ signal must follow application o f an appropriate concentration 
of specific TRPV 1 agonists, such as 1 -  10 pM capsaicin (EC50 = 0.48 at 
pH 7.4 in TRPV 1-transfected HEK cells (Ryu et al., 2007)).
2 The fluorescence intensity indicating a Ca2+ signal, and/or the proportion 
of cells fluorescing, in response to a TRPV1 agonist should increase 
when the extracellular pH is decreased to show potentiation of the 
channel-activation by protons.
3 A decrease in pH itself should not induce a Ca2+ signal in the absence of 
any TRPV 1 agonists.
4 Capsaicin-desensitisation should be apparent following the initial 
application o f capsaicin. Further applications should not induce a Ca2+
signal at the same pH.
2+
5 The Ca signal should be due to direct activation of TRPV 1, and not 
secondary Ca signalling due to TRPV 1-stimulated glutamate release. 
Therefore, glutamatergic Ca2+ signalling should either be absent in
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response to application of glutamate, or glutamate receptor antagonists 
should not impair any capsaicin-induced Ca2+ signal.
6.1.5.1 Experimental strategy
In order to achieve the above aims, calcium imaging experiments made use of 
the fluorescent Ca2+ indicator fluo-3. This chemiluminescent compound was 
first introduced by Minta et al. (1989) and has the advantage of producing a 
large increase in fluorescence with Ca chelation.
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6.2 Methods
6.2.1 Cell culture
MG63 cells (passage number 11) were cultured, counted and seeded as 
described in chapter 2, sections 2.1, 2.2 and 2.5, and calcium imaging 
experiments were conducted as described in section 2.5.
6.2.2 Ca2+ imaging protocol
MG63 cells were cultured in 35 mm culture dishes with a 10 mm diameter 
glass-bottom of standard thickness 1.0 (MatTek Corporation, Ashland, MA, 
USA) and incubated for two to three days in DMEM supplemented with 5 % 
FBS and penicillin-streptomycin 1000: 1000. Cells were loaded in culture 
medium with 5 pM Fluo-3 acetoxymethyl (Molecular Probes, Invitrogen, 
Eugene, OR, USA) prepared with 20 % pluronic F I27 (Molecular Probes) in 
DMSO (Sigma) for 20 minutes at 37 °C in the dark. Cells were then washed in 
culture medium and again incubated for 20 minutes at 37 °C in the dark for the 
loaded dye to de-esterify. For the experiments, the culture medium was 
replaced with sodium ‘Locke’ solution (mM: 150 NaCl, 3 KC1, 2 CaCh, 2 
MgCh, 10 HEPES, 10 D-glucose) and additions were made directly to the dish 
with a variable volume pipettor. All drugs were prepared in sodium ‘Locke’ 
solution, where possible, at 10x final concentrations.
Experiments were carried out using a laser scanning confocal microscope 
(Zeiss LSM 510) with a C-Apochromat 63x/1.2 n.a. water-immersion lens for
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high resolution imaging The fluorescent dye was excited by the 488 11111 line of
an argon/2 laser running at 1 % power, and emitted light was collected with a
bandpass IR filter of between 500 and 550 nm. Images of 512 x 512 pixels
were acquired with a pixel dwell-time o f 2.56 ps, resulting in an acquisition
rate of 1.576 seconds per frame.
Image data were saved as Zeiss .Ism files in databases and later converted from 
.Ism sequences to .avi movie file sequences using Zeiss LSM Image Browser 
(version 4,2,0,121). Movie file sequences were then analysed with Photek 
IFS32 (C-Vision/Im32 Version 5.25 X3.1490) software by drawing Odd Area 
Profiles (OAP) around cells and extracting Odd Area Set (OAS) intensity data 
for the entire set of images in the movie sequence. These values were then 
plotted against time using Origin 7 software (OriginLab®).
6.2.3 Interpretation of data
Image fluorescence intensity was measured for each frame of the odd area set 
(OAS) of cells in each 512 x 512 pixel area recorded (see Figure 6.2, and as 
described in section 2.5) over time courses of around 550 to 750 seconds (364 
to 481 frames, with 1.576 seconds between frames). Data were copied into 
Microsoft Office Excel 2003 and the first 10 frames of each odd area profile 
(OAP) were averaged to get a baseline intensity value (Flo). The relative 
fluorescence intensity was calculated for each frame of each OAP by dividing 
each measured intensity value (FI) by the averaged baseline value (FI/FI0).
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Figure 6.2 Example of a 512 x 512 pixel frame showing Odd Area 
Profiles (OAP) drawn around MG63 cells, collectively forming an Odd 
Area Set (OAS). Intensity data were measured for each OAP in each frame.
Relative fluorescence intensity values were copied to Origin software and 
average values for all cells in each frame were plotted against time. Increases 
in fluorescence intensity with fluo-3 stained cells indicates increases in [Ca2+]j 
of these cells.
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6.3 Results
6.3.1 Optimisation of fluorescent dye loading
Adjustments to the fluo-3 loading protocol described in the methods section 
were required to achieve optimised loading. The loading protocol reported by 
Labelle et al. (2007) which uses 2 pM fluo-3 (with pluronic F I27) incubating 
for 45 minutes followed by washing and 45 minutes in Locke solution to allow 
the dye to de-esterify resulted in poor dye loading into the MG63 cells. 
Increasing fluo-3 concentrations to 5 pM and 10 pM and incubating for 20 
minutes, with a 20 minute wash/de-esterification period resulted in improved 
dye-loading and this amended protocol, with 5 pM fluo-3, was therefore 
followed for all the experiments.
6.3.2 Capsaicin pH-dependently induces a calcium signal
The TRPV1 agonist capsaicin induced calcium signals in the MG63 cells, 
which were potentiated by a decrease in pH from 7.4 to 6.3, thereby meeting 
criteria 1 and 2 for TRPV 1-mediated Ca2+ signalling (see 6.1.4). On application 
of 1 pM or 10 pM capsaicin at physiological pH (7.4), increases in cell 
fluorescence intensity corresponding to increased [Ca2+]i were heterogeneous, 
with just 50% or less of cells showing detectably increased fluorescence 
intensity. Figure 6.3 shows no increase in fluorescence intensity (0/8 cells 
produced calcium responses) when challenged with 1 pM or 10 pM capsaicin, 
whereas in Figures 6.4 and 6.5 in naive cells, 3/6 and 2/12 cells respectively
218
CHAPTER 6: CA PSA ICIN-IND U CED  CALCIUM  SIGNALLING IN M G63 CELLS
VIA THE TRPV1 CHANNEL
displayed 11 and 14 increased fluorescence intensity within 2 - 5  seconds 
of challenge with 1 pM capsaicin.
The [Ca2+]i increase in response to 1 pM capsaicin appeared to be transient 
rather than sustained, and after quickly reaching maximum fluorescence in 
approximately 10 seconds, the intensity decreased steadily over a period of 
approximately 100 seconds before levelling out at pre-capsaicin intensity 
values in the 3/6 cells that responded (Figure 6.4).
Decreasing the extracellular pH from 7.4 to 6.3 with HC1 appeared to
9+potentiate the [Ca ]; response of the cells to capsaicin as expected (Figures 
6.4, 6.5 and 6.6). As demonstrated by Figure 6.4, the capsaicin-induced [Ca2+]j 
rise at pH 7.4 was mixed, with only 3/6 o f the cells showing increased 
fluorescence intensity (overall intensity increased 1.1 x), and following a pH 
drop to 6.3 the capsaicin response was homogeneous (6/6 cells) with a greater 
fluorescence intensity increase to 1.4* the relative fluorescence intensity (RFI). 
Figure 6.5 also shows that in the presence of 1 pM capsaicin, decreasing the 
extracellular pH to 6.3 without further application of capsaicin causes [Ca2+]j to 
rise above the initial response to capsaicin at pH 7.4 (1.4x increase overall; 
2/12 cells), to around 3.6* the RFI (12/12 cells).
To show that protons alone do not lead to [Ca2+]i rises, extracellular pH was 
decreased after 75 seconds recording at pH 7.4 to pH 6.3 as a challenge to 
naive cells and, as expected, the cells (0/10) did not display any detectable
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change in fluorescence intensity (Figure 6 6) On application of 1 pM capsaicin 
following pH decrease, the fluorescence intensity of 3/10 cells increased 
transiently to a total RFI o f 1.2x, indicating a TRPV 1-mediated calcium signal. 
The fact that protons do not induce a Ca2+ signal in the absence of capsaicin 
shows that the above responses are due to capsaicin, and these responses are 
simply potentiated by decreased pH. This satisfies criterion 3 for TRPV1- 
mediated calcium signals in osteoblasts (see 6.1.4).
6.3.3 Desensitisation of the capsaicin-response
Multiple applications of capsaicin revealed that initial capsaicin-induced 
calcium signals were non repeatable at the same pH (n = 3, Figures 6.4 - 6.6), 
indicating a mechanism for capsaicin-desensitisation. This satisfies the 4th 
criterion for osteoblastic TRPV 1-mediated calcium signals (see 6.1.4).
At physiological pH (7.4), a single application of 1 pM capsaicin to the MG63 
cells induced a calcium signal in 3/6 cells (total RFI 1.1 x), but a second 
application of 10 pM capsaicin produced no response (Figure 6.4) indicating 
capsaicin-desensitisation. However, following pH change to 6.3 (with HC1) a 
third application of capsaicin (10 pM) induced a large calcium signal in 6/6 
cells, with a total RFI increase to 1.4* from background. This shows that at 
physiological pH, capsaicin-desensitisation occurs, but can seemingly be 
reversed by acidifying the extracellular environment. But does capsaicin- 
desensitisation also occur at pH 6.3?
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Figure 6 5 shows that it does An initial application of 1 pM capsaicin at pH
7.4 induced a small total change (1.4x) in fluorescence signal, corresponding to 
2/12 cells. With the capsaicin still in the bath, HC1 was added to decrease the 
pH to 6.3 and a much larger calcium signal can be seen at around 3.6X change 
in fluorescence intensity (from background), due to a homogeneous cellular 
calcium response (2/12 cells). A further application of 1 pM capsaicin 
produced no response at the same pH.
In Figure 6.6, the bathing solution was acidified to pH 6.3 prior to exposure to 
capsaicin. The initial 1 pM capsaicin application induced a calcium signal 
(1.2* RFI increase, corresponding to 3/10 cells), but a second 10 pM 
application o f capsaicin produced no response, again showing capsaicin- 
desensitisation.
6.3.4 No calcium response to challenges with L-glutamate
Application of L-glutamate produced no detectable calcium responses in the 
MG63 cells at the concentrations used (n = 5, representative data shown in 
Figures 6.3 and 6.7), which indicates that capsaicin-induced Ca2+ signals are 
probably not due to the effects of osteoblastic TRPV 1-stimulated glutamate 
release acting on NMDA receptors (see Medvedeva et al., 2008; Lappin et al., 
2006), or glutamate-induced TRPV1 activation (Ahem et al., 2006) thus 
satisfying the 5th and final criterion for TRPV 1-induced Ca2+ signalling (see
6.1.4). When various concentrations of L-glutamate (sodium salt, Sigma) from 
30 pM to 100 pM were added to the bath, there was no detectable increase in
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fluorescence in the MG63 cells up to 140 seconds post addition (Figures 6 3
and 6.7). In both examples shown, the cells were naive to challenges by other
drugs and increases in fluorescence were demonstrated with 100 mM CaCh
applied to the bath as a positive control.
6.3.5 KCI causes [Ca ]; to increase
KC1 causes an increase in intracellular calcium, which is probably due to
2  j
membrane depolarisation and Ca entry via VDCCs. This effect was used as a 
positive control at the end of each experiment to show that the fluo-3 loading 
had worked effectively and did not affect cell viability. Application o f 50 mM 
KCI to the bath (final concentration) caused a small [Ca2+]j increase (RFI 
increased by l.lx ; n = 2), reaching a sustained maximum after 10-30 seconds 
from the initial response (Figures 6.4 and 6.7). The [Ca2+]i maximum was 
sustained for at least 130 seconds before challenge with CaCb. Figure 6.4B 
shows a decrease in fluorescence intensity in response to 50 mM KCI when 
measuring fluorescence over total cell area as drawn at time = 0. This conflicts 
with the effects seen in Figures 6.3 and 6.7, but on closer inspection the cells in 
Figure 6.4 shrink on application of KCI. If  the fluorescence intensity is 
measured for the entire time course based on cell area after cell shrinkage, the 
fluorescence intensity of the cells increases in response to KCI, as shown in 
Figure 6.4C.
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6.4 Discussion
6.4.1 Optimisation of fluorescent dye loading
Dye loading was optimised by amending the protocol fluo-3 concentration and 
incubation times. Although the same cell line was used for these experiments, 
the dye was incubated with the cells in culture medium whereas Labelle et al. 
incubated the cells in a less complex (by number of ingredients) HEPES- 
buffered saline solution. It is noted that the product information given for fluo 
calcium indicators (Molecular Probes, Invitrogen) states that in addition to
• (K)using the non-ionic detergent Pluromc F I27 as a dispersing agent to facilitate 
dye loading into cells, BSA or FBS may also facilitate cell loading. Therefore 
it is possible that a shorter loading time may be required when using culture 
medium containing FBS than for a buffer solution. However, in the 
experiments discussed in this thesis, all media contained 5% FBS and no 
attempt was made to investigate this systematically.
However, the recommendations also state that a loading buffer free o f primary 
and secondary amines is used to minimise extracellular hydrolysis of fluo-3 
acetoxymethyl esters. DMEM does contain amines and the use of this medium 
as a loading buffer may explain the need to increase the fluo-3 loading 
concentration due to dye ester hydrolysis.
Although the dye-loading protocol used for this thesis deviates slightly from 
the manufacturers’ recommendations and that of Labelle et al. (2007), slight
223
C H A PTER  6: C A PSA IC IN -IN D U C ED  CALCIUM  SIGNALLING IN M G63 CELLS
VIA THE TRPV1 CHANNEL
modifications resulted in good dye-uptake and low background (baseline)
fluorescence giving good signal-noise ratio fluorescence intensities during
experiments.
6.4.2 Capsaicin-induced calcium signals
6.4.2.1 Effects o f  capsaicin are potentiated by acidification
At pH 7.4 the intracellular free calcium responses to capsaicin were 
heterogeneous, whereas at pH 6.3 all cells showed increased [Ca2+]i. It is 
recognised that TRPV1 channel activation is potentiated by protons, resulting 
in a lower EC50 o f capsaicin in more acid conditions: at pH 7.4, EC50 = 0.48 ± 
0.03 pM and at pH 6.5, EC50 = 0.05 ± 0.004 pM (Ryu et al., 2007) making 
capsaicin approximately 1 order of magnitude more potent at pH 6.5. 
Puntambekar et al. (2004), for example, have reported that capsaicin causes 
[Ca2+]i increases in TRPV 1-transfected Xenopus laevis oocytes, and many 
groups have shown that small reductions in pH potentiates activation of 
TRPV1 by capsaicin and resiniferatoxin (e.g. Caterina et al., 1997; Jordt et al., 
2000; Ryu et al., 2007). However, the expression of TRPV lb  either as a 
heteromultimer or a homomultimer has been shown to negatively regulate the 
channel, rendering it much less responsive to capsaicin or protons (Lu et al., 
2005; Schumacher et al., 2000; Vos et al., 2006; Wang, C. et al., 2004).
It would seem reasonable, given the data shown here, to draw the conclusion 
that TRPV1 homomultimers must be expressed in MG63 cells as [Ca2+]j is 
increased by capsaicin, and the effect is clearly enhanced by reducing the
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extracellular pH If the conclusions drawn by Lu, Schumacher, Vos and .Wang 
(ibid) are to be believed then the MG63 cell membranes cannot be populated 
by TRPVlb/TRPVl heteromultimers or TRPV lb homomultimers alone.
6.4.2.2 Desensitisation o f  capsaicin-evoked [Ca2+]i increases 
The fact that [Ca2+]i responses to capsaicin challenge were not repeatable at the 
same pH shows that desensitisation o f the TRPV1 channel occurs in 
osteoblasts. Following desensitisation by capsaicin, depolarisation of the cell 
membrane by KCI does still cause [Ca2+]j to rise, showing that the capsaicin- 
desensitisation is specific and exclusive of other mechanisms o f cytosolic free 
calcium-entry. This capsaicin desensitisation in MG63 cells is very much like 
the desensitisation seen in dorsal root ganglia and thus it is tempting to propose 
a common underlying mechanism.
I
The capsaicin-induced MG63 cell TRPV1 activation and [Ca ], response at pH 
6.3, following apparent capsaicin-desensitisation at pH 7.4 (normal), can 
probably be explained yet again by the potentiating effects of protons on 
capsaicin-evoked TRPV1 activation. The results show that only a small 
proportion o f cells display increased fluorescence intensity on application of 
capsaicin at pH 7.4, but all cells light up at pH 6.3 in the presence of 1 pM 
capsaicin. So why do some cells respond at pH 7.4 when others do not? There 
are a variety of possible explanations for this, such as heterogeneous 
expression levels o f TRPV 1 across the cells, different phosphorylation states of 
TRPV1 channels in different cells, TRPV 1/TRPV lb  heteromultimer
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expression level differentials, and cells at various stages of the cell cycle, to 
name but a few. It is likely that at pH 7.4, 1 pM capsaicin produces a 
submaximal response resulting in desensitisation of those channels that were 
activated, but at pH 6.3 the proton-potentiated homogeneous response was at or 
near the maximum due to reduction in EC50 concentrations o f capsaicin and 
was therefore followed by homogeneous desensitisation of TRPV 1.
6.4.3 Calcium signal not due to downstream glutamate action
* 71Fluorimetric measurements of [Ca ]i showed that glutamate did not cause a 
rise in [Ca ]i o f cells bathed in Locke solution at concentrations between 30 
pM and 100 pM. However, as fluorescence intensity increases were observed 
on application o f capsaicin, calcium signals must be directly due to Ca2+ influx 
via TRPV1 channels rather than a secondary effect due to TRPV 1-stimulated 
glutamate release. Primary osteoblasts and osteoblast-like cells such as MG63 
and SaOS-2 are recognised to express a variety of metabotropic and ionotropic 
glutamate receptors including NMDA receptors and glutamate has been shown 
to cause increases in [Ca2+]i in these cells (Gu et al., 2002; Laketic-Ljubojevic 
et al., 1999). The authors recognise that these [Ca2+]i increases could be 
effected by any glutamate receptor type, but report that 1 mM extracellular
*74-Mg caused partial channel block and changed the I/V curve shape (Gu et al., 
2002) and in 0-Mg2+ extracellular solution glutamate caused [Ca2+]j to rise. 
Laketic-Ljubojevic et al. (1999) similarly report complete inhibition of [Ca2+]j 
increase with 3 mM extracellular Mg2+. Blockade by Mg2+ ions is a recognised 
distinguishing characteristic of NMDA receptors which differs from other
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glutamate receptor types: therefore [Ca2+]i rises shown by Gu and Laketic-
Ljubojevic were probably due to activation of NMDA receptors.
The Locke solution used to bathe the MG63 cells for experiments in this thesis 
contained 2 mM MgCL. It is likely that the lack of calcium responses to 
glutamate was therefore due to NMDA receptor Mg2+ blockade. If this is true, 
it also suggests that other glutamate receptor types express at low levels or not 
at all.
6.4.4 KCl-induced [Ca ], increases
Application o f 50 mM KCI to the bath, in order to depolarise the cell
i
membrane, caused [Ca ]j to increase. It should be noted that depolarisation 
here simply means that cell membrane potential becomes more positive than 
the resting membrane potential, and in inexcitable cells there is no threshold 
potential, after which in excitable cells an action potential would follow. The 
mechanism o f depolarisation by external KCI application and the resultant 
increased intracellular Ca2+ signal can be explained due to a disruption o f the 
Gibbs-Donnan equilibrium. There is a resultant change in the Nemst potential 
o f the membrane for K+, from -85 .5  mV ([5]o/[140]i) to -2 3 .9  mV 
([55]o/[140]i). This is a clear positive shift in the membrane potential, and 
therefore the membrane is said to be depolarised.
In turn, cell membrane depolarisation causes voltage-dependent Ca2+ channels 
(VDCCs) to open, and this is the presumed route of Ca2+ entry into the
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osteoblasts, leading to increased intracellular Ca2+ concentration as shown by 
the experimental data (Figures 6.3, 6.4 and 6.7). Although the expression of 
VDCCs is said to define an excitable cell (Hille, 2001), evidence is emerging 
for lower levels of expression o f members of this ion channel group in 
inexcitable cells, recently including skeletal tissue (Shao et al., 2005; Mancilla 
et al., 2007) and osteoblasts (Cox, personal communication, 2007).
In the data presented in this thesis, the KCl-induced [Ca2+]i increase was used 
as a positive control to show that the fluo-3 dye was present and able to chelate 
calcium in the cells in which [Ca2+]j was not changed by other drugs. A clear
2  j
[Ca ]j response is seen after application o f KCI in Figure 6.7, whereas a much
2+
smaller [Ca ]j response is seen in Figure 6.3 but is nevertheless detectable. In 
Figure 6.4 the fluorescence vs. time graph appears to show a decrease in [Ca2+]i 
on application o f KCI but this is due to cell shrinkage which reduced the 
fluorescing region of the odd area set (OAS) measured and intracellular free 
calcium actually increased as shown in Figure 6.4C. The cell shrinkage 
observed is probably due to a hyperosmotic extracellular solution and a cell 
membrane that is relatively impermeable to CF resulting in water passing from 
the cytosol into the extracellular environment, as described by Boyle and 
Conway (1941) and Hodgkin and Horowicz (1959), according to:
[K]o[Cl]0 = [K]j[Cl]j
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6.4.5 Possible consequences of acid-potentiation of TRPV1 activation on 
bone in vivo
The effects of acid pH on osteoblasts and osteoclasts are known to be opposite. 
Reduction of pH from 7.4 to < 7.0 effectively switches osteoclasts on, with 
maximum bone mineral absorption taking place by osteoclasts at around pH 
6.9 (Arnett, 2007). At the same time, acid conditions cause osteoblasts to be 
switched off -  growth, differentiation and mineralisation are all reduced or 
inhibited. Arnett (2007) believes that TRPV1 is a candidate for H+ ion 
detection and has a regulatory role in bone metabolism. In this chapter, 
capsaicin-induced [Ca2+]j increases in MG63 cells are shown to be potentiated 
by acidic conditions, and therefore TRPV1 activation may be important as a 
switch for osteoblast growth and function.
6.4.6 Chapter conclusions and future work
The chapter hypothesis that TRPV1 channel activation by capsaicin induces a 
Ca2+ signal in osteoblasts, and that this signal can be potentiated by protons, is 
therefore proven correct. TRPV1 channels are proven for the first time to be 
expressed and functional as Ca2+-permeant ion channels in human 
osteosarcoma cells, and presumably also in primary human osteoblasts.
The data presented here are a beginning in the understanding of the Ca2+ signal 
evoked by TRPV1 activation in osteoblasts by capsaicin, and the potentiation 
of this channel by acidic extracellular conditions, where the apparent channel 
expression is the full-length TRPV1 and the dominant negative splice variant
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TRPVlb There is plenty of scope for a more comprehensive study in this area, 
but some of the more immediate questions that require future attention include:
• Do other TRPV1 agonists such as resiniferatoxin or anandamide evoke 
the Ca2+ signal in osteoblasts, and does an acidic extracellular 
environment potentiate the [Ca2+]i signal with these agonists?
• Is the capsaicin-induced (and potentially other TRPV1 agonists-induced)
2+[Ca ]j increase blocked by TRPV1 antagonists, such as capsazepine and 
SB366791?
• Can the putative endogenous agonist anandamide and antagonist
adenosine effectively mimic the effects of capsaicin and a TRPV1 
antagonist on the Ca signal?
• Can further increases in proton concentration, by further decreases in
extracellular pH, activate the TRPV1 channel alone (i.e. no agonists) to 
induce a [Ca2+]i increase?
• And importantly, is the Ca2+ entry route via TRPV1 alone, or do other
Ca2+-permeable channels (e.g. VDCCs) contribute? Establish using
2+
antagonists o f other Ca cha-nnels, such as dihydropyridines.
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Figure 6.3 Glutamate and capsaicin do not cause [Ca2+]i to increase at physiological pH. (A) As also observed in figure 6.7, 
glutamate does not increase [Ca2+]j and 1 - 1 0  pM capsaicin also does not detectably increase [Ca2+];. Application of 50 mM KCI 
causes a slight increase in fluorescence in some cells, whereas 100 mM CaCh causes all cells to fluoresce brightly. (B) Averaged 
relative fluorescence intensity data from all cells showing effects of drug challenges on [Ca2+]j.
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Figure 6.4 Decreasing pH potentiates [Ca2+|j increases 
due to capsaicin. (A) At pH 7.4. I pM capsaicin causes a 
small increase in fluorescence. At pH 6.3 10 pM capsaicin 
causes a much larger increase. (B) Averaged RFI data 
showing that the [Ca2+]j increase due to capsaicin cannot 
be repeated by a higher concentration at the same pH. but 
after reducing pH to 6.3, a much larger calcium response is 
seen to 10 pM capsaicin. The drop in fluorescence on 
application of KCI is due to cell shrinkage as demonstrated 
in (C) where shrinkage can be seen in the fluorescence 
images, and a [Ca2+]j increase is seen if the OAS is 
decreased to fit the shrunken cell as highlighted in red.
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Figure 6.5 Decreasing pH in the presence of capsaicin 
causes a large [Ca2+]j increase. (A) Time frames (with seconds 
shown) show initial fluorescence. (B) two cells responding to 1 
pM capsaicin at pH 7.4. (C) all cells responding in the presence 
of capsaicin when pH is reduced to 6.3 and (D) that further 
capsaicin challenges have no effect. (E) Averaged RFI values 
for all cells showing the above plotted against time.
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Figure 6.6 Protons do not increase [Ca2+]j alone, but potentiate calcium responses to capsaicin. (A) Fluorescence imaging frames 
showing no [Ca2+]j increase after reducing pH to 6.3, but a slight increase at this pH when 1 pM capsaicin is applied. The capsaicin- 
induced [Ca‘+]j increase cannot be repeated even with 10 pM concentration after the initial response during the time recorded. (B) 
Averaged RFI vs. time plot showing the above.
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Figure 6.7 No calcium response to glutamate challenge in MG63 cells. (A) Neither 30 pM glutamate nor 90 pM (total 
concentration) caused a detectable change in [Ca2+]j. 50 mM KCI caused an small increase in [Ca2+]j which can be seen as a slight 
increase in fluorescence. (B) Eight frames showing the large increase in fluorescence caused by application of 100 mM CaCh. The 
increase is rapid and uniform (both cytoplasm and nucleus light up together). (C) Averaged relative fluorescence intensity data from all 
cells showing effects of drug challenges on [Ca2+]j. Times are shown for each frame in seconds.
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7 GENERAL DISCUSSION & CONCLUSIONS
7.1 Discussion
The evolution o f ion channels is thought to have begun soon after the 
encapsulation o f primitive life forms by a phospholipid barrier, separating the 
inner workings o f the cell from the surrounding environment. The incarceration 
o f the organelles in this manner, although advantageous as a collective and 
protective consequence, prevented the transport o f ionised particles into or out 
o f the cell. Therefore, mechanisms evolved to overcome this problem, allowing 
the passage o f selected ionised particles across the membrane. The pioneering, 
Nobel prize-winning work by Hodgkin and Huxley (1952) demonstrating their 
theory o f the electrical mechanism o f nerve conduction, showed the importance 
of ionic exchange across cell membranes, and although carrier proteins were 
originally the favoured theory o f  ion transport, ion channels were confirmed as 
the accepted mechanism following the establishment of Neher and Sakmann’s 
patch-clamp technique (Neher & Sakmann, 1976; Hamill et al., 1981). It is 
now recognised that mammalian ion channel homologues stretch far back in 
the evolutionary tree, with Caenorhabditis elegans expressing voltage-gated
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Na+ and K+ channels, TRP channels, mechanosensitive CF channels, and many 
other ion channels homologous to those found in much more recently evolved 
organisms. Mammalian cells o f all types have been shown to express a huge 
variety of ion channels, which are not necessarily limited to obvious functions: 
e.g. voltage-gated channels that have a clear purpose in excitable cells, such as 
the conduction o f action potentials in neurons, are also to be found in many 
non-excitable cells where their purpose is less easily identifiable in the first 
instance. As the expression o f so many ion channels is conserved in such a 
diverse range o f tissues and cells, then the real question turns to their purpose 
in these systems. If channel proteins are found to be present, are they simply 
redundant entities awaiting the brokers yard o f evolution, or are they fully 
functional either as ion channels or as enzymes or coupling proteins, for 
example, serving an important role in cellular processes?
This Thesis picks up on that very question and has attempted to firstly confirm 
the expression o f a selection o f ion channels (K+ and TRP channels) in human 
osteoblastic cells, and then to go some way towards characterising the channels 
and testing the hypothesis that the proteins have key functions in these cells.
The osteoblast cell-lines and primary osteoblast cultures were new to the 
laboratory. However, the cells were found to be hardy and doubled at an 
approximate rate of once every 24 hours, and when cell husbandry protocols 
were established and optimised the routine maintenance o f these cells became 
straightforward. The expressions o f maxi-K channel subunits a and (31-4
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(KCNMA1 and KCNMB1-4), KATp subunits KIR6.1, KiR6.2, SUR1 and 
SUR2B, and TRP channels TRPV1 and TRPM7, were confirmed at messenger 
level in human MG63 and SaOS-2 osteosarcoma cells and primary osteoblasts. 
The expressions o f TRPV5, TRPV6 and TRPM8, however, were not 
ubiquitous in the osteoblasts, or across a panel o f prostate cancer and breast 
cancer cells, indicating that these proteins have functions that are more specific 
to different cell-types or to different stages in cell differentiation. These 
expression data laid the foundations for subsequent characterisation of the 
ubiquitously expressed channels in human osteoblasts using the patch-clamp 
technique, and raised the question stated above on the possibility of functional 
roles in osteoblasts.
The osteoblastic cells were amenable to single-channel patch-clamping, and 
high-resistance seal formation was readily achievable. Patch-clamping showed 
that MG63 and SaOS-2 cells expressed a large-conductance channel with the 
hallmarks o f the Kca channel o f  large conductance, known as maxi-K, 
consistent with the RT-PCR data. The channels were large conductance (> 180 
pS), activated with depolarising voltage, were calcium-activated (as evidenced 
by glutamate application), displayed voltage-dependent deactivation at large 
depolarising potentials, and were blocked by TEA. The powerful and highly- 
sensitive patch-clamp technique illustrated that this channel-type, previously 
identified in osteoblasts as having neuronal type-II characteristics (Moreau et 
al., 1996), was found to be in abundance in MG63 and SaOS-2 cells, often with 
5 or 6 channels per patch. Importantly, this Thesis describes some o f the first
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examples of work characterising the maxi-K channel in primary human 
osteoblasts, which also have an abundance of maxi-K channels in the plasma 
membrane. The data presented show that MG63 and SaOS-2 cells are good 
models for primary osteoblasts in terms of maxi-K channel character and 
expression. This work also provides what is probably the first maxi-K channel 
kinetic data in osteoblasts, showing that voltage-activation increases open 
probability by increasing open burst duration rather than simply increasing 
burst number.
Possible roles for the maxi-K channel in osteoblasts were not systematically 
explored in this Thesis, but work elsewhere in the laboratory has provided 
clues that some pharmacological compounds which target maxi-K, such as the 
plant alkaloid tetrandrine, have putative proliferative effects in osteoblasts (Li 
et al., 2007 abstract). Excitingly, the K+ channel blocker tetraethylammonium 
(TEA) appears to increase osteoblast mineralisation in SaOS-2 cells and HOB- 
c primary osteoblasts (Evans, B.A.J., 2008 and Li, B., 2008, personal 
communications), although it is not known if this effect is due to maxi-K 
blockade or another target o f this promiscuous ligand. Finally, there are 
emerging data that the specific maxi-K channel blocker iberiotoxin may also 
have an enhancing effect on osteoblast mineralisation (Li, 2008, personal 
communication).
The K a t p  channels have not been electrophysio logically characterised in this 
Thesis, but the proliferative effects o f pinacidil may indicate that these
240
C H A PT E R  7: G E N E R A L  D ISCU SSIO N  & CO N CLU SIO N S
channels have an important functional role in osteoblasts. The mechanism of 
this proliferative effect is untested here, but if it is indeed due to K Atp channel 
activation, as is likely, then either membrane potential change or cell volume 
change are two often-cited hypotheses. K + channels in the plasma membrane 
are well recognised to regulate cell division in many, if not all, cell types 
(Dubois et al., 1993; Nilius & Droogmans, 1993; Wonderlin & Strobl, 1996) 
by one of the two hypotheses suggested above: in the membrane potential 
hypothesis K+ channel inhibitors cause electrochemical rundown and Ca2+- 
entry decreases, preventing mitogenesis, whereas in the cell volume hypothesis 
K+ channel modulators affect ion transport across the membrane and therefore 
the osmotic potential o f the cell, with volume changes resulting in intracellular 
concentration changes (of other components) and cytoskeletal reorganisation. It 
is likely, o f  course, that the mechanisms described in these two hypotheses are 
not separate but linked, as a change in one will almost certainly affect the 
other. But whatever the mechanism, the effect o f pinacidil-induced osteoblast 
proliferation is interesting and warrants further investigation in future work 
(see below).
O f the TRP channels identified in osteoblasts by RT-PCR, the TRPV1 channel 
was selected for further investigation due to the advantage of previously 
described channel pharmacology. However, the patch-clamp technique did not 
prove fruitful when attempting to find and characterise the TRPV1 channel in 
osteoblasts, despite its apparent expression at mRNA level in the MG63 cells. 
Generally, the electrophysiology data collected and reported here do not
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support the hypothesis that TRPV1 proteins are functional as channels in 
osteoblasts. It is worth noting here that attempts were made in this thesis to 
find native TRPV1 channels in osteoblasts, without attempting up-regulation or 
transfection o f the channel. In contrast, previous reports characterising the 
TRPV1 channel electrophysiology by other groups have been conducted in 
either excitable cells (particularly dorsal root ganglionic cells) (e.g. Caterina et 
al., 1997; Raisinghani et al., 2005) where TRPV1 is highly expressed, or 
TRPV1-transfected non-excitable cells with high channel expression levels 
(e.g. Hui et al., 2003; Jung et al., 2002). O f course, it could be argued in 
hindsight that the choice of the single-channel technique was perhaps less 
appropriate than the macroscopic alternative, which is whole-cell membrane 
current recording. The advantage o f this would be that ionic currents flowing 
through the entire population o f TRPV1 channels in the plasma membrane 
could be recorded, solving the problem o f having to find individual TRPV1 
channel currents. As a possible explanation o f the single-channel negative 
findings, further RT-PCR experiments identified for the first time in any bone 
cells the expression o f the dominant negative splice variant TRPV lb, which 
markedly reduces the affinity o f the channel for capsaicin (and possibly other 
similar ligands). Although the co-expression o f TRPV lb  with TRPV1 in other 
cells does not appear to prevent ion channel function (only activation by certain 
ligands is affected), the effect in osteoblasts is unknown.
In contrast to the patch-clamp data, the Ca2+ fluorescence imaging experiments 
show that TRPV1 is functional as an ion channel in the plasma membrane, and
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• • 2+ • • • • ♦is involved in Ca signalling within osteoblastic cells. Although it is possible
that another mechanism for Ca2+ entry may be present, for example TRPV1- 
activation o f plasma membrane Ca2+ channels by coupling or downstream 
signalling, evidence points to Ca2+ entry via TRPV1 channels. The capsaicin-
• 2 ~ b  * •induced [Ca ]i signals were desensitised on repeated exposure to capsaicin, 
and were pH sensitive with greater fluorescence (indicating higher [Ca2+]i 
levels) in more acidic conditions. In this way, the responses displayed some of 
the hallmarks o f the TRPV1 channel and these data fit with previous reports of 
capsaicin-induced calcium signals in other cell-types (e.g. Puntambekar et al., 
2004). However, TRPV1 channels are normally associated with the detection 
o f pain and heat in sensory pathways, so what might be the role or roles of 
TRPV 1 channels in osteoblasts?
One very exciting discovery in this Thesis is that TRPV1 may be involved in 
osteoblast differentiation, regulating the pathway taken by osteoblastic 
precursor cells to either mature osteoblasts or to adipocytes. Stimulation of the 
TRPV1 channel by various agonists prevented the differentiation of the 
osteoblastic precursors into adipocytes, despite promotion o f the adipocytic 
route with adipocyte-differentiation medium. TRPV1 antagonists did not 
prevent adipocyte differentiation, and were able to block the anti-adipogenic 
effects of the TRPV 1 agonists. The mechanism of this function is presumably 
linked with the Ca2+ entry following TRPV1 channel activation, which must 
interrupt the intracellular signalling processes leading to adipocyte 
differentiation. These very interesting findings begin to fill in the gap created
243
C H A PT E R  7: G E N E R A L  D ISC U SSIO N  & CO N CLU SIO N S
by the works o f Thompson et al. (1998) who reported on osteoblastic precursor 
differentiation to adipocytes and Zhang et a l  (2008) who reported that TRPV1 
stimulation could prevent adipogenesis from pre-adipocyte cells. These 
findings fit into the osteoporosis story very nicely: osteoporosis has long been 
associated with increased adipocyte content o f the bones, presumably at the 
expense of osteoblasts via this very differentiation pathway. Therefore, this is 
an exciting preliminary finding which potentially provides a lead for future 
drug development and treatment o f osteoporosis.
7.2 Recommendations for further work
The findings presented in this thesis raise some interesting questions and 
provide several new avenues for further research. The following is a series of 
suggestions and ideas for future investigation, which due to the constraints of 
time were not possible to pursue here.
The role of K+ channels in osteoblasts
Given the preliminary data presented here, a more complete investigation into 
the characterisation and roles o f K+ channels in osteoblasts is recommended. In 
particular, the abundance o f  the maxi-K channel in osteoblasts implies an 
important functional role, which surely begs to be discovered. However, 
pertinent to this implied functional importance is the apparent lack o f maxi-K 
activity at rest in these cells. It would perhaps be fair to argue that as these cells 
are not excitable, and therefore probably do not undergo large fluctuations in 
plasma membrane potential, maxi-K would remain inactive or ‘dormant’ in the
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plasma membrane being superfluous for use as an excitatory braking 
mechanism for Ca2+ influx following action potential firing, which is an 
important regulatory mechanism in neuronal cells, but of course not required in 
non-excitable cells. Therefore, if maxi-K is presumed not to be activated by 
membrane depolarisation in osteoblasts, is there another activating 
mechanism? Can intracellular Ca2+ levels rise high enough to activate the 
channel alone? Or maybe the maxi-K channel has a functional role in 
osteoblasts that does not depend on channel gating by Ca2+ or voltage? For 
example, the long cytoplasmic C-terminus o f the a-subunit may have folds or 
loops which confer enzymatic activity, leading to active substrates. 
Furthermore, the maxi K channel in osteoblasts needs to be characterised in 
terms of p subunit composition. Whilst this Thesis shows that all four known p 
subunit messages are expressed, the translated protein composition that locates 
to the plasma membrane is unknown, but ultimately determines the 
pharmacology of the channel. Sausbier et al. (2004) describe a BKca_/ mouse 
model, which would provide useful data on the phenotypic consequences of the 
loss o f maxi-K function in bone, and further down the line a ‘conditional 
knockout’ of maxi-K from bone, meaning a tissue-specific gene deletion, 
would be a very powerful tool for determining maxi-K function in bone.
Further work is also suggested on the putative proliferative role for K a t p  
channels in osteoblasts, as demonstrated in this Thesis with pinacidil, using 
other similar KCOs such as minoxidil and nicorandil which are in clinical use 
(see above for suggested mechanisms o f KATP-regulated proliferation). A full
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characterisation o f K a t p  channel electro physio logy in these cells is also 
required, and again, knowledge o f the channel-protein subunit composition 
would be useful for pharmacological characterisation.
TRPV1 channel characterisation in osteoblasts
It is recommended that future work concentrating on characterising the TRPVT 
channel in osteoblasts should either use the whole-cell patch-clamp technique 
to record macroscopic membrane currents, or use TRPV 1-transfected 
osteoblasts so that the density o f  TRPV 1 channels in the plasma membrane is 
high and therefore allowing successful single-channel patch-clamp recording. 
In addition, Western blotting and immunocytochemistry should be carried out 
to search for TRPV1 and splice-variant protein expression in the osteoblast 
plasma membranes, and as the expression o f the TRPV lb  splice variant in 
other cells putatively limits the use o f pharmacological tools, the 
cells/membrane patches should be subjected to heat (> 42 °C) as an activator of 
the TRPV1 channel. Whichever methods are used, the electrophysio logical 
characterisation of TRPV 1 and its splice variant(s) are an important part of the 
understanding o f the channel in osteoblasts. The Ca2+ signalling experiments, 
which served here to show that TRPV 1 is able to carry calcium currents across 
the plasma membrane, require further work to help in establishing a more 
complete picture of the pharmacology o f the channel in osteoblasts. As 
discussed above, Ca2+ signalling presumably plays a role in TRPV 1-regulation 
of osteoblast differentiation, but it is likely that Ca2+ entry via TRPV1 has other 
roles in these cells, for example in proliferation or secretion.
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The role of TRPV1 in differentiation
Although it is fair to say that the role postulated here for TRPV 1 in osteoblastic 
differentiation is based on somewhat tentative findings, given the small number 
of experiments carried out, the findings are nevertheless very interesting and 
provide a potentially useful lead for further investigation. Such work should 
concentrate on further repeats o f the same, perhaps with longer periods of 
treatments to try to enhance the inhibitory effect o f the TRPV1 agonists. In 
addition, quantitative measurements o f lipid production would enable graphic 
representation o f the results, and allow the data to be tested for statistical 
significance. Taking a step further, a carefully planned series o f experiments 
using an in vivo model for osteoporosis which displayed increased adipocyte 
content of the bone, would perhaps serve to show whether adipocyte 
differentiation is decreased in individuals treated with TRPV1 agonists, and 
importantly whether bone mineral density is higher in these individuals than in 
controls or those treated with TRPV1 antagonists. The use o f tissue-specific 
TRPVl_/_ animals, with the knockout targeted at bone, would serve as a 
particularly useful tool in determining the true in vivo role o f this channel in 
bone and possibly highlight any pathophysiological consequences o f TRPV1 
modulation.
7.3 Conclusions
In conclusion, the findings o f this thesis confirm the expression o f maxi-K, 
K a t p , TRPV1 and TRPM7 channels in osteoblasts and go some way towards
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testing the hypothesis that these ion channels have functional roles in
osteoblasts, as reiterated by the points below.
• RT-PCR confirms the expression o f  maxi-K channel a and (31-4 subunits, 
K a t p  channel K,R6.1/6.2 and SUR1/2B subunits, TRPV1 and TRPM7 
channel subunits.
• Electrophysiology further confirms the expression of a large-conductance 
(> 180 pS) Ca - and voltage-activated channel which displays the 
characteristic electrophysio logical hallmarks o f the maxi-K channel. This 
channel is abundantly expressed in the plasma membranes o f MG63 and 
SaOS-2 osteosarcoma cells and HOB-c human primary osteoblasts, and 
activated with depolarised voltages. Channel kinetic data shows that 
voltage activation increases open burst length rather than increasing the 
number of shorter open bursts.
• The K a t p  channel opener pinacidil significantly promotes proliferation of 
osteoblastic cells in culture, and this effect is not blocked by 
glibenclamide or tolbutamide.
• Despite the lack of electrophysio logical evidence for TRPV1 activity in 
osteoblasts, the Ca2+ fluorescence imaging data shows that the TRPV1 
channel carries Ca2+ currents into the cell, and that this Ca2+-entry is 
capsaicin and pH sensitive, and becomes desensitized to capsaicin 
following multiple exposures.
• RT-PCR shows that TRPV 1 and the splice-variant TRPV lb  are expressed 
at messenger level in human primary osteoblasts and osteosarcoma cell
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lines, and therefore this may result in reduced channel sensitivity to 
capsaicin and protons.
• 7F2 osteoblastic precursor cells treated with adipocyte-inducing medium
undergo complete differentiation into adipocytes, rather than mature 
mineralising osteoblasts. Stimulation o f these cells with the TRPV1 
agonists capsaicin, resiniferatoxin or the cannabinoid anandamide 
prevents differentiation along the adipocyte pathway, whereas TRPV1 
antagonists capsazepine and SB366791 themselves do not prevent 
adipogenesis, but are able to antagonise the effects of the TRPV1 
agonists. This implies an important functional role for the TRPV1 
channel in osteoblastic differentiation.
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APPENDICES
8.1 Publications relevant to this thesis
Peer-reviewed meeting abstracts
Li, B., Henney, N.C., Evans, B.A.J. & Wann, K.T. (2007) Large conductance 
potassium channel in human osteoblast cells. Proceedings o f  the British 
Pharmacological Society at http://bps.conference- 
services.net/viewPDF.asp?conferenceID=l 175&abstractID=l 77854
Henney, N.C., Evans, B.A.J., Campbell, A.K. & Wann, K.T. (2007) TRP 
channels are both present and functional in human osteoblast-like cells. J  Bone 
Miner Res. 22(suppl 1): T022
Li, B., Henney, N.C., Evans, B.A.J., Reviriego, P., Campbell, A.K. & Wann, 
K.T. (2007) BK channels in human osteoblast-like cells - properties and 
function. J  Bone Miner Res. 22(suppl 1): W045
Henney, N.C., Evans, B.A., Campbell, A.K. & Wann, K.T. (2007) Make no 
bones about TRP channels. Proc Life Sciences. PC231
Li, B., Henney, N.C., Evans, B.A., Reviriego, P., Campbell, A.K. & Wann, 
K.T. (2007) BK channels are expressed and functional in human osteoblast-like 
cells. Proc Life Sciences. PC 162
Henney, N.C., Li, B., Evans, B.A.J., Hall, E.J. & Wann, K.T. (2006)
Potassium channel subunits in human osteoblast-like cells. J  Bone Miner Res. 
21(7): 1169
251
A PPE N D IC E S
8.2 Cell culture media formulae
MINIMAL ESSENTIAL MEDIUM (MEM) ALPHA
COMPONENTS MW Concentration
(mg/L)
Amino Acids
G lycine 75 50
L-A lanine 89 25
L-A rginine 211 105
L -A sparagine-H 20  150 25
L-A spartic acid 133 30
L-C ysteine hydrochloride-H 20  176 100
L-C ystine 313 31
L-G lutam ic Acid 147 75
L-G lutam ine 146 292
L-H istidine 155 31
L -Isoleucine 131 52.4
L -Leucine 131 52
L -Lysine 183 73
L-M ethionine 149 15
L -Phenylalanine 165 32
L -Proline 115 40
L-Serine 105 25
L-Threonine 119 48
L-Tryptophan 204 10
L-T yrosine 181 36
L -V aline 117 46
Vitamins
A scorbic Acid 176 50
Biotin 244 0.1
C holine chloride 140 1
D -C alcium  pantothenate 477 1
Folic Acid 441 1
N iacinam ide 122 1
Pyridoxal hydrochloride 204 1
R iboflavin 376 0.1
Thiam ine hydrochloride 337 1
V itam in B12 1355 1.36
i-Inositol 180 2
Inorganic Salts
Calcium  Chloride (CaC l2-2H 20 )  147 264
M agnesium  Sulfate (M g S 0 4) (anhyd .) 120 97.67
Potassium  Chloride (KCI) 75 400
Sodium  Bicarbonate (N a H C 0 3) 84 2200
Sodium Chloride (NaCl) 58 6800
Sodium Phosphate m onobasic 156 158
(N aH 2P 0 4-2H 20 )
Other Components
D -G lucose (D extrose) 180 1000
Lipoic Acid 206 0.2
Phenol Red 376.4 10
Sodium Pyruvate 110 110
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RPMI 1640 MEDIUM
COMPONENTS MW Concentration
(mg/L)
Amino Acids
G lycine 75 10
L-A rginine 174 200
L-A sparagine 132 50
L-Aspartic acid 133 20
L-C ystine 240  20
L-G lutam ic Acid 147 20
L-G lutam ine 146 300
L-H istidine 155 15
L-H ydroxyproline 131 20
L-Isoleucine 131 50
L-Leucine 131 50
L-Lysine hydrochloride 183 40
L-M ethionine 149 15
L-Phenylalanine 165 15
L -Proline 115 20
L-Serine 105 30
L-Threonine 119 20
L-Tryptophan 204  5
L-Tyrosine 181 20
L -V aline 117 20
Vitamins
B iotin 244  0.2
C holine chloride 140 3
D -C alcium  pantothenate 477 0.25
Folic A cid 441 1
N iacinam ide 122 1
Para-A m inobenzoic A cid 137 1
Pyridoxine hydrochloride 206  1
R iboflavin 376 0.2
T hiam ine hydrochloride 337 1
V itam in B12 1355 0.005
i-Inositol 180 35
Inorganic Salts
Calcium  nitrate (C a(N 0 3)2 4H 20 )  236 100
M agnesium  Sulfate (M g S 0 4-7H 20 )  246 100
Potassium  Chloride (KCI) 75 400
Sodium  Bicarbonate (N a H C 0 3) 84 2000
Sodium  C hloride (N aC l) 58 6000
Sodium  Phosphate dibasic (N a2H P 0 4) anhyd. 142 800
Other components
D -G lucose (D extrose) 180 2000
G lutathione (reduced) 307 1
Phenol Red 376.4 5
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DULBECCO’S MODIFIED EAGLE MEDIUM (D-MEM)
COMPONENTS MW Concentration
(mg/L)
Amino Acids
G lycine 75 30
L-A rginine hydrochloride 211 84
L-Cystine 2HC1 313 63
L-G lutam ine 146 580
L-H istidine hyd roch lo ride-H 20  210  42
L -lsoleucine 131 105
L-Leucine 131 105
L-Lysine hydrochloride 183 146
L-M ethionine 149 30
L-Phenylalanine 165 66
L-Serine 105 42
L-Threonine 119 95
L-Tryptophan 204 16
L-Tyrosine 181 72
L-V aline 117 94
Vitamins
C holine chloride 140 4
D -C alcium  pantothenate 477  4
Folic A cid 441 4
N iacinam ide 122 4
Pyridoxine hydrochloride 204 4
R iboflavin 376 0.4
T hiam ine hydrochloride 337 4
i-Inositol 180 7.2
Inorganic Salts
C alcium  Chloride (CaC l2-2H 20 )  147 264
Ferric N itrate (F e (N 0 3)3-9H 20 )  404  0.1
M agnesium  Sulfate (M g S 0 4-7H 20 )  246  200
Potassium  Chloride (KC1) 75 400
Sodium  Bicarbonate (N a H C 0 3) 84 3700
Sodium  Chloride (NaCl) 58 6400
Sodium  Phosphate m onobasic (N aH 2P 0 4-2H 20 )  154 141
Other components
D -G lucose (D extrose) 180 4500
Phenol Red 376.4  15
Sodium  Pyruvate 110 110
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8.3 Supplier details
(Amersham Biosciences) Fisher Scientific UK
GE Healthcare UK Ltd. Bishop Meadow Road
Amersham Place Loughborough
Little Chalfont Leicestershire
Buckinghamshire HP7 9NA LEI 1 5RG
http://www.gelifesciences.com http://www.fisher.co.uk
Phone: 0870 606 1921 Phone: 01509 231166
Fax: 01494 544350 Fax: 01509 231893
Applied Biosystems/Ambion
2130 Woodward St.
Austin, TX 78744-1832 
USA
http://www.ambion.com 
Phone: (+1)512 651-0200 
Fax: (+1)512 651-0190
Axon Instruments Inc.
GRI Ltd 
Gene House 
Queensborough Lane 
Rayne 
Braintree 
Essex CM7 8TF 
Phone: 01376 332900 
Fax: 01376 344724
Gibco , Invitrogen Ltd.
3 Fountain Drive 
Inchinnan Business Park 
Paisley 
UK
PA4 9RF
http://www.invitrogen.com 
Phone: 0141 814 6100 
Fax: 0141 814 6260
Harvard Apparatus, Ltd.
Fircroft Way, Edenbridge 
Kent TN8 6HE 
UK
Phone: 01732 864001
Fax: 01732 863356
http ://www.harvardapparatus.co .uk
Biogene Ltd.
6 The Business Centre 
Harvard Way 
Kimbolton 
Cambridgshire 
PE28 ONJ
http://www.biogene.com 
Phone: 0845 1300 950 
Fax: 0845 1300 960
Bio-Rad Laboratories Ltd.
Bio-Rad House 
Maxted Road 
Hemel Hempstead 
Hertfordshire HP2 7DX 
http://www.bio-rad.co.uk 
Phone: 0800 181134 
Fax: 0208 328 2550
Pierce Biotechnology, Inc.
3747 N. Meridian Rd.
P.O. Box 117 
Rockford, IL 61105 
USA
http://www.piercenet.com 
Phone: (+1)800 874 3723 
Fax: (+1)815 968 7316
Pro meg a UK
Delta House
Southampton Science Park 
Southampton SO 16 7NS 
UK
http://www.promega.com/uk 
Phone: 023 8076 0225 
Fax: 023 8076 7014
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PromoCell GmbH
Sickingenstr. 63/65 
D-69126 Heidelberg 
Germany
http://www.promocell.com 
Phone (UK): 0800 960333 
Fax (UK): 0800 1698554
Sigma-Aid rich Company Ltd.
Fancy Road 
Poole 
Dorset 
BH12 4QH
http://www.sigma-aldrich.com 
Phone: 0800 717181 
Fax: 0800 378785
Tocris Cookson Ltd.
Northpoint 
Fourth Way 
Avonmouth 
Bristol 
BS11 8TA
http://www.tocris.com 
Phone: 0117 916 3333 
Fax: 0117 916 3344
Whatman
GE Healthcare UK Ltd.
Amersham Place 
Little Chalfont 
Buckinghamshire HP7 9NA 
England
http://www.whatman.com 
Phone: 01622 676670 
Fax: 01622 670755
World Precision Instruments
Astonbury Farm Business Centre
Aston
Stevenage
Hertfordshire
SG2 7EG
Phone: 01438 880025 
Fax: 01438 880026
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